JP2023051985A - Composition for young female odor replenishment - Google Patents
Composition for young female odor replenishment Download PDFInfo
- Publication number
- JP2023051985A JP2023051985A JP2022202821A JP2022202821A JP2023051985A JP 2023051985 A JP2023051985 A JP 2023051985A JP 2022202821 A JP2022202821 A JP 2022202821A JP 2022202821 A JP2022202821 A JP 2022202821A JP 2023051985 A JP2023051985 A JP 2023051985A
- Authority
- JP
- Japan
- Prior art keywords
- weight
- odor
- composition
- acid
- aging
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 155
- -1 lactone compound Chemical class 0.000 claims abstract description 118
- 208000035985 Body Odor Diseases 0.000 claims abstract description 104
- 206010040904 Skin odour abnormal Diseases 0.000 claims abstract description 100
- 230000032683 aging Effects 0.000 claims abstract description 42
- 230000003712 anti-aging effect Effects 0.000 claims abstract description 33
- 239000000126 substance Substances 0.000 claims abstract description 27
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 21
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 19
- 230000001502 supplementing effect Effects 0.000 claims abstract description 4
- 238000000034 method Methods 0.000 claims description 18
- 238000012360 testing method Methods 0.000 claims description 18
- 239000004753 textile Substances 0.000 claims description 11
- 230000003716 rejuvenation Effects 0.000 claims description 8
- 238000013513 substance screening Methods 0.000 claims description 5
- 238000012216 screening Methods 0.000 claims description 4
- 235000019645 odor Nutrition 0.000 abstract description 129
- 239000000047 product Substances 0.000 abstract description 16
- 238000011156 evaluation Methods 0.000 abstract description 14
- 239000013589 supplement Substances 0.000 abstract description 5
- 238000009472 formulation Methods 0.000 description 50
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 43
- 235000002639 sodium chloride Nutrition 0.000 description 28
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 27
- 239000003795 chemical substances by application Substances 0.000 description 25
- 150000003839 salts Chemical class 0.000 description 21
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 20
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 20
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 20
- 239000002304 perfume Substances 0.000 description 20
- 239000000843 powder Substances 0.000 description 20
- BSAIUMLZVGUGKX-UHFFFAOYSA-N 2-Nonenal Natural products CCCCCCC=CC=O BSAIUMLZVGUGKX-UHFFFAOYSA-N 0.000 description 18
- 235000014113 dietary fatty acids Nutrition 0.000 description 18
- 229930195729 fatty acid Natural products 0.000 description 18
- 239000000194 fatty acid Substances 0.000 description 18
- 239000004615 ingredient Substances 0.000 description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 18
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 17
- 230000000694 effects Effects 0.000 description 16
- IFYYFLINQYPWGJ-UHFFFAOYSA-N gamma-decalactone Chemical compound CCCCCCC1CCC(=O)O1 IFYYFLINQYPWGJ-UHFFFAOYSA-N 0.000 description 16
- PHXATPHONSXBIL-UHFFFAOYSA-N xi-gamma-Undecalactone Chemical compound CCCCCCCC1CCC(=O)O1 PHXATPHONSXBIL-UHFFFAOYSA-N 0.000 description 16
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 15
- 229920001296 polysiloxane Polymers 0.000 description 15
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 14
- 150000004665 fatty acids Chemical class 0.000 description 13
- 150000002596 lactones Chemical class 0.000 description 13
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 12
- 239000007788 liquid Substances 0.000 description 12
- 108090000765 processed proteins & peptides Proteins 0.000 description 12
- 239000011734 sodium Substances 0.000 description 12
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 11
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 11
- 239000004094 surface-active agent Substances 0.000 description 11
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 10
- 230000007423 decrease Effects 0.000 description 10
- 235000011187 glycerol Nutrition 0.000 description 10
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 10
- 229910052708 sodium Inorganic materials 0.000 description 10
- 229940083542 sodium Drugs 0.000 description 10
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 9
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 9
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 9
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 9
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 9
- 230000001166 anti-perspirative effect Effects 0.000 description 9
- 239000003213 antiperspirant Substances 0.000 description 9
- 235000015165 citric acid Nutrition 0.000 description 9
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 9
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 9
- 229940088594 vitamin Drugs 0.000 description 9
- 229930003231 vitamin Natural products 0.000 description 9
- 235000013343 vitamin Nutrition 0.000 description 9
- 239000011782 vitamin Substances 0.000 description 9
- 229940024606 amino acid Drugs 0.000 description 8
- 235000001014 amino acid Nutrition 0.000 description 8
- 229960000686 benzalkonium chloride Drugs 0.000 description 8
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 8
- 229960003237 betaine Drugs 0.000 description 8
- 235000009508 confectionery Nutrition 0.000 description 8
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 8
- IFYYFLINQYPWGJ-VIFPVBQESA-N gamma-Decalactone Natural products CCCCCC[C@H]1CCC(=O)O1 IFYYFLINQYPWGJ-VIFPVBQESA-N 0.000 description 8
- PHXATPHONSXBIL-JTQLQIEISA-N gamma-Undecalactone Natural products CCCCCCC[C@H]1CCC(=O)O1 PHXATPHONSXBIL-JTQLQIEISA-N 0.000 description 8
- 229940020436 gamma-undecalactone Drugs 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 8
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 8
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 8
- 230000001953 sensory effect Effects 0.000 description 8
- 239000007921 spray Substances 0.000 description 8
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 7
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 7
- 150000001413 amino acids Chemical class 0.000 description 7
- 239000002781 deodorant agent Substances 0.000 description 7
- 229960005323 phenoxyethanol Drugs 0.000 description 7
- 150000005846 sugar alcohols Polymers 0.000 description 7
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 6
- 108010035532 Collagen Proteins 0.000 description 6
- 102000008186 Collagen Human genes 0.000 description 6
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 6
- 229910019142 PO4 Inorganic materials 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 6
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 6
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 6
- 235000010323 ascorbic acid Nutrition 0.000 description 6
- 239000011668 ascorbic acid Substances 0.000 description 6
- 239000002585 base Substances 0.000 description 6
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 6
- 239000004359 castor oil Substances 0.000 description 6
- 235000019438 castor oil Nutrition 0.000 description 6
- 229920001436 collagen Polymers 0.000 description 6
- 238000007796 conventional method Methods 0.000 description 6
- 230000003247 decreasing effect Effects 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 6
- 150000007524 organic acids Chemical class 0.000 description 6
- 239000010452 phosphate Substances 0.000 description 6
- 102000004196 processed proteins & peptides Human genes 0.000 description 6
- 239000002453 shampoo Substances 0.000 description 6
- 239000000344 soap Substances 0.000 description 6
- 239000000454 talc Substances 0.000 description 6
- 229910052623 talc Inorganic materials 0.000 description 6
- 235000019157 thiamine Nutrition 0.000 description 6
- 239000011721 thiamine Substances 0.000 description 6
- 229960003495 thiamine Drugs 0.000 description 6
- 239000002562 thickening agent Substances 0.000 description 6
- 229920002554 vinyl polymer Polymers 0.000 description 6
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 5
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 5
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 5
- 235000013162 Cocos nucifera Nutrition 0.000 description 5
- 244000060011 Cocos nucifera Species 0.000 description 5
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 5
- 229920001214 Polysorbate 60 Polymers 0.000 description 5
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 5
- 229920002125 Sokalan® Polymers 0.000 description 5
- 239000000654 additive Substances 0.000 description 5
- 229960000458 allantoin Drugs 0.000 description 5
- 150000001412 amines Chemical class 0.000 description 5
- 239000003240 coconut oil Substances 0.000 description 5
- 235000019864 coconut oil Nutrition 0.000 description 5
- 229920001577 copolymer Polymers 0.000 description 5
- 150000002148 esters Chemical class 0.000 description 5
- 229920002674 hyaluronan Polymers 0.000 description 5
- 229960003160 hyaluronic acid Drugs 0.000 description 5
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 5
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 5
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 5
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 5
- 235000014655 lactic acid Nutrition 0.000 description 5
- 239000004310 lactic acid Substances 0.000 description 5
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 5
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 5
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 5
- BSAIUMLZVGUGKX-BQYQJAHWSA-N (E)-non-2-enal Chemical compound CCCCCC\C=C\C=O BSAIUMLZVGUGKX-BQYQJAHWSA-N 0.000 description 4
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 4
- OALYTRUKMRCXNH-UHFFFAOYSA-N 5-pentyloxolan-2-one Chemical compound CCCCCC1CCC(=O)O1 OALYTRUKMRCXNH-UHFFFAOYSA-N 0.000 description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 4
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 4
- VLSVVMPLPMNWBH-UHFFFAOYSA-N Dihydro-5-propyl-2(3H)-furanone Chemical compound CCCC1CCC(=O)O1 VLSVVMPLPMNWBH-UHFFFAOYSA-N 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 4
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 4
- 108010076876 Keratins Proteins 0.000 description 4
- 102000011782 Keratins Human genes 0.000 description 4
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 4
- 239000004677 Nylon Substances 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- 235000009827 Prunus armeniaca Nutrition 0.000 description 4
- 244000018633 Prunus armeniaca Species 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 4
- 229920002472 Starch Polymers 0.000 description 4
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 4
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 150000001298 alcohols Chemical class 0.000 description 4
- 150000001299 aldehydes Chemical class 0.000 description 4
- 239000002280 amphoteric surfactant Substances 0.000 description 4
- 229960005070 ascorbic acid Drugs 0.000 description 4
- CUFNKYGDVFVPHO-UHFFFAOYSA-N azulene Chemical compound C1=CC=CC2=CC=CC2=C1 CUFNKYGDVFVPHO-UHFFFAOYSA-N 0.000 description 4
- 235000019437 butane-1,3-diol Nutrition 0.000 description 4
- 229960000541 cetyl alcohol Drugs 0.000 description 4
- 239000003610 charcoal Substances 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 239000003599 detergent Substances 0.000 description 4
- 229940105990 diglycerin Drugs 0.000 description 4
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 4
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 4
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 239000004744 fabric Substances 0.000 description 4
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 4
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 4
- 239000006210 lotion Substances 0.000 description 4
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 4
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 4
- 229920001778 nylon Polymers 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 235000019198 oils Nutrition 0.000 description 4
- 239000003002 pH adjusting agent Substances 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- 229960004889 salicylic acid Drugs 0.000 description 4
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 4
- 235000012239 silicon dioxide Nutrition 0.000 description 4
- 229920002545 silicone oil Polymers 0.000 description 4
- 239000000600 sorbitol Substances 0.000 description 4
- 235000010356 sorbitol Nutrition 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- 239000008107 starch Substances 0.000 description 4
- 235000019698 starch Nutrition 0.000 description 4
- 229940012831 stearyl alcohol Drugs 0.000 description 4
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 4
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 4
- ZNVKGUVDRSSWHV-UHFFFAOYSA-L zinc;4-hydroxybenzenesulfonate Chemical compound [Zn+2].OC1=CC=C(S([O-])(=O)=O)C=C1.OC1=CC=C(S([O-])(=O)=O)C=C1 ZNVKGUVDRSSWHV-UHFFFAOYSA-L 0.000 description 4
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 3
- UIVPNOBLHXUKDX-UHFFFAOYSA-N 3,5,5-trimethylhexyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CCOC(=O)CC(C)CC(C)(C)C UIVPNOBLHXUKDX-UHFFFAOYSA-N 0.000 description 3
- XPFCZYUVICHKDS-UHFFFAOYSA-N 3-methylbutane-1,3-diol Chemical compound CC(C)(O)CCO XPFCZYUVICHKDS-UHFFFAOYSA-N 0.000 description 3
- GUOCOOQWZHQBJI-UHFFFAOYSA-N 4-oct-7-enoxy-4-oxobutanoic acid Chemical compound OC(=O)CCC(=O)OCCCCCCC=C GUOCOOQWZHQBJI-UHFFFAOYSA-N 0.000 description 3
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 3
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 3
- 239000004386 Erythritol Substances 0.000 description 3
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 3
- 239000001856 Ethyl cellulose Substances 0.000 description 3
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 3
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 3
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 3
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 3
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 3
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 3
- 229930195725 Mannitol Natural products 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- 239000004698 Polyethylene Substances 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- 239000004372 Polyvinyl alcohol Substances 0.000 description 3
- 235000021307 Triticum Nutrition 0.000 description 3
- 244000098338 Triticum aestivum Species 0.000 description 3
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 3
- 229910052782 aluminium Inorganic materials 0.000 description 3
- 229960002684 aminocaproic acid Drugs 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 235000003704 aspartic acid Nutrition 0.000 description 3
- 229960005261 aspartic acid Drugs 0.000 description 3
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 229940082500 cetostearyl alcohol Drugs 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 229940008099 dimethicone Drugs 0.000 description 3
- 239000004205 dimethyl polysiloxane Substances 0.000 description 3
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 3
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 3
- 229940009714 erythritol Drugs 0.000 description 3
- 235000019414 erythritol Nutrition 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- 235000019325 ethyl cellulose Nutrition 0.000 description 3
- 229920001249 ethyl cellulose Polymers 0.000 description 3
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 3
- 235000019152 folic acid Nutrition 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 239000000174 gluconic acid Substances 0.000 description 3
- 235000012208 gluconic acid Nutrition 0.000 description 3
- 239000004220 glutamic acid Substances 0.000 description 3
- 235000013922 glutamic acid Nutrition 0.000 description 3
- 229930182470 glycoside Natural products 0.000 description 3
- 150000002338 glycosides Chemical class 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 229940093915 gynecological organic acid Drugs 0.000 description 3
- ACCCMOQWYVYDOT-UHFFFAOYSA-N hexane-1,1-diol Chemical compound CCCCCC(O)O ACCCMOQWYVYDOT-UHFFFAOYSA-N 0.000 description 3
- 229930195733 hydrocarbon Natural products 0.000 description 3
- 150000002430 hydrocarbons Chemical class 0.000 description 3
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 3
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 3
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 3
- 229940100554 isononyl isononanoate Drugs 0.000 description 3
- 229940057995 liquid paraffin Drugs 0.000 description 3
- 239000000594 mannitol Substances 0.000 description 3
- 235000010355 mannitol Nutrition 0.000 description 3
- 229960001855 mannitol Drugs 0.000 description 3
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 3
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 230000003020 moisturizing effect Effects 0.000 description 3
- 239000002736 nonionic surfactant Substances 0.000 description 3
- 235000005985 organic acids Nutrition 0.000 description 3
- 235000019161 pantothenic acid Nutrition 0.000 description 3
- UWJJYHHHVWZFEP-UHFFFAOYSA-N pentane-1,1-diol Chemical compound CCCCC(O)O UWJJYHHHVWZFEP-UHFFFAOYSA-N 0.000 description 3
- 235000019477 peppermint oil Nutrition 0.000 description 3
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 3
- 229920000573 polyethylene Polymers 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 229920002451 polyvinyl alcohol Polymers 0.000 description 3
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 230000002797 proteolythic effect Effects 0.000 description 3
- 229940057950 sodium laureth sulfate Drugs 0.000 description 3
- SXHLENDCVBIJFO-UHFFFAOYSA-M sodium;2-[2-(2-dodecoxyethoxy)ethoxy]ethyl sulfate Chemical compound [Na+].CCCCCCCCCCCCOCCOCCOCCOS([O-])(=O)=O SXHLENDCVBIJFO-UHFFFAOYSA-M 0.000 description 3
- 229960002920 sorbitol Drugs 0.000 description 3
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 3
- 235000020955 thiamine monophosphate Nutrition 0.000 description 3
- 239000011621 thiamine monophosphate Substances 0.000 description 3
- IWLROWZYZPNOFC-UHFFFAOYSA-O thiamine triphosphate Chemical compound CC1=C(CCOP(O)(=O)OP(O)(=O)OP(O)(O)=O)SC=[N+]1CC1=CN=C(C)N=C1N IWLROWZYZPNOFC-UHFFFAOYSA-O 0.000 description 3
- GUGWNSHJDUEHNJ-UHFFFAOYSA-N thiamine(1+) monophosphate chloride Chemical compound [Cl-].CC1=C(CCOP(O)(O)=O)SC=[N+]1CC1=CN=C(C)N=C1N GUGWNSHJDUEHNJ-UHFFFAOYSA-N 0.000 description 3
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 3
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 3
- 239000001993 wax Substances 0.000 description 3
- 239000000811 xylitol Substances 0.000 description 3
- 235000010447 xylitol Nutrition 0.000 description 3
- 229960002675 xylitol Drugs 0.000 description 3
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 3
- 239000011787 zinc oxide Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 description 2
- 239000001730 (5R)-5-butyloxolan-2-one Substances 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical compound CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 2
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- LVYLCBNXHHHPSB-UHFFFAOYSA-N 2-hydroxyethyl salicylate Chemical compound OCCOC(=O)C1=CC=CC=C1O LVYLCBNXHHHPSB-UHFFFAOYSA-N 0.000 description 2
- WGPCZPLRVAWXPW-NSHDSACASA-N 5-octyloxolan-2-one Chemical compound CCCCCCCC[C@H]1CCC(=O)O1 WGPCZPLRVAWXPW-NSHDSACASA-N 0.000 description 2
- 239000005995 Aluminium silicate Substances 0.000 description 2
- 244000144730 Amygdalus persica Species 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 2
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- 235000007866 Chamaemelum nobile Nutrition 0.000 description 2
- 240000003538 Chamaemelum nobile Species 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- 229920002261 Corn starch Polymers 0.000 description 2
- 235000009917 Crataegus X brevipes Nutrition 0.000 description 2
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 description 2
- 235000009685 Crataegus X maligna Nutrition 0.000 description 2
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 description 2
- 235000009486 Crataegus bullatus Nutrition 0.000 description 2
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 description 2
- 235000009682 Crataegus limnophila Nutrition 0.000 description 2
- 235000004423 Crataegus monogyna Nutrition 0.000 description 2
- 240000000171 Crataegus monogyna Species 0.000 description 2
- 235000002313 Crataegus paludosa Nutrition 0.000 description 2
- 235000009840 Crataegus x incaedua Nutrition 0.000 description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 2
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 2
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 2
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical class [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 102000016942 Elastin Human genes 0.000 description 2
- 108010014258 Elastin Proteins 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 2
- FWKQNCXZGNBPFD-UHFFFAOYSA-N Guaiazulene Chemical compound CC(C)C1=CC=C(C)C2=CC=C(C)C2=C1 FWKQNCXZGNBPFD-UHFFFAOYSA-N 0.000 description 2
- 229920002907 Guar gum Polymers 0.000 description 2
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 240000007049 Juglans regia Species 0.000 description 2
- 235000009496 Juglans regia Nutrition 0.000 description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 2
- 239000005639 Lauric acid Substances 0.000 description 2
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 235000021314 Palmitic acid Nutrition 0.000 description 2
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 2
- 241000218657 Picea Species 0.000 description 2
- 229920001213 Polysorbate 20 Polymers 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 2
- 235000006040 Prunus persica var persica Nutrition 0.000 description 2
- RADKZDMFGJYCBB-UHFFFAOYSA-N Pyridoxal Chemical compound CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229920002385 Sodium hyaluronate Polymers 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- MSCCTZZBYHQMQJ-AZAGJHQNSA-N Tocopheryl nicotinate Chemical compound C([C@@](OC1=C(C)C=2C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CC1=C(C)C=2OC(=O)C1=CC=CN=C1 MSCCTZZBYHQMQJ-AZAGJHQNSA-N 0.000 description 2
- QVFOGJXHRGAFSH-UHFFFAOYSA-N acetic acid;1-dodecoxydodecane Chemical compound CC(O)=O.CCCCCCCCCCCCOCCCCCCCCCCCC QVFOGJXHRGAFSH-UHFFFAOYSA-N 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 2
- 125000003342 alkenyl group Chemical group 0.000 description 2
- 150000005215 alkyl ethers Chemical class 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 235000012211 aluminium silicate Nutrition 0.000 description 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 150000003863 ammonium salts Chemical class 0.000 description 2
- 239000003945 anionic surfactant Substances 0.000 description 2
- 229940121363 anti-inflammatory agent Drugs 0.000 description 2
- 239000002260 anti-inflammatory agent Substances 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
- 229960003121 arginine Drugs 0.000 description 2
- 229940072107 ascorbate Drugs 0.000 description 2
- 239000003899 bactericide agent Substances 0.000 description 2
- 238000003287 bathing Methods 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- KVYGGMBOZFWZBQ-UHFFFAOYSA-N benzyl nicotinate Chemical compound C=1C=CN=CC=1C(=O)OCC1=CC=CC=C1 KVYGGMBOZFWZBQ-UHFFFAOYSA-N 0.000 description 2
- UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-alanine Chemical compound NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 2
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 2
- 239000004204 candelilla wax Substances 0.000 description 2
- 235000013868 candelilla wax Nutrition 0.000 description 2
- 229940073532 candelilla wax Drugs 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 229920003064 carboxyethyl cellulose Polymers 0.000 description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 2
- 235000010418 carrageenan Nutrition 0.000 description 2
- 229920001525 carrageenan Polymers 0.000 description 2
- 239000000679 carrageenan Substances 0.000 description 2
- 229940113118 carrageenan Drugs 0.000 description 2
- 239000003093 cationic surfactant Substances 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 239000002738 chelating agent Substances 0.000 description 2
- 239000003638 chemical reducing agent Substances 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 230000002508 compound effect Effects 0.000 description 2
- 239000002826 coolant Substances 0.000 description 2
- 239000008120 corn starch Substances 0.000 description 2
- 229940099112 cornstarch Drugs 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 description 2
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 description 2
- PGRHXDWITVMQBC-UHFFFAOYSA-N dehydroacetic acid Chemical compound CC(=O)C1C(=O)OC(C)=CC1=O PGRHXDWITVMQBC-UHFFFAOYSA-N 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- XXJWXESWEXIICW-UHFFFAOYSA-N diethylene glycol monoethyl ether Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 description 2
- 229940075557 diethylene glycol monoethyl ether Drugs 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 231100000676 disease causative agent Toxicity 0.000 description 2
- 239000002270 dispersing agent Substances 0.000 description 2
- 229960000735 docosanol Drugs 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 229920002549 elastin Polymers 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 229960003720 enoxolone Drugs 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- FVTCRASFADXXNN-SCRDCRAPSA-N flavin mononucleotide Chemical compound OP(=O)(O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O FVTCRASFADXXNN-SCRDCRAPSA-N 0.000 description 2
- 229960000304 folic acid Drugs 0.000 description 2
- 239000011724 folic acid Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 2
- WGPCZPLRVAWXPW-LLVKDONJSA-N gamma-Dodecalactone Natural products CCCCCCCC[C@@H]1CCC(=O)O1 WGPCZPLRVAWXPW-LLVKDONJSA-N 0.000 description 2
- OALYTRUKMRCXNH-QMMMGPOBSA-N gamma-Nonalactone Natural products CCCCC[C@H]1CCC(=O)O1 OALYTRUKMRCXNH-QMMMGPOBSA-N 0.000 description 2
- FODTZLFLDFKIQH-FSVGXZBPSA-N gamma-Oryzanol (TN) Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)O[C@@H]2C([C@@H]3CC[C@H]4[C@]5(C)CC[C@@H]([C@@]5(C)CC[C@@]54C[C@@]53CC2)[C@H](C)CCC=C(C)C)(C)C)=C1 FODTZLFLDFKIQH-FSVGXZBPSA-N 0.000 description 2
- JBFHTYHTHYHCDJ-UHFFFAOYSA-N gamma-caprolactone Chemical compound CCC1CCC(=O)O1 JBFHTYHTHYHCDJ-UHFFFAOYSA-N 0.000 description 2
- 125000000457 gamma-lactone group Chemical group 0.000 description 2
- IPBFYZQJXZJBFQ-UHFFFAOYSA-N gamma-octalactone Chemical compound CCCCC1CCC(=O)O1 IPBFYZQJXZJBFQ-UHFFFAOYSA-N 0.000 description 2
- GAEKPEKOJKCEMS-UHFFFAOYSA-N gamma-valerolactone Chemical compound CC1CCC(=O)O1 GAEKPEKOJKCEMS-UHFFFAOYSA-N 0.000 description 2
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 2
- 239000001685 glycyrrhizic acid Substances 0.000 description 2
- 229960004949 glycyrrhizic acid Drugs 0.000 description 2
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 2
- 235000019410 glycyrrhizin Nutrition 0.000 description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 2
- 235000010417 guar gum Nutrition 0.000 description 2
- 239000000665 guar gum Substances 0.000 description 2
- 229960002154 guar gum Drugs 0.000 description 2
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- YOZNUFWCRFCGIH-BYFNXCQMSA-L hydroxocobalamin Chemical compound O[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O YOZNUFWCRFCGIH-BYFNXCQMSA-L 0.000 description 2
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 2
- 229920003063 hydroxymethyl cellulose Polymers 0.000 description 2
- 229940031574 hydroxymethyl cellulose Drugs 0.000 description 2
- 150000007529 inorganic bases Chemical class 0.000 description 2
- 150000002484 inorganic compounds Chemical class 0.000 description 2
- 229910010272 inorganic material Inorganic materials 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- 229940119170 jojoba wax Drugs 0.000 description 2
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- 239000003915 liquefied petroleum gas Substances 0.000 description 2
- 239000002932 luster Substances 0.000 description 2
- 229940078752 magnesium ascorbyl phosphate Drugs 0.000 description 2
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 2
- 239000011976 maleic acid Substances 0.000 description 2
- 239000001630 malic acid Substances 0.000 description 2
- 235000011090 malic acid Nutrition 0.000 description 2
- 230000000873 masking effect Effects 0.000 description 2
- 229940041616 menthol Drugs 0.000 description 2
- 229940098779 methanesulfonic acid Drugs 0.000 description 2
- 229920000609 methyl cellulose Polymers 0.000 description 2
- YNBADRVTZLEFNH-UHFFFAOYSA-N methyl nicotinate Chemical compound COC(=O)C1=CC=CN=C1 YNBADRVTZLEFNH-UHFFFAOYSA-N 0.000 description 2
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 2
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 2
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 2
- 235000010981 methylcellulose Nutrition 0.000 description 2
- 239000001923 methylcellulose Substances 0.000 description 2
- 229960002216 methylparaben Drugs 0.000 description 2
- 239000010445 mica Substances 0.000 description 2
- 229910052618 mica group Inorganic materials 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- 235000001968 nicotinic acid Nutrition 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- OEIJHBUUFURJLI-UHFFFAOYSA-N octane-1,8-diol Chemical compound OCCCCCCCCO OEIJHBUUFURJLI-UHFFFAOYSA-N 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 150000007530 organic bases Chemical class 0.000 description 2
- SECPZKHBENQXJG-FPLPWBNLSA-N palmitoleic acid Chemical compound CCCCCC\C=C/CCCCCCCC(O)=O SECPZKHBENQXJG-FPLPWBNLSA-N 0.000 description 2
- 150000002948 pantothenic acids Chemical class 0.000 description 2
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 2
- 239000003504 photosensitizing agent Substances 0.000 description 2
- 235000002949 phytic acid Nutrition 0.000 description 2
- 239000000467 phytic acid Substances 0.000 description 2
- 229940068041 phytic acid Drugs 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2
- 229920001451 polypropylene glycol Polymers 0.000 description 2
- 229920000053 polysorbate 80 Polymers 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 2
- 235000019192 riboflavin Nutrition 0.000 description 2
- 229960002477 riboflavin Drugs 0.000 description 2
- 239000002151 riboflavin Substances 0.000 description 2
- 238000005201 scrubbing Methods 0.000 description 2
- 210000002374 sebum Anatomy 0.000 description 2
- 229940010747 sodium hyaluronate Drugs 0.000 description 2
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 2
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 2
- FWFUWXVFYKCSQA-UHFFFAOYSA-M sodium;2-methyl-2-(prop-2-enoylamino)propane-1-sulfonate Chemical compound [Na+].[O-]S(=O)(=O)CC(C)(C)NC(=O)C=C FWFUWXVFYKCSQA-UHFFFAOYSA-M 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 210000004243 sweat Anatomy 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 235000018553 tannin Nutrition 0.000 description 2
- 229920001864 tannin Polymers 0.000 description 2
- 239000001648 tannin Substances 0.000 description 2
- 235000013616 tea Nutrition 0.000 description 2
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 2
- 235000008170 thiamine pyrophosphate Nutrition 0.000 description 2
- 239000011678 thiamine pyrophosphate Substances 0.000 description 2
- YXVCLPJQTZXJLH-UHFFFAOYSA-N thiamine(1+) diphosphate chloride Chemical compound [Cl-].CC1=C(CCOP(O)(=O)OP(O)(O)=O)SC=[N+]1CC1=CN=C(C)N=C1N YXVCLPJQTZXJLH-UHFFFAOYSA-N 0.000 description 2
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 2
- 235000010384 tocopherol Nutrition 0.000 description 2
- 229960001295 tocopherol Drugs 0.000 description 2
- 229930003799 tocopherol Natural products 0.000 description 2
- 239000011732 tocopherol Substances 0.000 description 2
- RUVINXPYWBROJD-ONEGZZNKSA-N trans-anethole Chemical compound COC1=CC=C(\C=C\C)C=C1 RUVINXPYWBROJD-ONEGZZNKSA-N 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- HTJNEBVCZXHBNJ-XCTPRCOBSA-H trimagnesium;(2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;diphosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O HTJNEBVCZXHBNJ-XCTPRCOBSA-H 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 235000020234 walnut Nutrition 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 230000002087 whitening effect Effects 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- DNIAPMSPPWPWGF-VKHMYHEASA-N (+)-propylene glycol Chemical compound C[C@H](O)CO DNIAPMSPPWPWGF-VKHMYHEASA-N 0.000 description 1
- JYVXNLLUYHCIIH-UHFFFAOYSA-N (+/-)-mevalonolactone Natural products CC1(O)CCOC(=O)C1 JYVXNLLUYHCIIH-UHFFFAOYSA-N 0.000 description 1
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- MRAMPOPITCOOIN-VIFPVBQESA-N (2r)-n-(3-ethoxypropyl)-2,4-dihydroxy-3,3-dimethylbutanamide Chemical compound CCOCCCNC(=O)[C@H](O)C(C)(C)CO MRAMPOPITCOOIN-VIFPVBQESA-N 0.000 description 1
- OAJLVMGLJZXSGX-CXGXMSGESA-L (2r,3r,4s,5r)-2-(6-aminopurin-9-yl)-5-methanidyloxolane-3,4-diol;cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[(4z,9z,14z)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8 Chemical compound [Co+3].O[C@@H]1[C@H](O)[C@@H]([CH2-])O[C@H]1N1C2=NC=NC(N)=C2N=C1.O([C@H]1[C@H]([C@H](O[C@@H]1CO)N1C2=CC(C)=C(C)C=C2N=C1)O)P([O-])(=O)OC(C)CNC(=O)CCC1(C)C(CC(N)=O)C2[N-]\C1=C(C)/C(C(C\1(C)C)CCC(N)=O)=N/C/1=C\C(C(C/1(CC(N)=O)C)CCC(N)=O)=N\C\1=C(C)/C1=NC2(C)C(C)(CC(N)=O)C1CCC(N)=O OAJLVMGLJZXSGX-CXGXMSGESA-L 0.000 description 1
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 1
- MFYAQFYIDXXKQG-MLCQCVOFSA-N (2s)-2-[[(2s)-4-amino-2-[[(2s)-2-[[(2s)-2-(hexadecanoylamino)-3-hydroxypropanoyl]amino]-3-hydroxypropanoyl]amino]-4-oxobutanoyl]amino]propanoic acid Chemical compound CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(O)=O MFYAQFYIDXXKQG-MLCQCVOFSA-N 0.000 description 1
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 1
- OMSJCIOTCFHSIT-MXYBEHONSA-N (3s,3ar,6s,6as)-3,6,6a-trihydroxy-6-(1h-indol-3-ylmethyl)-3,3a-dihydro-2h-furo[3,2-b]furan-5-one Chemical compound C1=CC=C2C(C[C@@]3(O)C(=O)O[C@H]4[C@]3(O)OC[C@@H]4O)=CNC2=C1 OMSJCIOTCFHSIT-MXYBEHONSA-N 0.000 description 1
- KAKVFSYQVNHFBS-UHFFFAOYSA-N (5-hydroxycyclopenten-1-yl)-phenylmethanone Chemical compound OC1CCC=C1C(=O)C1=CC=CC=C1 KAKVFSYQVNHFBS-UHFFFAOYSA-N 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 description 1
- PSBDWGZCVUAZQS-UHFFFAOYSA-N (dimethylsulfonio)acetate Chemical compound C[S+](C)CC([O-])=O PSBDWGZCVUAZQS-UHFFFAOYSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-propanediol Substances OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- QWOZZTWBWQMEPD-UHFFFAOYSA-N 1-(2-ethoxypropoxy)propan-2-ol Chemical compound CCOC(C)COCC(C)O QWOZZTWBWQMEPD-UHFFFAOYSA-N 0.000 description 1
- VUICSPKQAQGLBU-UHFFFAOYSA-N 1-(4-methylphenyl)ethyl pyridine-3-carboxylate Chemical compound C=1C=C(C)C=CC=1C(C)OC(=O)C1=CC=CN=C1 VUICSPKQAQGLBU-UHFFFAOYSA-N 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 1
- YAYNEUUHHLGGAH-UHFFFAOYSA-N 1-chlorododecane Chemical compound CCCCCCCCCCCCCl YAYNEUUHHLGGAH-UHFFFAOYSA-N 0.000 description 1
- CLWAXFZCVYJLLM-UHFFFAOYSA-N 1-chlorohexadecane Chemical compound CCCCCCCCCCCCCCCCCl CLWAXFZCVYJLLM-UHFFFAOYSA-N 0.000 description 1
- CPKVUHPKYQGHMW-UHFFFAOYSA-N 1-ethenylpyrrolidin-2-one;molecular iodine Chemical compound II.C=CN1CCCC1=O CPKVUHPKYQGHMW-UHFFFAOYSA-N 0.000 description 1
- JOLQKTGDSGKSKJ-UHFFFAOYSA-N 1-ethoxypropan-2-ol Chemical compound CCOCC(C)O JOLQKTGDSGKSKJ-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- RECMXJOGNNTEBG-UHFFFAOYSA-N 1-phenylmethoxyethanol Chemical compound CC(O)OCC1=CC=CC=C1 RECMXJOGNNTEBG-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- DJCYDDALXPHSHR-UHFFFAOYSA-N 2-(2-propoxyethoxy)ethanol Chemical compound CCCOCCOCCO DJCYDDALXPHSHR-UHFFFAOYSA-N 0.000 description 1
- XYVAYAJYLWYJJN-UHFFFAOYSA-N 2-(2-propoxypropoxy)propan-1-ol Chemical compound CCCOC(C)COC(C)CO XYVAYAJYLWYJJN-UHFFFAOYSA-N 0.000 description 1
- FLPJVCMIKUWSDR-UHFFFAOYSA-N 2-(4-formylphenoxy)acetamide Chemical compound NC(=O)COC1=CC=C(C=O)C=C1 FLPJVCMIKUWSDR-UHFFFAOYSA-N 0.000 description 1
- FKOKUHFZNIUSLW-UHFFFAOYSA-N 2-Hydroxypropyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(C)O FKOKUHFZNIUSLW-UHFFFAOYSA-N 0.000 description 1
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 1
- PFRQBZFETXBLTP-RCIYGOBDSA-N 2-[(2e,6e,10e,14e,18e)-3,7,11,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaen-1-yl]-3-methyl-1,4-dihydronaphthalene-1,4-dione Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CC/C=C(C)/CC/C=C(C)/CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)=C(C)C(=O)C2=C1 PFRQBZFETXBLTP-RCIYGOBDSA-N 0.000 description 1
- YBRJTUFWBLSLHY-UHFFFAOYSA-N 2-[2-(2-octadecanoyloxyethoxy)ethoxy]ethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOCCOCCOC(=O)CCCCCCCCCCCCCCCCC YBRJTUFWBLSLHY-UHFFFAOYSA-N 0.000 description 1
- UHDPBLMLEMNPKP-UHFFFAOYSA-M 2-[3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-4-methyl-1,3-thiazol-3-ium-5-yl]ethanol thiocyanate Chemical compound [S-]C#N.CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N UHDPBLMLEMNPKP-UHFFFAOYSA-M 0.000 description 1
- POAOYUHQDCAZBD-UHFFFAOYSA-N 2-butoxyethanol Chemical compound CCCCOCCO POAOYUHQDCAZBD-UHFFFAOYSA-N 0.000 description 1
- TWJNQYPJQDRXPH-UHFFFAOYSA-N 2-cyanobenzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C#N TWJNQYPJQDRXPH-UHFFFAOYSA-N 0.000 description 1
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 description 1
- JGUMTYWKIBJSTN-UHFFFAOYSA-N 2-ethylhexyl 4-[[4,6-bis[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 JGUMTYWKIBJSTN-UHFFFAOYSA-N 0.000 description 1
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 1
- OMIGHNLMNHATMP-UHFFFAOYSA-N 2-hydroxyethyl prop-2-enoate Chemical compound OCCOC(=O)C=C OMIGHNLMNHATMP-UHFFFAOYSA-N 0.000 description 1
- QTWJRLJHJPIABL-UHFFFAOYSA-N 2-methylphenol;3-methylphenol;4-methylphenol Chemical compound CC1=CC=C(O)C=C1.CC1=CC=CC(O)=C1.CC1=CC=CC=C1O QTWJRLJHJPIABL-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 1
- YEYKMVJDLWJFOA-UHFFFAOYSA-N 2-propoxyethanol Chemical compound CCCOCCO YEYKMVJDLWJFOA-UHFFFAOYSA-N 0.000 description 1
- JAUFWPNLLLUYNV-UHFFFAOYSA-N 3-(16-methylheptadecoxy)propane-1,2-diol Chemical compound CC(C)CCCCCCCCCCCCCCCOCC(O)CO JAUFWPNLLLUYNV-UHFFFAOYSA-N 0.000 description 1
- OTTPFCJTQXRWHO-UHFFFAOYSA-N 3-(2,3-dichloroanilino)cyclohex-2-en-1-one Chemical compound ClC1=CC=CC(NC=2CCCC(=O)C=2)=C1Cl OTTPFCJTQXRWHO-UHFFFAOYSA-N 0.000 description 1
- RPZXOTMHMSORAD-UHFFFAOYSA-N 3-(5-benzylidene-3-methoxy-2,4-dioxoimidazolidin-1-yl)-2-methoxypropanoic acid Chemical compound COC(C(O)=O)CN1C(=O)N(OC)C(=O)C1=CC1=CC=CC=C1 RPZXOTMHMSORAD-UHFFFAOYSA-N 0.000 description 1
- ZGSCRDSBTNQPMS-UJURSFKZSA-N 3-O-Ethylascorbic acid Chemical compound CCOC1=C(O)C(=O)O[C@@H]1[C@@H](O)CO ZGSCRDSBTNQPMS-UJURSFKZSA-N 0.000 description 1
- IXOCGRPBILEGOX-UHFFFAOYSA-N 3-[3-(dodecanoylamino)propyl-dimethylazaniumyl]-2-hydroxypropane-1-sulfonate Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC(O)CS([O-])(=O)=O IXOCGRPBILEGOX-UHFFFAOYSA-N 0.000 description 1
- DDGPBVIAYDDWDH-UHFFFAOYSA-N 3-[dodecyl(dimethyl)azaniumyl]-2-hydroxypropane-1-sulfonate Chemical compound CCCCCCCCCCCC[N+](C)(C)CC(O)CS([O-])(=O)=O DDGPBVIAYDDWDH-UHFFFAOYSA-N 0.000 description 1
- RIAJTMUAPNIDSS-UHFFFAOYSA-N 3-aminopropan-1-ol;hydron;chloride Chemical compound Cl.NCCCO RIAJTMUAPNIDSS-UHFFFAOYSA-N 0.000 description 1
- 229940120145 3-o-ethylascorbic acid Drugs 0.000 description 1
- LDMRLRNXHLPZJN-UHFFFAOYSA-N 3-propoxypropan-1-ol Chemical compound CCCOCCCO LDMRLRNXHLPZJN-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- NMUKKQFFBNEVJY-UHFFFAOYSA-K 4-O-bis[(4-oct-1-enoxy-4-oxobutanoyl)oxy]alumanyl 1-O-oct-1-enyl butanedioate Chemical compound [Al+3].CCCCCCC=COC(=O)CCC([O-])=O.CCCCCCC=COC(=O)CCC([O-])=O.CCCCCCC=COC(=O)CCC([O-])=O NMUKKQFFBNEVJY-UHFFFAOYSA-K 0.000 description 1
- HBTAOSGHCXUEKI-UHFFFAOYSA-N 4-chloro-n,n-dimethyl-3-nitrobenzenesulfonamide Chemical compound CN(C)S(=O)(=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 HBTAOSGHCXUEKI-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- 229940090248 4-hydroxybenzoic acid Drugs 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- XZIIFPSPUDAGJM-UHFFFAOYSA-N 6-chloro-2-n,2-n-diethylpyrimidine-2,4-diamine Chemical compound CCN(CC)C1=NC(N)=CC(Cl)=N1 XZIIFPSPUDAGJM-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- IYLLULUTZPKQBW-UHFFFAOYSA-N Acrinol Chemical compound CC(O)C(O)=O.C1=C(N)C=CC2=C(N)C3=CC(OCC)=CC=C3N=C21 IYLLULUTZPKQBW-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 240000002234 Allium sativum Species 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 235000011437 Amygdalus communis Nutrition 0.000 description 1
- 241001105098 Angelica keiskei Species 0.000 description 1
- 241000086254 Arnica montana Species 0.000 description 1
- OMSJCIOTCFHSIT-UHFFFAOYSA-N Ascorbigen A Natural products C1=CC=C2C(CC3(O)C(=O)OC4C3(O)OCC4O)=CNC2=C1 OMSJCIOTCFHSIT-UHFFFAOYSA-N 0.000 description 1
- 239000004261 Ascorbyl stearate Substances 0.000 description 1
- LITUBCVUXPBCGA-WMZHIEFXSA-N Ascorbyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O LITUBCVUXPBCGA-WMZHIEFXSA-N 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 229940123208 Biguanide Drugs 0.000 description 1
- 241000167854 Bourreria succulenta Species 0.000 description 1
- FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 description 1
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
- BYUQATUKPXLFLZ-UIOOFZCWSA-N CCCCCCCCCCCCCCCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(O)=O)CC1=CN=CN1 Chemical compound CCCCCCCCCCCCCCCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(O)=O)CC1=CN=CN1 BYUQATUKPXLFLZ-UIOOFZCWSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000131283 Cantharis Species 0.000 description 1
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 1
- 235000002568 Capsicum frutescens Nutrition 0.000 description 1
- 235000014653 Carica parviflora Nutrition 0.000 description 1
- 244000132059 Carica parviflora Species 0.000 description 1
- QRYRORQUOLYVBU-VBKZILBWSA-N Carnosic acid Natural products CC([C@@H]1CC2)(C)CCC[C@]1(C(O)=O)C1=C2C=C(C(C)C)C(O)=C1O QRYRORQUOLYVBU-VBKZILBWSA-N 0.000 description 1
- 108010087806 Carnosine Proteins 0.000 description 1
- VQAWRQZAAIQXHM-UHFFFAOYSA-N Cepharanthine Natural products O1C(C=C2)=CC=C2CC(C=23)N(C)CCC3=CC=3OCOC=3C=2OC(=CC=23)C(OC)=CC=2CCN(C)C3CC2=CC=C(O)C1=C2 VQAWRQZAAIQXHM-UHFFFAOYSA-N 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 241000212948 Cnidium Species 0.000 description 1
- RGJOEKWQDUBAIZ-IBOSZNHHSA-N CoASH Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCS)O[C@H]1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-IBOSZNHHSA-N 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- CIWBSHSKHKDKBQ-DUZGATOHSA-N D-araboascorbic acid Natural products OC[C@@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-DUZGATOHSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- SBJKKFFYIZUCET-JLAZNSOCSA-N Dehydro-L-ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(=O)C1=O SBJKKFFYIZUCET-JLAZNSOCSA-N 0.000 description 1
- 239000004287 Dehydroacetic acid Substances 0.000 description 1
- SBJKKFFYIZUCET-UHFFFAOYSA-N Dehydroascorbic acid Natural products OCC(O)C1OC(=O)C(=O)C1=O SBJKKFFYIZUCET-UHFFFAOYSA-N 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- AZJUFRDUYTYIHV-NKFKGCMQSA-N Dibenzoyl Thiamine Chemical compound C=1C=CC=CC=1C(=O)OCC\C(SC(=O)C=1C=CC=CC=1)=C(/C)N(C=O)CC1=CN=C(C)N=C1N AZJUFRDUYTYIHV-NKFKGCMQSA-N 0.000 description 1
- 235000011511 Diospyros Nutrition 0.000 description 1
- 244000236655 Diospyros kaki Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 235000009161 Espostoa lanata Nutrition 0.000 description 1
- 240000001624 Espostoa lanata Species 0.000 description 1
- FPVVYTCTZKCSOJ-UHFFFAOYSA-N Ethylene glycol distearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOC(=O)CCCCCCCCCCCCCCCCC FPVVYTCTZKCSOJ-UHFFFAOYSA-N 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- 244000061408 Eugenia caryophyllata Species 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 239000001293 FEMA 3089 Substances 0.000 description 1
- 235000004204 Foeniculum vulgare Nutrition 0.000 description 1
- 240000006927 Foeniculum vulgare Species 0.000 description 1
- 239000005792 Geraniol Substances 0.000 description 1
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 1
- 235000008100 Ginkgo biloba Nutrition 0.000 description 1
- 244000194101 Ginkgo biloba Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 240000002045 Guettarda speciosa Species 0.000 description 1
- 235000001287 Guettarda speciosa Nutrition 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 241000208690 Hamamelis Species 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical class OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- XPJVKCRENWUEJH-UHFFFAOYSA-N Isobutylparaben Chemical compound CC(C)COC(=O)C1=CC=C(O)C=C1 XPJVKCRENWUEJH-UHFFFAOYSA-N 0.000 description 1
- CMHMMKSPYOOVGI-UHFFFAOYSA-N Isopropylparaben Chemical compound CC(C)OC(=O)C1=CC=C(O)C=C1 CMHMMKSPYOOVGI-UHFFFAOYSA-N 0.000 description 1
- 241000721662 Juniperus Species 0.000 description 1
- FAIXYKHYOGVFKA-UHFFFAOYSA-N Kinetin Natural products N=1C=NC=2N=CNC=2C=1N(C)C1=CC=CO1 FAIXYKHYOGVFKA-UHFFFAOYSA-N 0.000 description 1
- MLSJBGYKDYSOAE-DCWMUDTNSA-N L-Ascorbic acid-2-glucoside Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=C1O MLSJBGYKDYSOAE-DCWMUDTNSA-N 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- 150000000996 L-ascorbic acids Chemical class 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 240000000599 Lentinula edodes Species 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 1
- ABSPRNADVQNDOU-UHFFFAOYSA-N Menaquinone 1 Natural products C1=CC=C2C(=O)C(CC=C(C)C)=C(C)C(=O)C2=C1 ABSPRNADVQNDOU-UHFFFAOYSA-N 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- BYBLEWFAAKGYCD-UHFFFAOYSA-N Miconazole Chemical compound ClC1=CC(Cl)=CC=C1COC(C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 BYBLEWFAAKGYCD-UHFFFAOYSA-N 0.000 description 1
- 235000021360 Myristic acid Nutrition 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- PSFABYLDRXJYID-VKHMYHEASA-N N-Methylserine Chemical compound CN[C@@H](CO)C(O)=O PSFABYLDRXJYID-VKHMYHEASA-N 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 1
- CQOVPNPJLQNMDC-UHFFFAOYSA-N N-beta-alanyl-L-histidine Natural products NCCC(=O)NC(C(O)=O)CC1=CN=CN1 CQOVPNPJLQNMDC-UHFFFAOYSA-N 0.000 description 1
- BAQMYDQNMFBZNA-UHFFFAOYSA-N N-biotinyl-L-lysine Natural products N1C(=O)NC2C(CCCCC(=O)NCCCCC(N)C(O)=O)SCC21 BAQMYDQNMFBZNA-UHFFFAOYSA-N 0.000 description 1
- PSFABYLDRXJYID-UHFFFAOYSA-N N-methyl-DL-serine Natural products CNC(CO)C(O)=O PSFABYLDRXJYID-UHFFFAOYSA-N 0.000 description 1
- 108010075308 N-palmitoyl-seryl-seryl-asparaginyl-alanine Proteins 0.000 description 1
- HDVDLQFPDLTOSI-UHFFFAOYSA-L O[AlH]O Chemical compound O[AlH]O HDVDLQFPDLTOSI-UHFFFAOYSA-L 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- 235000021319 Palmitoleic acid Nutrition 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- 235000002789 Panax ginseng Nutrition 0.000 description 1
- RVSTWRHIGKXTLG-WCXIOVBPSA-N Pangamic acid Chemical compound CC(C)N(C(C)C)C(N(C(C)C)C(C)C)C(=O)OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RVSTWRHIGKXTLG-WCXIOVBPSA-N 0.000 description 1
- RVSTWRHIGKXTLG-UHFFFAOYSA-N Pangamic acid Natural products CC(C)N(C(C)C)C(N(C(C)C)C(C)C)C(=O)OCC(O)C(O)C(O)C(O)C(O)=O RVSTWRHIGKXTLG-UHFFFAOYSA-N 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 241000745768 Pluchea carolinensis Species 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 229920000153 Povidone-iodine Polymers 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- HDSBZMRLPLPFLQ-UHFFFAOYSA-N Propylene glycol alginate Chemical compound OC1C(O)C(OC)OC(C(O)=O)C1OC1C(O)C(O)C(C)C(C(=O)OCC(C)O)O1 HDSBZMRLPLPFLQ-UHFFFAOYSA-N 0.000 description 1
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical class CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- 241000219492 Quercus Species 0.000 description 1
- 235000016976 Quercus macrolepis Nutrition 0.000 description 1
- JYVXNLLUYHCIIH-ZCFIWIBFSA-N R-mevalonolactone, (-)- Chemical compound C[C@@]1(O)CCOC(=O)C1 JYVXNLLUYHCIIH-ZCFIWIBFSA-N 0.000 description 1
- MJNIWUJSIGSWKK-BBANNHEPSA-N Riboflavin butyrate Chemical compound CCCC(=O)OC[C@@H](OC(=O)CCC)[C@@H](OC(=O)CCC)[C@@H](OC(=O)CCC)CN1C2=CC(C)=C(C)C=C2N=C2C1=NC(=O)NC2=O MJNIWUJSIGSWKK-BBANNHEPSA-N 0.000 description 1
- 235000019774 Rice Bran oil Nutrition 0.000 description 1
- 235000004443 Ricinus communis Nutrition 0.000 description 1
- 244000178231 Rosmarinus officinalis Species 0.000 description 1
- 241001247145 Sebastes goodei Species 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 244000044822 Simmondsia californica Species 0.000 description 1
- 235000004433 Simmondsia californica Nutrition 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 239000004288 Sodium dehydroacetate Substances 0.000 description 1
- IYFATESGLOUGBX-YVNJGZBMSA-N Sorbitan monopalmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O IYFATESGLOUGBX-YVNJGZBMSA-N 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- VBIIFPGSPJYLRR-UHFFFAOYSA-M Stearyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C VBIIFPGSPJYLRR-UHFFFAOYSA-M 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical class OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 240000002657 Thymus vulgaris Species 0.000 description 1
- 235000007303 Thymus vulgaris Nutrition 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- SLINHMUFWFWBMU-UHFFFAOYSA-N Triisopropanolamine Chemical compound CC(O)CN(CC(C)O)CC(C)O SLINHMUFWFWBMU-UHFFFAOYSA-N 0.000 description 1
- UWHZIFQPPBDJPM-FPLPWBNLSA-M Vaccenic acid Natural products CCCCCC\C=C/CCCCCCCCCC([O-])=O UWHZIFQPPBDJPM-FPLPWBNLSA-M 0.000 description 1
- 235000021322 Vaccenic acid Nutrition 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- MECHNRXZTMCUDQ-UHFFFAOYSA-N Vitamin D2 Natural products C1CCC2(C)C(C(C)C=CC(C)C(C)C)CCC2C1=CC=C1CC(O)CCC1=C MECHNRXZTMCUDQ-UHFFFAOYSA-N 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 1
- 241001135917 Vitellaria paradoxa Species 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 239000004110 Zinc silicate Substances 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- FGUZFFWTBWJBIL-XWVZOOPGSA-N [(1r)-1-[(2s,3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)O[C@H](CO)[C@H]1OC[C@H](O)[C@H]1O FGUZFFWTBWJBIL-XWVZOOPGSA-N 0.000 description 1
- NCHJGQKLPRTMAO-XWVZOOPGSA-N [(2R)-2-[(2R,3R,4S)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NCHJGQKLPRTMAO-XWVZOOPGSA-N 0.000 description 1
- LWZFANDGMFTDAV-BURFUSLBSA-N [(2r)-2-[(2r,3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] dodecanoate Chemical compound CCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O LWZFANDGMFTDAV-BURFUSLBSA-N 0.000 description 1
- TXGSMRRWACWHFZ-MVIDNBQJSA-N [(2r,3s,4s)-5-(7,8-dimethyl-2,4-dioxobenzo[g]pteridin-10-yl)-2,3,4-tris(pyridine-3-carbonyloxy)pentyl] pyridine-3-carboxylate Chemical compound O([C@@H](CN1C=2C(C(NC(=O)N=2)=O)=NC=2C=C(C(=CC=21)C)C)[C@H](OC(=O)C=1C=NC=CC=1)[C@@H](COC(=O)C=1C=NC=CC=1)OC(=O)C=1C=NC=CC=1)C(=O)C1=CC=CN=C1 TXGSMRRWACWHFZ-MVIDNBQJSA-N 0.000 description 1
- OEWBEINAQKIQLZ-CMRBMDBWSA-N [(2s)-2-[(2r)-3,4-bis(2-hexyldecanoyloxy)-5-oxo-2h-furan-2-yl]-2-(2-hexyldecanoyloxy)ethyl] 2-hexyldecanoate Chemical compound CCCCCCCCC(CCCCCC)C(=O)OC[C@H](OC(=O)C(CCCCCC)CCCCCCCC)[C@H]1OC(=O)C(OC(=O)C(CCCCCC)CCCCCCCC)=C1OC(=O)C(CCCCCC)CCCCCCCC OEWBEINAQKIQLZ-CMRBMDBWSA-N 0.000 description 1
- DDEDPQYNISJXLF-XTMYEIJHSA-N [(z)-4-[(4-amino-2-methylpyrimidin-5-yl)methyl-formylamino]-3-benzoylsulfanylpent-3-enyl] benzoate;hydrochloride Chemical compound Cl.C=1C=CC=CC=1C(=O)OCC\C(SC(=O)C=1C=CC=CC=1)=C(/C)N(C=O)CC1=CN=C(C)N=C1N DDEDPQYNISJXLF-XTMYEIJHSA-N 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- VLSOAXRVHARBEQ-UHFFFAOYSA-N [4-fluoro-2-(hydroxymethyl)phenyl]methanol Chemical compound OCC1=CC=C(F)C=C1CO VLSOAXRVHARBEQ-UHFFFAOYSA-N 0.000 description 1
- GWVPJQDUGPKIOI-UQKRIMTDSA-N [Na].CCCCCCCCCCCC(=O)CN[C@@H](C)C(O)=O Chemical compound [Na].CCCCCCCCCCCC(=O)CN[C@@H](C)C(O)=O GWVPJQDUGPKIOI-UQKRIMTDSA-N 0.000 description 1
- GNKTZDSRQHMHLZ-UHFFFAOYSA-N [Si].[Si].[Si].[Ti].[Ti].[Ti].[Ti].[Ti] Chemical compound [Si].[Si].[Si].[Ti].[Ti].[Ti].[Ti].[Ti] GNKTZDSRQHMHLZ-UHFFFAOYSA-N 0.000 description 1
- ZFJFYUXFKXTXGT-UHFFFAOYSA-N [dimethyl(methylsilyloxy)silyl]oxy-[dimethyl(trimethylsilyloxy)silyl]oxy-dimethylsilane Chemical compound C[SiH2]O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C ZFJFYUXFKXTXGT-UHFFFAOYSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 229920003054 adipate polyester Polymers 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229940023476 agar Drugs 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 229960003767 alanine Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 125000005250 alkyl acrylate group Chemical group 0.000 description 1
- 125000005211 alkyl trimethyl ammonium group Chemical group 0.000 description 1
- 235000020224 almond Nutrition 0.000 description 1
- 229940061720 alpha hydroxy acid Drugs 0.000 description 1
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 150000004263 amino monosaccharides Chemical class 0.000 description 1
- 229960002298 aminohydroxybutyric acid Drugs 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 229940011037 anethole Drugs 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- 235000019276 ascorbyl stearate Nutrition 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 108010045569 atelocollagen Proteins 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- 235000012216 bentonite Nutrition 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
- 229960001950 benzethonium chloride Drugs 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 229960004365 benzoic acid Drugs 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 229950004580 benzyl nicotinate Drugs 0.000 description 1
- IZJRISIINLJVBU-UHFFFAOYSA-N beta-Butoxyethyl nicotinate Chemical compound CCCCOCCOC(=O)C1=CC=CN=C1 IZJRISIINLJVBU-UHFFFAOYSA-N 0.000 description 1
- 229940000635 beta-alanine Drugs 0.000 description 1
- BAQMYDQNMFBZNA-MNXVOIDGSA-N biocytin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)NCCCC[C@H](N)C(O)=O)SC[C@@H]21 BAQMYDQNMFBZNA-MNXVOIDGSA-N 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 150000001615 biotins Chemical class 0.000 description 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 1
- 229940116229 borneol Drugs 0.000 description 1
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 description 1
- RNSLCHIAOHUARI-UHFFFAOYSA-N butane-1,4-diol;hexanedioic acid Chemical compound OCCCCO.OC(=O)CCCCC(O)=O RNSLCHIAOHUARI-UHFFFAOYSA-N 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- 229960004203 carnitine Drugs 0.000 description 1
- 229940044199 carnosine Drugs 0.000 description 1
- CQOVPNPJLQNMDC-ZETCQYMHSA-N carnosine Chemical compound [NH3+]CCC(=O)N[C@H](C([O-])=O)CC1=CNC=N1 CQOVPNPJLQNMDC-ZETCQYMHSA-N 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- YVPXVXANRNDGTA-WDYNHAJCSA-N cepharanthine Chemical compound C1C(C=C2)=CC=C2OC(=C2)C(OC)=CC=C2C[C@H](C2=C3)N(C)CCC2=CC(OC)=C3OC2=C(OCO3)C3=CC3=C2[C@H]1N(C)CC3 YVPXVXANRNDGTA-WDYNHAJCSA-N 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
- 229910000420 cerium oxide Inorganic materials 0.000 description 1
- JIHMVMRETUQLFD-UHFFFAOYSA-N cerium(3+);dioxido(oxo)silane Chemical compound [Ce+3].[Ce+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O.[O-][Si]([O-])=O JIHMVMRETUQLFD-UHFFFAOYSA-N 0.000 description 1
- 229940074979 cetyl palmitate Drugs 0.000 description 1
- 229940119217 chamomile extract Drugs 0.000 description 1
- 235000020221 chamomile extract Nutrition 0.000 description 1
- 235000019693 cherries Nutrition 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- KXKPYJOVDUMHGS-OSRGNVMNSA-N chondroitin sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](OS(O)(=O)=O)[C@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](C(O)=O)O1 KXKPYJOVDUMHGS-OSRGNVMNSA-N 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 229930007050 cineol Natural products 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- 239000010630 cinnamon oil Substances 0.000 description 1
- SECPZKHBENQXJG-UHFFFAOYSA-N cis-palmitoleic acid Natural products CCCCCCC=CCCCCCCCC(O)=O SECPZKHBENQXJG-UHFFFAOYSA-N 0.000 description 1
- 239000001926 citrus aurantium l. subsp. bergamia wright et arn. oil Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000012459 cleaning agent Substances 0.000 description 1
- RGJOEKWQDUBAIZ-UHFFFAOYSA-N coenzime A Natural products OC1C(OP(O)(O)=O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-UHFFFAOYSA-N 0.000 description 1
- 239000005516 coenzyme A Substances 0.000 description 1
- 229940093530 coenzyme a Drugs 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 108010006161 conchiolin Proteins 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 229960003624 creatine Drugs 0.000 description 1
- 239000006046 creatine Substances 0.000 description 1
- 229930003836 cresol Natural products 0.000 description 1
- 235000000639 cyanocobalamin Nutrition 0.000 description 1
- 239000011666 cyanocobalamin Substances 0.000 description 1
- 229960002104 cyanocobalamin Drugs 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 229940086555 cyclomethicone Drugs 0.000 description 1
- 229960002433 cysteine Drugs 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- INSRQEMEVAMETL-UHFFFAOYSA-N decane-1,1-diol Chemical compound CCCCCCCCCC(O)O INSRQEMEVAMETL-UHFFFAOYSA-N 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 235000019258 dehydroacetic acid Nutrition 0.000 description 1
- 229940061632 dehydroacetic acid Drugs 0.000 description 1
- 235000020960 dehydroascorbic acid Nutrition 0.000 description 1
- 239000011615 dehydroascorbic acid Substances 0.000 description 1
- 230000001877 deodorizing effect Effects 0.000 description 1
- KDTSHFARGAKYJN-UHFFFAOYSA-N dephosphocoenzyme A Natural products OC1C(O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 KDTSHFARGAKYJN-UHFFFAOYSA-N 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- JAUGGEIKQIHSMF-UHFFFAOYSA-N dialuminum;dimagnesium;dioxido(oxo)silane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[Mg+2].[Mg+2].[Al+3].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O.[O-][Si]([O-])=O JAUGGEIKQIHSMF-UHFFFAOYSA-N 0.000 description 1
- 229940028356 diethylene glycol monobutyl ether Drugs 0.000 description 1
- LVTYICIALWPMFW-UHFFFAOYSA-N diisopropanolamine Chemical compound CC(O)CNCC(C)O LVTYICIALWPMFW-UHFFFAOYSA-N 0.000 description 1
- 229940043276 diisopropanolamine Drugs 0.000 description 1
- 229940031578 diisopropyl adipate Drugs 0.000 description 1
- PSHRANCNVXNITH-UHFFFAOYSA-N dimethylamino acetate Chemical compound CN(C)OC(C)=O PSHRANCNVXNITH-UHFFFAOYSA-N 0.000 description 1
- PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 description 1
- 229940079779 disodium cocoyl glutamate Drugs 0.000 description 1
- GLSRFBDXBWZNLH-UHFFFAOYSA-L disodium;2-chloroacetate;2-(4,5-dihydroimidazol-1-yl)ethanol;hydroxide Chemical compound [OH-].[Na+].[Na+].[O-]C(=O)CCl.OCCN1CCN=C1 GLSRFBDXBWZNLH-UHFFFAOYSA-L 0.000 description 1
- RLPQZSVUADVLBS-UHFFFAOYSA-L disodium;3-hydroxypropyl phosphate Chemical compound [Na+].[Na+].OCCCOP([O-])([O-])=O RLPQZSVUADVLBS-UHFFFAOYSA-L 0.000 description 1
- YVIGPQSYEAOLAD-UHFFFAOYSA-L disodium;dodecyl phosphate Chemical compound [Na+].[Na+].CCCCCCCCCCCCOP([O-])([O-])=O YVIGPQSYEAOLAD-UHFFFAOYSA-L 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- UVCJGUGAGLDPAA-UHFFFAOYSA-N ensulizole Chemical compound N1C2=CC(S(=O)(=O)O)=CC=C2N=C1C1=CC=CC=C1 UVCJGUGAGLDPAA-UHFFFAOYSA-N 0.000 description 1
- 229960000655 ensulizole Drugs 0.000 description 1
- 229960002061 ergocalciferol Drugs 0.000 description 1
- 235000010350 erythorbic acid Nutrition 0.000 description 1
- 239000004318 erythorbic acid Substances 0.000 description 1
- 125000004185 ester group Chemical group 0.000 description 1
- 239000010696 ester oil Substances 0.000 description 1
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 125000001033 ether group Chemical group 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- 239000010642 eucalyptus oil Substances 0.000 description 1
- 229940044949 eucalyptus oil Drugs 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000010643 fennel seed oil Substances 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- 235000001785 ferulic acid Nutrition 0.000 description 1
- 229940114124 ferulic acid Drugs 0.000 description 1
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 1
- VWWQXMAJTJZDQX-UYBVJOGSSA-N flavin adenine dinucleotide Chemical compound C1=NC2=C(N)N=CN=C2N1[C@@H]([C@H](O)[C@@H]1O)O[C@@H]1CO[P@](O)(=O)O[P@@](O)(=O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C2=NC(=O)NC(=O)C2=NC2=C1C=C(C)C(C)=C2 VWWQXMAJTJZDQX-UYBVJOGSSA-N 0.000 description 1
- 235000019162 flavin adenine dinucleotide Nutrition 0.000 description 1
- 239000011714 flavin adenine dinucleotide Substances 0.000 description 1
- 229940013640 flavin mononucleotide Drugs 0.000 description 1
- 239000011768 flavin mononucleotide Substances 0.000 description 1
- FVTCRASFADXXNN-UHFFFAOYSA-N flavin mononucleotide Natural products OP(=O)(O)OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O FVTCRASFADXXNN-UHFFFAOYSA-N 0.000 description 1
- 229940093632 flavin-adenine dinucleotide Drugs 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 150000002224 folic acids Chemical class 0.000 description 1
- 230000002431 foraging effect Effects 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- YQGDEPYYFWUPGO-UHFFFAOYSA-N gamma-amino-beta-hydroxybutyric acid Chemical compound [NH3+]CC(O)CC([O-])=O YQGDEPYYFWUPGO-UHFFFAOYSA-N 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 229940113087 geraniol Drugs 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 229940108690 glucosyl hesperidin Drugs 0.000 description 1
- 229960002989 glutamic acid Drugs 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 229960002743 glutamine Drugs 0.000 description 1
- 235000004554 glutamine Nutrition 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 229960002449 glycine Drugs 0.000 description 1
- 229960002389 glycol salicylate Drugs 0.000 description 1
- 229940094952 green tea extract Drugs 0.000 description 1
- 235000020688 green tea extract Nutrition 0.000 description 1
- 229960002350 guaiazulen Drugs 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 1
- PXDJXZJSCPSGGI-UHFFFAOYSA-N hexadecanoic acid hexadecyl ester Natural products CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC PXDJXZJSCPSGGI-UHFFFAOYSA-N 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 229960002885 histidine Drugs 0.000 description 1
- 239000010903 husk Substances 0.000 description 1
- BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical compound [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 235000004867 hydroxocobalamin Nutrition 0.000 description 1
- 239000011704 hydroxocobalamin Substances 0.000 description 1
- 229960001103 hydroxocobalamin Drugs 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 239000001023 inorganic pigment Substances 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 229940026239 isoascorbic acid Drugs 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229940074928 isopropyl myristate Drugs 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 229940075495 isopropyl palmitate Drugs 0.000 description 1
- QANMHLXAZMSUEX-UHFFFAOYSA-N kinetin Chemical compound N=1C=NC=2N=CNC=2C=1NCC1=CC=CO1 QANMHLXAZMSUEX-UHFFFAOYSA-N 0.000 description 1
- 229960001669 kinetin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 125000000400 lauroyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940091554 lauryl peg-9 polydimethylsiloxyethyl dimethicone Drugs 0.000 description 1
- 229960003136 leucine Drugs 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 229960003646 lysine Drugs 0.000 description 1
- 229960003511 macrogol Drugs 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 description 1
- 239000000347 magnesium hydroxide Substances 0.000 description 1
- 229910001862 magnesium hydroxide Inorganic materials 0.000 description 1
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- 239000001683 mentha spicata herb oil Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 229960004452 methionine Drugs 0.000 description 1
- 229960001047 methyl salicylate Drugs 0.000 description 1
- XJRBAMWJDBPFIM-UHFFFAOYSA-N methyl vinyl ether Chemical compound COC=C XJRBAMWJDBPFIM-UHFFFAOYSA-N 0.000 description 1
- 229960001238 methylnicotinate Drugs 0.000 description 1
- 229940057061 mevalonolactone Drugs 0.000 description 1
- 229960002509 miconazole Drugs 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- LPUQAYUQRXPFSQ-DFWYDOINSA-M monosodium L-glutamate Chemical compound [Na+].[O-]C(=O)[C@@H](N)CCC(O)=O LPUQAYUQRXPFSQ-DFWYDOINSA-M 0.000 description 1
- 239000010813 municipal solid waste Substances 0.000 description 1
- SLCVBVWXLSEKPL-UHFFFAOYSA-N neopentyl glycol Chemical compound OCC(C)(C)CO SLCVBVWXLSEKPL-UHFFFAOYSA-N 0.000 description 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
- 150000002814 niacins Chemical class 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229910017464 nitrogen compound Inorganic materials 0.000 description 1
- 150000002830 nitrogen compounds Chemical class 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- WNIFXKPDILJURQ-JKPOUOEOSA-N octadecyl (2s,4as,6ar,6as,6br,8ar,10s,12as,14br)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1h-picene-2-carboxylate Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CC[C@@](C(=O)OCCCCCCCCCCCCCCCCCC)(C)C[C@H]5C4=CC(=O)[C@@H]3[C@]21C WNIFXKPDILJURQ-JKPOUOEOSA-N 0.000 description 1
- KSCKTBJJRVPGKM-UHFFFAOYSA-N octan-1-olate;titanium(4+) Chemical compound [Ti+4].CCCCCCCC[O-].CCCCCCCC[O-].CCCCCCCC[O-].CCCCCCCC[O-] KSCKTBJJRVPGKM-UHFFFAOYSA-N 0.000 description 1
- 229940073665 octyldodecyl myristate Drugs 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 238000006864 oxidative decomposition reaction Methods 0.000 description 1
- BMMGVYCKOGBVEV-UHFFFAOYSA-N oxo(oxoceriooxy)cerium Chemical compound [Ce]=O.O=[Ce]=O BMMGVYCKOGBVEV-UHFFFAOYSA-N 0.000 description 1
- JCGNDDUYTRNOFT-UHFFFAOYSA-N oxolane-2,4-dione Chemical compound O=C1COC(=O)C1 JCGNDDUYTRNOFT-UHFFFAOYSA-N 0.000 description 1
- 125000005702 oxyalkylene group Chemical group 0.000 description 1
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 1
- 125000001312 palmitoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940093441 palmitoyl oligopeptide Drugs 0.000 description 1
- 229940055705 pangamic acid Drugs 0.000 description 1
- 108700024047 pangamic acid Proteins 0.000 description 1
- DJWYOLJPSHDSAL-ROUUACIJSA-N pantethine Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSSCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)CO DJWYOLJPSHDSAL-ROUUACIJSA-N 0.000 description 1
- 229940101267 panthenol Drugs 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 239000011619 pantothenol Substances 0.000 description 1
- 235000020957 pantothenol Nutrition 0.000 description 1
- RUVINXPYWBROJD-UHFFFAOYSA-N para-methoxyphenyl Natural products COC1=CC=C(C=CC)C=C1 RUVINXPYWBROJD-UHFFFAOYSA-N 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229940088608 peg-9 polydimethylsiloxyethyl dimethicone Drugs 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 229960005190 phenylalanine Drugs 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- MBWXNTAXLNYFJB-NKFFZRIASA-N phylloquinone Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CCC[C@H](C)CCC[C@H](C)CCCC(C)C)=C(C)C(=O)C2=C1 MBWXNTAXLNYFJB-NKFFZRIASA-N 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 235000019175 phylloquinone Nutrition 0.000 description 1
- 239000011772 phylloquinone Substances 0.000 description 1
- 229960001898 phytomenadione Drugs 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 229940068977 polysorbate 20 Drugs 0.000 description 1
- 229940113124 polysorbate 60 Drugs 0.000 description 1
- 229940068968 polysorbate 80 Drugs 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920000166 polytrimethylene carbonate Polymers 0.000 description 1
- 229960004839 potassium iodide Drugs 0.000 description 1
- 229940114930 potassium stearate Drugs 0.000 description 1
- MQOCIYICOGDBSG-UHFFFAOYSA-M potassium;hexadecanoate Chemical compound [K+].CCCCCCCCCCCCCCCC([O-])=O MQOCIYICOGDBSG-UHFFFAOYSA-M 0.000 description 1
- ANBFRLKBEIFNQU-UHFFFAOYSA-M potassium;octadecanoate Chemical compound [K+].CCCCCCCCCCCCCCCCCC([O-])=O ANBFRLKBEIFNQU-UHFFFAOYSA-M 0.000 description 1
- PYJBVGYZXWPIKK-UHFFFAOYSA-M potassium;tetradecanoate Chemical compound [K+].CCCCCCCCCCCCCC([O-])=O PYJBVGYZXWPIKK-UHFFFAOYSA-M 0.000 description 1
- 229960001621 povidone-iodine Drugs 0.000 description 1
- OIGNJSKKLXVSLS-VWUMJDOOSA-N prednisolone Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OIGNJSKKLXVSLS-VWUMJDOOSA-N 0.000 description 1
- 229960005205 prednisolone Drugs 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 229960002429 proline Drugs 0.000 description 1
- 235000010409 propane-1,2-diol alginate Nutrition 0.000 description 1
- 239000000770 propane-1,2-diol alginate Substances 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 229940093625 propylene glycol monostearate Drugs 0.000 description 1
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- 229960003581 pyridoxal Drugs 0.000 description 1
- 235000008164 pyridoxal Nutrition 0.000 description 1
- 239000011674 pyridoxal Substances 0.000 description 1
- PFIPZKASKUWLHH-UHFFFAOYSA-N pyridoxamine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CN)=C1O PFIPZKASKUWLHH-UHFFFAOYSA-N 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 229950001574 riboflavin phosphate Drugs 0.000 description 1
- 235000019231 riboflavin-5'-phosphate Nutrition 0.000 description 1
- 239000008165 rice bran oil Substances 0.000 description 1
- 235000019719 rose oil Nutrition 0.000 description 1
- 239000010666 rose oil Substances 0.000 description 1
- 229940058287 salicylic acid derivative anticestodals Drugs 0.000 description 1
- 150000003872 salicylic acid derivatives Chemical class 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 239000013535 sea water Substances 0.000 description 1
- 229960001153 serine Drugs 0.000 description 1
- 229940057910 shea butter Drugs 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 229920005573 silicon-containing polymer Polymers 0.000 description 1
- 229920002050 silicone resin Polymers 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 235000010378 sodium ascorbate Nutrition 0.000 description 1
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 description 1
- 229960005055 sodium ascorbate Drugs 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 229960003885 sodium benzoate Drugs 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 229940096501 sodium cocoamphoacetate Drugs 0.000 description 1
- 229940079781 sodium cocoyl glutamate Drugs 0.000 description 1
- 229940065859 sodium cocoyl glycinate Drugs 0.000 description 1
- 235000019259 sodium dehydroacetate Nutrition 0.000 description 1
- 229940079839 sodium dehydroacetate Drugs 0.000 description 1
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 description 1
- GCLGEJMYGQKIIW-UHFFFAOYSA-H sodium hexametaphosphate Chemical compound [Na]OP1(=O)OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])O1 GCLGEJMYGQKIIW-UHFFFAOYSA-H 0.000 description 1
- 235000019982 sodium hexametaphosphate Nutrition 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 229940048086 sodium pyrophosphate Drugs 0.000 description 1
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 description 1
- 229940074404 sodium succinate Drugs 0.000 description 1
- ZDQYSKICYIVCPN-UHFFFAOYSA-L sodium succinate (anhydrous) Chemical compound [Na+].[Na+].[O-]C(=O)CCC([O-])=O ZDQYSKICYIVCPN-UHFFFAOYSA-L 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 229940001482 sodium sulfite Drugs 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 235000010265 sodium sulphite Nutrition 0.000 description 1
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 description 1
- DSOWAKKSGYUMTF-GZOLSCHFSA-M sodium;(1e)-1-(6-methyl-2,4-dioxopyran-3-ylidene)ethanolate Chemical compound [Na+].C\C([O-])=C1/C(=O)OC(C)=CC1=O DSOWAKKSGYUMTF-GZOLSCHFSA-M 0.000 description 1
- IKGKWKGYFJBGQJ-UHFFFAOYSA-M sodium;2-(dodecanoylamino)acetate Chemical compound [Na+].CCCCCCCCCCCC(=O)NCC([O-])=O IKGKWKGYFJBGQJ-UHFFFAOYSA-M 0.000 description 1
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 description 1
- HWCHICTXVOMIIF-UHFFFAOYSA-M sodium;3-(dodecylamino)propanoate Chemical compound [Na+].CCCCCCCCCCCCNCCC([O-])=O HWCHICTXVOMIIF-UHFFFAOYSA-M 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 229940057429 sorbitan isostearate Drugs 0.000 description 1
- 229950006451 sorbitan laurate Drugs 0.000 description 1
- 229940035044 sorbitan monolaurate Drugs 0.000 description 1
- 235000011067 sorbitan monolaureate Nutrition 0.000 description 1
- 235000011071 sorbitan monopalmitate Nutrition 0.000 description 1
- 239000001570 sorbitan monopalmitate Substances 0.000 description 1
- 229940031953 sorbitan monopalmitate Drugs 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 239000001587 sorbitan monostearate Substances 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 235000019710 soybean protein Nutrition 0.000 description 1
- 235000019721 spearmint oil Nutrition 0.000 description 1
- 150000003410 sphingosines Chemical class 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- WNIFXKPDILJURQ-UHFFFAOYSA-N stearyl glycyrrhizinate Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=O)OCCCCCCCCCCCCCCCCCC)(C)CC5C4=CC(=O)C3C21C WNIFXKPDILJURQ-UHFFFAOYSA-N 0.000 description 1
- 229940117986 sulfobetaine Drugs 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 150000003464 sulfur compounds Chemical class 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 229940104261 taurate Drugs 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 235000019818 tetrasodium diphosphate Nutrition 0.000 description 1
- 229920001187 thermosetting polymer Polymers 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 229960000344 thiamine hydrochloride Drugs 0.000 description 1
- 235000019190 thiamine hydrochloride Nutrition 0.000 description 1
- 239000011747 thiamine hydrochloride Substances 0.000 description 1
- UIERGBJEBXXIGO-UHFFFAOYSA-N thiamine mononitrate Chemical compound [O-][N+]([O-])=O.CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N UIERGBJEBXXIGO-UHFFFAOYSA-N 0.000 description 1
- 229960002898 threonine Drugs 0.000 description 1
- 235000008521 threonine Nutrition 0.000 description 1
- 239000001585 thymus vulgaris Substances 0.000 description 1
- 229940098465 tincture Drugs 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 229950009883 tocopheryl nicotinate Drugs 0.000 description 1
- JIVZKJJQOZQXQB-UHFFFAOYSA-N tolazoline Chemical compound C=1C=CC=CC=1CC1=NCCN1 JIVZKJJQOZQXQB-UHFFFAOYSA-N 0.000 description 1
- 229960002312 tolazoline Drugs 0.000 description 1
- 108010021724 tonin Proteins 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 1
- 229960000401 tranexamic acid Drugs 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 1
- UWHZIFQPPBDJPM-BQYQJAHWSA-N trans-vaccenic acid Chemical compound CCCCCC\C=C\CCCCCCCCCC(O)=O UWHZIFQPPBDJPM-BQYQJAHWSA-N 0.000 description 1
- 229960001325 triclocarban Drugs 0.000 description 1
- ICUTUKXCWQYESQ-UHFFFAOYSA-N triclocarban Chemical compound C1=CC(Cl)=CC=C1NC(=O)NC1=CC=C(Cl)C(Cl)=C1 ICUTUKXCWQYESQ-UHFFFAOYSA-N 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- 229940052016 turmeric extract Drugs 0.000 description 1
- 239000008513 turmeric extract Substances 0.000 description 1
- 235000020240 turmeric extract Nutrition 0.000 description 1
- 229940096998 ursolic acid Drugs 0.000 description 1
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 229960004295 valine Drugs 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000001892 vitamin D2 Nutrition 0.000 description 1
- 239000011653 vitamin D2 Substances 0.000 description 1
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 description 1
- 235000005282 vitamin D3 Nutrition 0.000 description 1
- 239000011647 vitamin D3 Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940021056 vitamin d3 Drugs 0.000 description 1
- 239000009538 yokuinin Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 229960001296 zinc oxide Drugs 0.000 description 1
- XSMMCTCMFDWXIX-UHFFFAOYSA-N zinc silicate Chemical compound [Zn+2].[O-][Si]([O-])=O XSMMCTCMFDWXIX-UHFFFAOYSA-N 0.000 description 1
- 235000019352 zinc silicate Nutrition 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
- 229910001928 zirconium oxide Inorganic materials 0.000 description 1
- 239000004711 α-olefin Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L9/00—Disinfection, sterilisation or deodorisation of air
- A61L9/01—Deodorant compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q13/00—Formulations or additives for perfume preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q15/00—Anti-perspirants or body deodorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/02—Preparations for cleaning the hair
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/12—Preparations containing hair conditioners
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Cosmetics (AREA)
- Fats And Perfumes (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Disinfection, Sterilisation Or Deodorisation Of Air (AREA)
- Detergent Compositions (AREA)
Abstract
Description
本発明は、若年女性臭補充用の組成物に関する。 The present invention relates to a composition for replenishing young female odor.
近年、男女を問わず、ニオイのエチケットへの人々の関心が高まっている。様々な体臭に関する研究が鋭意進められ、汗臭、腋臭、足臭、加齢臭等の主要な原因臭気は同定されている。例えば体臭は、一般的に体表面で皮脂からつくられる脂肪酸や不飽和アルデヒドが一因であると考えられている。そして、加齢臭と呼ばれるニオイも同様に、皮脂が分解されて生じるω不飽和脂肪酸(パルミトレイン酸やバクセン酸)が更に酸化的に分解されて2-ノネナールと呼ばれる不飽和アルデヒドが体表面で発生することに深く関連していることが報告されている(非特許文献1)。 In recent years, people's interest in odor etiquette has increased, regardless of gender. Research on various body odors has been intensively advanced, and major causative odors such as sweat odor, armpit odor, foot odor, and aging odor have been identified. For example, body odor is generally considered to be caused by fatty acids and unsaturated aldehydes produced from sebum on the body surface. Similarly, the odor called aging odor is also generated on the body surface by oxidative decomposition of ω-unsaturated fatty acids (palmitoleic acid and vaccenic acid) produced by the decomposition of sebum, and unsaturated aldehydes called 2-nonenal are generated on the body surface. It has been reported that it is deeply related to doing (Non-Patent Document 1).
このような加齢臭等の体臭を防止する技術としては、香水等でマスキングする方法や炭の臭い吸着効能を利用する方法(特許文献1)等が知られている。また、ワレモコウの根部及び根茎部からの抽出物を用いる方法(特許文献2)や、縮合型カキタンニンを用いる方法(特許文献3)等も提案されている。更に、不快なニオイ成分を洗い流すための洗浄剤の開発も進められている。 Techniques for preventing body odors such as aging odors include a method of masking with perfume or the like and a method of utilizing the odor adsorption effect of charcoal (Patent Document 1). A method using extracts from the root and rhizome of burnet (Patent Document 2) and a method using condensed persimmon tannin (Patent Document 3) have also been proposed. Furthermore, the development of detergents for washing off unpleasant odor components is also underway.
一方、このような加齢臭等の体臭は、男女問わず存在すると言われてはいるものの、女性の加齢に伴う体臭変化に関する研究は十分進んでいないのが実情である。そのため、女性に適した加齢臭対策用の製品の開発が望まれている。 On the other hand, although it is said that body odors such as age-related odors are present in both men and women, the actual situation is that research on changes in body odors in women due to aging has not progressed sufficiently. Therefore, the development of anti-ageing odor products suitable for women is desired.
本発明は、かかる状況に鑑みてなされたものであり、女性に適した、体臭を若返らせるための製品、加齢臭対策用の製品を提供することを目的とする。さらに本発明は、女性の加齢に伴う体臭変化に着目し、アンチエージング効果のある物質の評価方法を提供することも目的とする。 The present invention has been made in view of such circumstances, and an object of the present invention is to provide a product for rejuvenating body odor and a product for combating aging odor suitable for women. Another object of the present invention is to provide a method for evaluating a substance having an anti-aging effect, focusing on changes in female body odor with aging.
本発明者らは、10代~50代の女性を対象に体臭成分の解析を行なった結果、10代から20代までの女性(若年女性)において、官能的に明らかに甘い香り(SWEET臭)が確認できることを見出した。官能評価後、その成分を分析し、具体的な体臭成分を同定した。また、一般的に加齢臭の原因物質として知られているノネナール臭は女性では男性に比べて弱く、さらに年代による差が見られないことも明らかにした。そして、加齢に伴って減少していく上記の若年女性の体臭を構成する匂い成分を補うことで、体臭の若返りを実現でき、女性の加齢臭を抑制できることを見出し、本発明を完成するに至った。 The present inventors have analyzed the body odor components of women in their teens to 50s, and found that women in their teens to 20s (young women) have a sensuously sweet scent (SWEET odor). found that it is possible to confirm After sensory evaluation, the components were analyzed to identify specific body odor components. In addition, it was clarified that nonenal odor, which is generally known as a causative agent of aging odor, is weaker in females than in males, and that there is no age difference. Then, by supplementing the odor components that make up the body odor of young women, which decreases with age, the body odor can be rejuvenated, and the aging odor of women can be suppressed, and the present invention has been completed. reached.
即ち、本発明の要旨は以下の通りである。 That is, the gist of the present invention is as follows.
[1]下記式(I)で表されるラクトン化合物を少なくとも含む組成物であって、
若年女性の体臭を構成する匂い成分を補うために用いられる、若年女性臭補充用の組成物。
[1] A composition containing at least a lactone compound represented by the following formula (I),
A composition for replenishing the odor of young women, which is used for supplementing odor components constituting the body odor of young women.
(式中、Rは、炭素数2~9のアルキル基である。)
[2]外用である、[1]に記載の組成物。
[3]女性用である、[2]に記載の組成物。
[4]体臭の若返りのために用いられる、[2]又は[3]に記載の組成物。
[5]繊維製品用、硬質表面用又は空間用である、[1]に記載の組成物。
[6]加齢臭対策用である、[1]から[5]のいずれかに記載の組成物。
[7]若年女性の体臭を構成する匂い成分を含有し、上記匂い成分として下記式(I)で表されるラクトン化合物を少なくとも含む、若年女性の体臭モデル組成物。
(Wherein, R is an alkyl group having 2 to 9 carbon atoms.)
[2] The composition of [1], which is for external use.
[3] The composition according to [2], which is for women.
[4] The composition according to [2] or [3], which is used for rejuvenating body odor.
[5] The composition according to [1], which is for textile products, hard surfaces or spaces.
[6] The composition according to any one of [1] to [5], which is an anti-aging odor.
[7] A body odor model composition for young women, which contains an odor component that constitutes the body odor of young women, and at least a lactone compound represented by the following formula (I) as the odor component.
(式中、Rは、炭素数2~9のアルキル基である。)
[8]下記式(I)で表されるラクトン化合物を少なくとも含む組成物であって、
女性の加齢臭判定の指標として用いられる、加齢臭判定用指標剤。
(Wherein, R is an alkyl group having 2 to 9 carbon atoms.)
[8] A composition containing at least a lactone compound represented by the following formula (I),
An index agent for judging aging odor, which is used as an index for judging aging odor in women.
(式中、Rは、炭素数2~9のアルキル基である。)
[9]被験物質の使用による、体臭中に含まれる下記式(I)で表されるラクトン化合物の含有量の変化を指標として、被験物質のアンチエージング効果を評価する、アンチエージング効果評価方法。
(Wherein, R is an alkyl group having 2 to 9 carbon atoms.)
[9] An anti-aging effect evaluation method, wherein the anti-aging effect of a test substance is evaluated using the change in the content of a lactone compound represented by the following formula (I) contained in body odor due to the use of the test substance as an index.
(式中、Rは、炭素数2~9のアルキル基である。)
[10]被験物質の使用による、体臭中に含まれる下記式(I)で表されるラクトン化合物の含有量の変化を指標として、アンチエージング効果を有する物質をスクリーニングする、アンチエージング物質スクリーニング方法。
(Wherein, R is an alkyl group having 2 to 9 carbon atoms.)
[10] An anti-aging substance screening method, which comprises screening for a substance having an anti-aging effect using, as an indicator, changes in the content of a lactone compound represented by the following formula (I) contained in body odor due to the use of a test substance.
(式中、Rは、炭素数2~9のアルキル基である。)
[11]体臭のアンチエージング効果を有する物質をスクリーニングする、[10]に記載の方法。
[12]下記式(I)で表されるラクトン化合物の産生促進物質及び/又は下記式(I)で表されるラクトン化合物の合成促進物質を含有することを特徴とする、体臭組成改善剤。
(Wherein, R is an alkyl group having 2 to 9 carbon atoms.)
[11] The method of [10], wherein a substance having an anti-aging effect on body odor is screened.
[12] A body odor composition-improving agent comprising a substance promoting the production of a lactone compound represented by the following formula (I) and/or a substance promoting the synthesis of a lactone compound represented by the following formula (I).
(式中、Rは、炭素数2~9のアルキル基である。)
[13][12]に記載の体臭組成改善剤を含む、加齢臭対策剤。
[14]女性用である、[13]に記載の加齢臭対策剤。
[15]下記式(I)で表されるラクトン化合物の作用を向上させる、ラクトン化合物作用向上剤。
(Wherein, R is an alkyl group having 2 to 9 carbon atoms.)
[13] An anti-aging odor agent containing the body odor composition improving agent according to [12].
[14] The anti-aging odor agent according to [13], which is for women.
[15] A lactone compound action improver that improves the action of a lactone compound represented by the following formula (I).
(式中、Rは、炭素数2~9のアルキル基である。)
[16][15]に記載のラクトン化合物作用向上剤を含有する、体臭改善剤。
(Wherein, R is an alkyl group having 2 to 9 carbon atoms.)
[16] A body odor improving agent containing the lactone compound effect improver according to [15].
本発明によれば、体臭を若返らせることができる、女性に適した加齢臭対策用の製品を提供することができる。さらに本発明によれば、アンチエージング効果のある物質の評価方法を提供することもできる。 ADVANTAGE OF THE INVENTION According to this invention, the product for aging odor measures suitable for a woman which can rejuvenate a body odor can be provided. Furthermore, according to the present invention, it is also possible to provide a method for evaluating a substance having an anti-aging effect.
以下、本発明について詳細に説明する。なお、本明細書中で使用される用語は、特に言及しない限り、当該技術分野で通常用いられる意味で解釈される。 The present invention will be described in detail below. In addition, the terms used in this specification are interpreted as meanings commonly used in the technical field unless otherwise specified.
[若年女性臭補充用の組成物]
本発明の組成物は、若年女性の体臭を構成する匂い成分を補うために用いられる、若年女性臭補充用の組成物であり、下記式(I)で表されるラクトン化合物を少なくとも含む。本発明の組成物は、女性の体臭を若返らせることができるため、女性の加齢臭対策用の外用組成物として好適に用いることができる。また一方で、例えば寝具などの使用等により体臭成分が付着しやすい対象物に対して本発明の組成物を用いることで、付着した体臭成分から発せられる匂いを若返らせる効果が期待できることから、繊維製品用、硬質表面用或いは空間用としても好適に用いることができる。なお、本発明における体臭は、女性が発する臭い全般を指し、背中、うなじ、耳の後ろからの臭いや、頭皮臭、汗臭、腋臭、足臭等が体臭に含まれる。
[Composition for replenishing the odor of young women]
The composition of the present invention is a composition for replenishing the odor of young women, which is used to supplement the odor components that make up the body odor of young women, and contains at least a lactone compound represented by the following formula (I). INDUSTRIAL APPLICABILITY The composition of the present invention can rejuvenate women's body odor, and therefore can be suitably used as an external composition for women's anti-aging odor. On the other hand, for example, by using the composition of the present invention on an object to which body odor components tend to adhere due to the use of bedding, etc., the effect of rejuvenating the odor emitted from the attached body odor components can be expected. It can be suitably used for products, hard surfaces, or spaces. The body odor in the present invention refers to all odors emitted by women, and includes odors from the back, nape, behind the ears, scalp odor, sweat odor, armpit odor, foot odor, and the like.
体臭は様々な成分から構成されているが、本発明者らの研究により、女性では、加齢とともに体臭中の特定のラクトン化合物の量が減少することが明らかとなった。すなわち、特定のラクトン化合物は、10代~20代前半までの若年女性の体臭中には十分含まれているものの、加齢とともに減少する。一方で、従来から知られている加齢臭の原因物質であるノネナールの体臭中の量は、女性の場合には元々少なく、加齢によって増加するという傾向も見られなかった。そこで、本発明者らは、女性の加齢臭対策としては、男性の加齢臭対策として通常行われているノネナール臭の抑制や、香水などによるマスキングよりも、若年女性の体臭に多く含まれているものの加齢に伴って減少する特定の成分を補うことがより有効なのではないかと考え、調査研究を進めたところ、本発明を完成し上述のような発明の効果が得られることがわかったというものである。 Body odor is composed of various components, and studies by the present inventors have revealed that the amount of a specific lactone compound in body odor decreases with age in women. That is, although a specific lactone compound is sufficiently contained in the body odor of young women in their teens to early twenties, it decreases with age. On the other hand, the amount of nonenal, which is a conventionally known causative agent of aging odor, in the body odor of women is originally small, and there was no tendency to increase with aging. Therefore, as a countermeasure against aging odor for women, the present inventors found that it is contained in a large amount in the body odor of young women rather than suppressing nonenal odor, which is usually performed as a countermeasure for men's aging odor, or masking with perfume or the like. I thought that it would be more effective to compensate for the specific ingredients that decrease with age, even though I have a lot of them, but when I proceeded with research and research, I completed the present invention and found that the above-mentioned effects of the invention can be obtained. It is said that
式中、Rは、炭素数2~9のアルキル基である。Rの炭素数は、3~9であることが好ましく、4~9であることがより好ましく、5~8であることが更に好ましく、6又は7であることが特に好ましい。上記アルキル基が含む水素原子は置換されていてもよい。 In the formula, R is an alkyl group having 2 to 9 carbon atoms. The number of carbon atoms in R is preferably 3 to 9, more preferably 4 to 9, even more preferably 5 to 8, and particularly preferably 6 or 7. A hydrogen atom contained in the above alkyl group may be substituted.
上記式(I)で表されるラクトン化合物の具体例としては、例えばγ-ヘキサラクトン、γ-ヘプタラクトン、γ―オクタラクトン、γ―ノナラクトン、γ―デカラクトン、γ―ウンデカラクトン、γ―ドデカラクトン、γ―トリデカラクトン等が挙げられる。これらのうち、γ―ノナラクトン、γ―デカラクトン、γ―ウンデカラクトン、γ―ドデカラクトンが好ましく、γ―デカラクトン、γ―ウンデカラクトンがより好ましい。これらのラクトン化合物は、モモ、杏、ココナッツ等のフルーツの香りを有する成分である。なお、ラクトン化合物は、1種単独で用いてもよいし、2種以上を併用してもよい。 Specific examples of the lactone compound represented by the formula (I) include γ-hexalactone, γ-heptalactone, γ-octalactone, γ-nonalactone, γ-decalactone, γ-undecalactone, γ-dodeca lactone, γ-tridecalactone and the like. Among these, γ-nonalactone, γ-decalactone, γ-undecalactone and γ-dodecalactone are preferred, and γ-decalactone and γ-undecalactone are more preferred. These lactone compounds are components having the aroma of fruits such as peach, apricot, and coconut. In addition, a lactone compound may be used individually by 1 type, and may use 2 or more types together.
本発明の組成物における式(I)で表されるラクトン化合物の含有量は、0.00001重量%~10重量%であり、女性の加齢臭対策への効果の観点から、0.00005重量%~5重量%であることが好ましく、0.0001重量%~3重量%であることがより好ましく、0.0005重量%~2重量%であることが更に好ましく、0.001重量%~1重量%であることが特に好ましい。なお、ラクトン化合物を2種以上併用する場合は、その総量が上記数値範囲となる。 The content of the lactone compound represented by formula (I) in the composition of the present invention is 0.00001% by weight to 10% by weight, and from the viewpoint of the effect on women's aging odor countermeasures, it is 0.00005% by weight. % to 5% by weight, more preferably 0.0001% to 3% by weight, even more preferably 0.0005% to 2% by weight, and 0.001% to 1% by weight. % by weight is particularly preferred. In addition, when using 2 or more types of lactone compounds together, the total amount falls within the above numerical range.
若年女性の体臭を構成する匂い成分は、上記式(I)で表されるラクトン化合物以外にも多種類存在する。本発明の組成物は、上記式(I)で表されるラクトン化合物以外のその他の若年女性の体臭を構成する匂い成分を含んでいてもよい。その他の若年女性の体臭を構成する匂い成分としては、例えばアルデヒド類、脂肪酸類、ケトン類、硫黄化合物(S系臭)、窒素化合物(N系臭)等が挙げられる。本発明の組成物が含むその他の若年女性の体臭を構成する匂い成分としては、女性の加齢に伴って体臭中の含有量が減少する成分が好ましい。 In addition to the lactone compound represented by the above formula (I), there are many types of odor components that constitute the body odor of young women. The composition of the present invention may contain odor components other than the lactone compound represented by formula (I), which constitute the body odor of young women. Other odor components that make up the body odor of young women include, for example, aldehydes, fatty acids, ketones, sulfur compounds (S-based odor), nitrogen compounds (N-based odor), and the like. As the other odor component that constitutes the body odor of young women contained in the composition of the present invention, a component whose content in the body odor decreases with aging of the woman is preferable.
本発明の組成物は、上述の成分以外にも、本発明の効果を損なわない範囲で、以下の任意成分を含むことができる。 In addition to the components described above, the composition of the present invention may contain the following optional components within a range that does not impair the effects of the present invention.
以下、本発明の組成物が(1)ヒトに対して用いる外用組成物である場合と、(2)ヒト以外に用いられる場合、具体的には繊維製品用、硬質表面用、空間用等として用いられる組成物である場合とに分けて説明する。 Hereinafter, when the composition of the present invention is (1) an external composition for use on humans, and (2) when it is used for something other than humans, it is specifically used for textile products, hard surfaces, spaces, etc. The description will be made separately for the case of the composition to be used.
(1)外用組成物である場合
本発明の組成物が外用組成物である場合、上記必須成分以外に含んでもよい任意成分としては、例えば、抗炎症剤、清涼化剤、殺菌剤、ビタミン類、有機酸、保湿成分、多価アルコール、スクラブ剤、紫外線吸収成分、紫外線散乱成分、収斂成分、ペプチド又はその誘導体、アミノ酸又はその誘導体、洗浄成分、角質柔軟成分、細胞賦活化成分、老化防止成分、血行促進作用成分、美白成分、粉体等が挙げられる。なお、本発明の組成物において、これらの成分はそれぞれ1種単独で用いてもよいし、2種以上を併用してもよい。
(1) When the composition of the present invention is a composition for external use When the composition of the present invention is a composition for external use, optional ingredients that may be included in addition to the above essential ingredients include, for example, anti-inflammatory agents, cooling agents, bactericidal agents, and vitamins. , organic acid, moisturizing ingredient, polyhydric alcohol, scrubbing agent, ultraviolet absorbing ingredient, ultraviolet scattering ingredient, astringent ingredient, peptide or its derivative, amino acid or its derivative, cleansing ingredient, keratin softening ingredient, cell activating ingredient, anti-aging ingredient , blood circulation-promoting ingredients, whitening ingredients, powders, and the like. In addition, in the composition of this invention, these components may each be used individually by 1 type, and may use 2 or more types together.
抗炎症剤としては、例えば、アラントイン及びその誘導体、グリチルレチン酸及びその誘導体、グリチルリチン酸及びその誘導体、サリチル酸誘導体、アミノカプロン酸、アズレン及びその誘導体、酸化亜鉛、酢酸トコフェロール、ヒドロコルチゾン、プレドニゾロン並びにこれらの塩等が挙げられる。中でも、アラントイン、アラントインクロルヒドロキシアルミニウム、アラントインジヒドロキシアルミニウム、グリチルレチン酸、グリチルリチン酸、グリチルレチン酸ステアリル、サリチル酸グリコール、サリチル酸メチル、イプシロンアミノカプロン酸、アズレン、グアイアズレン及びこれらの塩が好ましい。なお、ここで「誘導体」とは、記載の化合物のエステル、エーテル、アルキル化物、配糖体等をいう。またここで「塩」とは、例えば、硫酸、塩酸又はリン酸等の鉱酸の塩、マレイン酸又はメタンスルホン酸等の有機酸の塩、ナトリウム又はカリウム等のアルカリ金属塩、アルカリ土類金属塩、アンモニウム塩等をいう。 Anti-inflammatory agents include, for example, allantoin and its derivatives, glycyrrhetinic acid and its derivatives, glycyrrhizic acid and its derivatives, salicylic acid derivatives, aminocaproic acid, azulene and its derivatives, zinc oxide, tocopherol acetate, hydrocortisone, prednisolone and salts thereof. is mentioned. Among them, allantoin, allantoin chlorohydroxyaluminum, allantoin dihydroxyaluminum, glycyrrhetinic acid, glycyrrhizic acid, stearyl glycyrrhetinate, glycol salicylate, methyl salicylate, epsilonaminocaproic acid, azulene, guaiazulene and salts thereof are preferred. Here, the term "derivatives" refers to esters, ethers, alkylated products, glycosides, etc. of the described compounds. Here, the term "salt" includes, for example, salts of mineral acids such as sulfuric acid, hydrochloric acid or phosphoric acid, salts of organic acids such as maleic acid or methanesulfonic acid, alkali metal salts such as sodium or potassium, alkaline earth metal A salt, an ammonium salt, etc.
上記清涼化剤としては、例えば、メントール、カンフル、ボルネオール、ゲラニオール、シネオール、アネトール、リモネン、オイゲノール等のテルペン類(これらはd体、l体又はdl体のいずれでもよい。);ユーカリ油、ベルガモット油、ペパーミント油、クールミント油、スペアミント油、ウイキョウ油、ハッカ油、ケイヒ油、ローズ油、テレビン油等の精油等が挙げられる。 Examples of the cooling agent include terpenes such as menthol, camphor, borneol, geraniol, cineol, anethole, limonene, and eugenol (these may be d-, l-, or dl-forms); eucalyptus oil, bergamot oil, peppermint oil, cool mint oil, spearmint oil, fennel oil, peppermint oil, cinnamon oil, rose oil, and turpentine oil.
上記殺菌剤としては、例えば、イソプロピルメチルフェノール、クロルヘキシジン、サリチル酸、塩化ベンザルコニウム、アクリノール、エタノール、塩化ベンゼトニウム、クレゾール、グルコン酸及びその誘導体、ポピドンヨード、ヨウ化カリウム、ヨウ素、トリクロカルバン、トリクロサン、感光素101号、感光素201号、パラベン、フェノキシエタノール、1,2-ペンタンジオール、塩酸アルキルジアミノグリシン、ピロクトオラミン、ミコナゾール等が挙げられる。 Examples of the disinfectant include isopropylmethylphenol, chlorhexidine, salicylic acid, benzalkonium chloride, acrinol, ethanol, benzethonium chloride, cresol, gluconic acid and its derivatives, povidone-iodine, potassium iodide, iodine, triclocarban, triclosan, and photosensitizer. 101, 201, paraben, phenoxyethanol, 1,2-pentanediol, alkyldiaminoglycine hydrochloride, pyroctoolamine, miconazole and the like.
上記ビタミン類としては、水溶性ビタミン及び油溶性ビタミンのいずれであってもよく、例えば、ピリドキシン、ピリドキサール、ピリドキサミン、5’-リン酸ピリドキサール、及びそれらの塩(例えば、塩酸ピリドキシン、酢酸ピリドキシン、塩酸ピリドキサール、塩酸ピリドキサミン)等のビタミンB6類;パントテン酸、パントテン酸カルシウム、パントテニルアルコール(パンテノール)、D-パンテサイン、D-パンテチン、補酵素A、パントテニルエチルエーテル、及びそれらの塩等のパントテン酸類;ニコチン酸、ニコチン酸dl-α-トコフェロール、ニコチン酸ベンジル、ニコチン酸メチル、ニコチン酸β-ブトキシエチル、ニコチン酸1-(4-メチルフェニル)エチル、ニコチン酸アミド、及びそれらの塩等のニコチン酸類;γ-オリザノール、チアミン、ジベンゾイルチアミン、チアミンセチル、チアミンモノリン酸エステル、チアミンジリン酸エステル、チアミントリリン酸エステル、及びそれらの塩(例えば、ジベンゾイルチアミン塩酸塩、チアミン塩酸塩、チアミンセチル塩酸塩、チアミンチオシアン酸塩、チアミンラウリル塩酸塩、チアミン硝酸塩、チアミンモノリン酸塩、チアミンリジン塩、チアミントリリン酸塩、チアミンモノリン酸エステルリン酸塩、チアミンジリン酸エステル塩酸塩、チアミントリリン酸エステルモノリン酸塩)等のビタミンB1類;リボフラビン、フラビンモノヌクレオチド、フラビンアデニンジヌクレオチド、リボフラビン酪酸エステル、リボフラビンテトラ酪酸エステル、リボフラビン5’-リン酸エステルナトリウム、リボフラビンテトラニコチン酸エステル、及びそれらの塩等のビタミンB2類;ビオチン、ビオシチン、及びそれらの塩等のビオチン類;葉酸、プテロイルグルタミン酸、及びそれらの塩等の葉酸類;シアノコバラミン、ヒドロキソコバラミン、デオキシアデノシルコバラミン、及びそれらの塩等のビタミンB12類;アスコルビン酸、デヒドロアスコルビン酸、アスコルビン酸リン酸エステル、アスコルビン酸-2-グルコシド、3-O-エチルアスコルビン酸等のアスコルビン酸誘導体、及びそれらの塩(例えば、アスコルビン酸ナトリウム、アスコルビン酸リン酸エステルナトリウム、アスコルビン酸リン酸エステルマグネシウム)等の水溶性のビタミンC類;dl-α-トコフェロール、酢酸dl-α-トコフェロール、コハク酸dl-α-トコフェロール、コハク酸dl-α-トコフェロールカルシウム等のビタミンE類;アスコルビゲン-A、アスコルビン酸ステアリン酸エステル、アスコルビン酸パルミチン酸エステル、ジパルミチン酸L-アスコルビル、テトラ2-ヘキシルデカン酸アスコルビル等の油溶性のビタミンC類;エルゴカルシフェロール、コレカルシフェロール等のビタミンD類;フィロキノン、ファルノキノン等のビタミンK類;フェルラ酸等のビタミン様作用因子等が挙げられる。 The above vitamins may be either water-soluble vitamins or oil-soluble vitamins. pyridoxal, pyridoxamine hydrochloride); pantothenic acid, calcium pantothenate, pantothenyl alcohol (panthenol), D-panthesaine, D-pantethine, coenzyme A, pantothenyl ethyl ether, salts thereof, etc. Pantothenic acids; nicotinic acid, dl-α-tocopherol nicotinate, benzyl nicotinate, methyl nicotinate, β-butoxyethyl nicotinate, 1-(4-methylphenyl)ethyl nicotinate, nicotinamide, and salts thereof, etc. nicotinic acids; γ-oryzanol, thiamine, dibenzoylthiamine, thiamine cetyl, thiamine monophosphate, thiamine diphosphate, thiamine triphosphate, and salts thereof (e.g., dibenzoylthiamine hydrochloride, thiamine hydrochloride, thiamine Cetyl hydrochloride, thiamine thiocyanate, thiamine lauryl hydrochloride, thiamine nitrate, thiamine monophosphate, thiamine lysine, thiamine triphosphate, thiamine monophosphate phosphate, thiamine diphosphate hydrochloride, thiamine triphosphate riboflavin, flavin mononucleotide, flavin adenine dinucleotide, riboflavin butyrate, riboflavin tetrabutyrate, riboflavin 5′-phosphate sodium, riboflavin tetranicotinate, salts thereof, etc. biotins such as biotin, biocytin and salts thereof; folic acids such as folic acid, pteroylglutamic acid and salts thereof; vitamins such as cyanocobalamin, hydroxocobalamin, deoxyadenosylcobalamin and salts thereof B12 class; ascorbic acid, dehydroascorbic acid, ascorbic acid phosphate, ascorbic acid-2-glucoside, 3-O-ethylascorbic acid and other ascorbic acid derivatives, and salts thereof (e.g., sodium ascorbate, phosphorous ascorbate Water-soluble vitamin Cs such as sodium acid ester, magnesium ascorbic acid phosphate); vitamin E; ascorbigen-A, ascorbyl stearate, ascorbate palmitate, L-ascorbyl dipalmitate, oil-soluble vitamin C such as ascorbyl tetra-2-hexyldecanoate; ergocalciferol, cholecalciferol vitamin Ds such as phylloquinone and farnoquinone; vitamin Ks such as ferulic acid;
上記有機酸としては、例えば、グルコン酸、アスパラギン酸、アミノエチルスルホン酸、クエン酸、グルタミン酸、コハク酸、シュウ酸、フマル酸、プロピオン酸、リンゴ酸、サリチル酸、グリコール酸、フィチン酸、酒石酸、酢酸、乳酸、及びこれらの塩が挙げられる。塩としては、例えば、硫酸、塩酸又はリン酸等の鉱酸の塩、マレイン酸又はメタンスルホン酸等の有機酸の塩、ナトリウム又はカリウム等のアルカリ金属塩、アルカリ土類金属塩、アンモニウム塩等が挙げられる。 Examples of the organic acid include gluconic acid, aspartic acid, aminoethylsulfonic acid, citric acid, glutamic acid, succinic acid, oxalic acid, fumaric acid, propionic acid, malic acid, salicylic acid, glycolic acid, phytic acid, tartaric acid, and acetic acid. , lactic acid, and salts thereof. Salts include, for example, salts of mineral acids such as sulfuric acid, hydrochloric acid or phosphoric acid, salts of organic acids such as maleic acid or methanesulfonic acid, alkali metal salts such as sodium or potassium, alkaline earth metal salts, ammonium salts and the like. is mentioned.
上記保湿成分としては、例えば、ジグリセリントレハロース;ヒアルロン酸ナトリウム、ヘパリン類似物質、コンドロイチン硫酸ナトリウム、コラーゲン、エラスチン、ケラチン、キチン、キトサン等の高分子化合物;グリシン、アスパラギン酸、アルギニン等のアミノ酸;乳酸ナトリウム、尿素、ピロリドンカルボン酸ナトリウム等の天然保湿因子;セラミド、コレステロール、リン脂質等の脂質;カミツレエキス、ハマメリスエキス、チャエキス、シソエキス等の植物抽出エキス等が挙げられる。 Examples of the moisturizing ingredients include diglycerin trehalose; sodium hyaluronate, heparin analogs, sodium chondroitin sulfate, collagen, elastin, keratin, chitin, chitosan, and other high-molecular compounds; glycine, aspartic acid, arginine, and other amino acids; lactic acid. natural moisturizing factors such as sodium, urea and sodium pyrrolidonecarboxylate; lipids such as ceramide, cholesterol and phospholipids; and plant extracts such as chamomile extract, hamamelis extract, tea extract and perilla extract.
上記多価アルコールとしては、炭素数2~10のものが好ましく、例えば、グリセリン、ジグリセリン、トリグリセリン、プロピレングリコール、ジプロピレングリコール、1,3-ブタンジオール、エチレングリコール、ジエチレングリコール、イソプレングリコール、1、3-ブチレングリコール、ソルビトール、キシリトール、エリスリトール、マンニトール、ペンタンジオール、ヘキサンジオール、オクタンジオール、デカンジオール、ネオペンチルグリコール等が挙げられる。これらの中でも、グリセリン、ジグリセリン、トリグリセリン、プロピレングリコール、ジプロピレングリコール、1,3-ブタンジオール、エチレングリコール、ジエチレングリコール、イソプレングリコール、ソルビトール、キシリトール、エリスリトール、マンニトール、ペンタンジオール、ヘキサンジオール、オクタンジオールが好ましく、グリセリン、ジグリセリン、プロピレングリコール、ジプロピレングリコール、1,3-ブタンジオール、ジエチレングリコール、イソプレングリコール、ソルビトール、キシリトール、エリスリトール、マンニトール、ペンタンジオール、ヘキサンジオールがより好ましい。 As the polyhydric alcohol, those having 2 to 10 carbon atoms are preferable, and examples thereof include glycerin, diglycerin, triglycerin, propylene glycol, dipropylene glycol, 1,3-butanediol, ethylene glycol, diethylene glycol, isoprene glycol, 1 , 3-butylene glycol, sorbitol, xylitol, erythritol, mannitol, pentanediol, hexanediol, octanediol, decanediol, neopentyl glycol and the like. Among these, glycerin, diglycerin, triglycerin, propylene glycol, dipropylene glycol, 1,3-butanediol, ethylene glycol, diethylene glycol, isoprene glycol, sorbitol, xylitol, erythritol, mannitol, pentanediol, hexanediol, octanediol are preferred, and glycerin, diglycerin, propylene glycol, dipropylene glycol, 1,3-butanediol, diethylene glycol, isoprene glycol, sorbitol, xylitol, erythritol, mannitol, pentanediol and hexanediol are more preferred.
上記スクラブ剤としては、例えば、アプリコット核粉末、アーモンド殻粉末、アンズ核粉末、塩化ナトリウム粒、オリーブ核粉末、海水乾燥物粒、キャンデリラワックス、くるみ殻粉末、さくらんぼ核粉末、サンゴ粉末、炭粉末、はしばみ殻粉末、ポリエチレン末、無水ケイ酸等が挙げられる。 Examples of the scrubbing agent include apricot kernel powder, almond shell powder, apricot kernel powder, sodium chloride grains, olive kernel powder, seawater dried grains, candelilla wax, walnut shell powder, cherry kernel powder, coral powder, and charcoal powder. , husk powder, polyethylene powder, silicic anhydride, and the like.
上記紫外線吸収成分としては、例えば、オクチルトリアゾン、ジメトキシベンジリデンジオキソイミダゾリジンプロピオン酸オクチル、パラメトキシケイ皮酸2-エチルヘキシル、フェニルベンズイミダゾールスルホン酸等が挙げられる。 Examples of the ultraviolet absorbing component include octyltriazone, dimethoxybenzylidenedioxoimidazolidinepropionate, 2-ethylhexyl paramethoxycinnamate, and phenylbenzimidazole sulfonic acid.
上記紫外線散乱成分としては、例えば、含水ケイ酸、ケイ酸亜鉛、ケイ酸セリウム、ケイ酸チタン、酸化ジルコニウム、酸化セリウム、酸化チタン、酸化鉄、無水ケイ酸等の無機化合物、これらの無機化合物を含水ケイ酸、水酸化アルミニウム、マイカやタルク等の無機粉体で被覆したり、ポリアミド、ポリエチレン、ポリエステル、ポリスチレン、ナイロン等の樹脂粉体に複合化したもの、さらにシリコーン油や脂肪酸アルミニウム塩等で処理したもの等が挙げられる。 Examples of the ultraviolet scattering component include inorganic compounds such as hydrous silicic acid, zinc silicate, cerium silicate, titanium silicate, zirconium oxide, cerium oxide, titanium oxide, iron oxide, and silicic anhydride, and these inorganic compounds. Coated with inorganic powder such as hydrated silicic acid, aluminum hydroxide, mica and talc, compounded with resin powder such as polyamide, polyethylene, polyester, polystyrene, nylon, silicone oil and fatty acid aluminum salt etc. processed ones, and the like.
上記収斂成分としては、例えば、硫酸亜鉛、塩化アルミニウム、スルホ石炭酸亜鉛、タンニン酸等が挙げられる。 Examples of the astringent component include zinc sulfate, aluminum chloride, zinc sulfonate, and tannic acid.
上記ペプチド又はその誘導体としては、例えば、ケラチン分解ペプチド、加水分解ケラチン、コラーゲン、魚由来コラーゲン、アテロコラーゲン、ゼラチン、エラスチン、エラスチン分解ペプチド、コラーゲン分解ペプチド、加水分解コラーゲン、塩化ヒドロキシプロピルアンモニウム加水分解コラーゲン、エラスチン分解ペプチド、コンキオリン分解ペプチド、加水分解コンキオリン、シルク蛋白分解ペプチド、加水分解シルク、ラウロイル加水分解シルクナトリウム、大豆蛋白分解ペプチド、加水分解大豆蛋白、小麦蛋白、小麦蛋白分解ペプチド、加水分解小麦蛋白、カゼイン分解ペプチド、アシル化ペプチド(パルミトイルオリゴペプチド、パルミトイルペンタペプチド、パルミトイルテトラペプチド等)等が挙げられる。 Examples of the peptides or derivatives thereof include keratin-degrading peptides, hydrolyzed keratin, collagen, fish-derived collagen, atelocollagen, gelatin, elastin, elastin-degrading peptides, collagen-degrading peptides, hydrolyzed collagen, hydroxypropylammonium chloride hydrolyzed collagen, Elastin-degrading peptide, conchiolin-degrading peptide, hydrolyzed conchiolin, silk proteolytic peptide, hydrolyzed silk, lauroyl hydrolyzed silk sodium, soybean proteolytic peptide, hydrolyzed soybean protein, wheat protein, wheat proteolytic peptide, hydrolyzed wheat protein, Examples include casein-degraded peptides, acylated peptides (palmitoyl oligopeptide, palmitoyl pentapeptide, palmitoyl tetrapeptide, etc.).
上記アミノ酸又はその誘導体としては、例えば、ベタイン(トリメチルグリシン)、プロリン、ヒドロキシプロリン、アルギニン、リジン、セリン、グリシン、アラニン、フェニルアラニン、β-アラニン、スレオニン、グルタミン酸、グルタミン、アスパラギン、アスパラギン酸、システイン、シスチン、メチオニン、ロイシン、イソロイシン、バリン、ヒスチジン、タウリン、γ-アミノ酪酸、γ-アミノ-β-ヒドロキシ酪酸、カルニチン、カルノシン、クレアチン等が挙げられる。 Examples of the above amino acids or derivatives thereof include betaine (trimethylglycine), proline, hydroxyproline, arginine, lysine, serine, glycine, alanine, phenylalanine, β-alanine, threonine, glutamic acid, glutamine, asparagine, aspartic acid, cysteine, Cystine, methionine, leucine, isoleucine, valine, histidine, taurine, γ-aminobutyric acid, γ-amino-β-hydroxybutyric acid, carnitine, carnosine, creatine and the like.
上記洗浄成分としては、例えば、ラウリン酸カリウム、ミリスチン酸カリウム、パルミチン酸カリウム又はステアリン酸カリウム等のアルカリ金属塩、アルカノールアミド塩又はアミノ酸塩等から選ばれる石けん類;ココイルグルタミン酸Na、ココイルメチルタウリンNa等のアミノ酸系界面活性剤;ラウレス硫酸Na等のエーテル硫酸エステル塩;ラウリルエーテル酢酸Na等のエーテルカルボン酸塩;アルキルスルホコハク酸エステルNa等のスルホコハク酸エステル塩;ヤシ油脂肪酸モノエタノールアミド、ヤシ油脂肪酸ジエタノールアミド等の脂肪酸アルカノールアミド;ラウリルリン酸ナトリウム、ポリオキシエチレンラウリルエーテルリン酸ナトリウム等のモノアルキルリン酸エステル塩;ヤシ油脂肪酸アミドプロピルジメチルアミノ酢酸ベタイン、ラウリルジメチルアミノ酢酸ベタイン、2-アルキル-N-カルボキシメチル-N-ヒドロキシエチルイミダゾリニウムベタイン、ラウリルヒドロキシスルホベタイン及びラウロイルアミドエチルヒドロキシエチルカルボキシメチルベタインヒドロキシプロピルリン酸ナトリウム等のベタイン型両性界面活性剤;ラウリルアミノプロピオン酸ナトリウム等のアミノ酸型両性界面活性剤等が挙げられる。 Examples of the cleaning component include soaps selected from alkaline metal salts such as potassium laurate, potassium myristate, potassium palmitate or potassium stearate, alkanolamide salts or amino acid salts; sodium cocoyl glutamate, sodium cocoyl methyltaurate. Amino acid-based surfactants such as amino acid-based surfactants; ether sulfate salts such as sodium laureth sulfate; ether carboxylates such as sodium lauryl ether acetate; sulfosuccinate salts such as alkyl sulfosuccinate Na; coconut oil fatty acid monoethanolamide, coconut oil Fatty acid alkanolamides such as fatty acid diethanolamide; monoalkyl phosphate ester salts such as sodium lauryl phosphate and sodium polyoxyethylene lauryl ether phosphate; coconut oil fatty acid amidopropyl dimethylamino acetate betaine, lauryl dimethylamino acetate betaine, 2-alkyl -N-carboxymethyl-N-hydroxyethylimidazolinium betaine, lauryl hydroxysulfobetaine and lauroylamidoethyl hydroxyethyl carboxymethyl betaine betaine-type amphoteric surfactants such as sodium hydroxypropyl phosphate; amino acids such as sodium laurylaminopropionate type amphoteric surfactants, and the like.
上記角質柔軟成分としては、例えば、乳酸、サリチル酸、グルコン酸、クエン酸、リンゴ酸、フルーツ酸、フィチン酸、尿素、イオウ等が挙げられる。 Examples of the keratin softening component include lactic acid, salicylic acid, gluconic acid, citric acid, malic acid, fruit acid, phytic acid, urea, and sulfur.
上記細胞賦活化成分としては、例えば、γ-アミノ酪酸等のアミノ酸類;レチノール、チアミン、リボフラビン、塩酸ピリドキシン、パントテン酸類等のビタミン類;グリコール酸、乳酸等のα-ヒドロキシ酸類;タンニン、フラボノイド、サポニン、感光素301号等が挙げられる。 Examples of the cell-activating components include amino acids such as γ-aminobutyric acid; vitamins such as retinol, thiamine, riboflavin, pyridoxine hydrochloride, and pantothenic acids; α-hydroxy acids such as glycolic acid and lactic acid; tannins, flavonoids, saponin, photosensitizer No. 301, and the like.
上記老化防止成分としては、例えば、パンガミン酸、カイネチン、ウルソール酸、ウコンエキス、スフィンゴシン誘導体、ケイ素、ケイ酸、N-メチル-L-セリン、メバロノラクトン等が挙げられる。 Examples of the antiaging component include pangamic acid, kinetin, ursolic acid, turmeric extract, sphingosine derivatives, silicon, silicic acid, N-methyl-L-serine, and mevalonolactone.
上記血行促進作用成分としては、植物(例えば、オタネニンジン、アシタバ、アルニカ、イチョウ、ウイキョウ、エンメイソウ、オランダカシ、カミツレ、ローマカミツレ、カロット、ゲンチアナ、ゴボウ、コメ、サンザシ、シイタケ、ショウガ、セイヨウサンザシ、セイヨウネズ、センキュウ、センブリ、タイム、チョウジ、チンピ、トウガラシ、トウキ、トウニン、トウヒ、ニンジン、ニンニク、ブッチャーブルーム、ブドウ、ボタン、マロニエ、メリッサ、ユズ、ヨクイニン、リョクチャ、ローズマリー、ローズヒップ、チンピ、トウキ、トウヒ、モモ、アンズ、クルミ、トウモロコシ等)に由来する成分;アセチルコリン、イクタモール、カンタリスチンキ、ガンマーオリザノール、セファランチン、トラゾリン、ニコチン酸トコフェロール、グルコシルヘスペリジン等が挙げられる。 Examples of the blood circulation-promoting ingredients include plants (e.g., Panax ginseng, Angelica keiskei, Arnica, Ginkgo biloba, Fennel, Trichophyllum japonicum, Holland oak, Chamomile, Roman chamomile, Carrot, Gentian, Burdock, Rice, Hawthorn, Shiitake mushroom, Ginger, Hawthorn, Juniperus juniper). , Cnidium, Senburi, Thyme, Clove, Chimp, Chili Pepper, Angelica, Tonin, Spruce, Carrot, Garlic, Butcher Bloom, Grape, Button, Horse Chestnut, Melissa, Yuzu, Yokuinin, Ryokucha, Rosemary, Rosehip, Chimp, Angelica, spruce, peach, apricot, walnut, corn, etc.); acetylcholine, ictamol, cantharis tincture, gamma oryzanol, cepharanthine, tolazoline, tocopherol nicotinate, glucosyl hesperidin, and the like.
上記美白成分としては、例えば、トコフェロール、トラネキサム酸等が挙げられる。 Examples of the whitening ingredients include tocopherol and tranexamic acid.
上記粉体成分としては、例えば、オクテニルコハク酸デンプンAl(オクテニルコハク酸デンプンアルミニウム)、タルク、コーンスターチ、水酸化マグネシウム、無水ケイ酸、軽質無水ケイ酸、マイカ、ヒドロキシアパタイト、酸化亜鉛、酸化チタン、ナイロン末、炭等が挙げられる。 Examples of the powder component include starch octenylsuccinate Al (starch aluminum octenylsuccinate), talc, corn starch, magnesium hydroxide, silicic anhydride, light silicic anhydride, mica, hydroxyapatite, zinc oxide, titanium oxide, and nylon powder. , charcoal and the like.
<pH>
本発明の外用組成物のpHは、通常pH3.0~8.0であり、pH3.5~7.5であることが好ましい。なお、このpHは、例えば後述するpH調整剤の使用により調整することができる。
<pH>
The pH of the topical composition of the present invention is generally pH 3.0 to 8.0, preferably pH 3.5 to 7.5. In addition, this pH can be adjusted, for example, by using a pH adjuster to be described later.
<外用組成物の製造方法>
本発明の外用組成物の製造方法は特に制限されず、必須成分である上記式(I)で表されるラクトン化合物、必要に応じて配合されるその他の若年女性の体臭を構成する匂い成分、外用組成物を製造するのに必要な各種成分(上記任意成分、後述する基剤又は担体、添加剤等)を適宜選択、配合して、常法により製造することができる。なお、本発明の外用組成物は乳化を行った組成物であってもよいし、可溶化させた組成物であってもよいし、溶解させた組成物であってもよい。
<Method for producing composition for external use>
The method for producing the composition for external use of the present invention is not particularly limited. Various components necessary for producing the composition for external use (the above optional components, the base or carrier described later, additives, etc.) can be appropriately selected and blended, and the composition can be produced by a conventional method. The composition for external use of the present invention may be an emulsified composition, a solubilized composition, or a dissolved composition.
<外用組成物の用途>
本発明の外用組成物は、例えば中年以降の加齢臭が気になる女性に対し、加齢と共に減少する匂い成分を含む本発明の外用組成物を用いることで、若年女性の体臭を構成する匂い成分を補い、体臭を若返らせ、加齢臭と感じさせるニオイを抑えることができる。このように、本発明の外用組成物は、女性の加齢臭対策のために使用することができる。このような目的で使用する本発明の外用組成物は、例えばボディソープ、洗顔剤等の洗浄剤、シャンプー、トリートメント、ドライシャンプー等のヘアケア剤、クレンジング剤、デオドラント剤、制汗剤、軟膏剤、液剤、懸濁剤、乳化剤(乳液及びクリーム)、ゲル剤、リニメント剤、ローション剤、パップ剤、ミスト、エアゾール剤、パウダー、顆粒等として好適に使用することができる。
<Uses of the composition for external use>
The composition for external use of the present invention, for example, for middle-aged and older women who are concerned about body odor caused by aging, uses the composition for external use of the present invention containing an odor component that decreases with age, thereby forming a body odor for young women. It supplements the odor components that cause body odor, rejuvenates body odor, and suppresses odors that make you feel like you are aging. Thus, the composition for external use of the present invention can be used as a countermeasure against aging odor in women. The composition for external use of the present invention used for such purposes includes, for example, cleaning agents such as body soaps and facial cleansers, hair care agents such as shampoos, treatments and dry shampoos, cleansing agents, deodorants, antiperspirants, ointments, It can be suitably used as liquids, suspensions, emulsifiers (emulsions and creams), gels, liniments, lotions, poultices, mists, aerosols, powders, granules and the like.
<製剤>
本発明の外用組成物は、その必須成分及び上記で説明したその他の成分等を、化粧品、医薬品、医薬部外品に通常使用される基剤又は担体、及び必要に応じて、後述する添加剤と共に常法に従い混合して、必要に応じて乳化又は可溶化を行い、各種の製剤形態の外用組成物とすることができる。
<Formulation>
The composition for external use of the present invention contains the essential ingredients and other ingredients described above, etc., as a base or carrier commonly used in cosmetics, pharmaceuticals, and quasi-drugs, and if necessary, additives described later. In accordance with a conventional method, emulsification or solubilization is carried out as necessary to prepare compositions for external use in various formulation forms.
上記基剤又は担体としては、例えば、流動パラフィン、スクワラン、ワセリン、ゲル化炭化水素(プラスチベース等)、オゾケライト、α-オレフィンオリゴマー、軽質流動パラフィン等の炭化水素;メチルポリシロキサン、高重合メチルポリシロキサン、環状シリコーン、アルキル変性シリコーン、アミノ変性シリコーン、ポリエーテル変性シリコーン、ポリグリセリン変性シリコーン、シリコーン・アルキル鎖共変性ポリエーテル変性シリコーン、シリコーン・アルキル鎖共変性ポリグリセリン変性シリコーン、ポリエーテル変性分岐シリコーン、ポリグリセリン変性分岐シリコーン、アクリルシリコーン、フェニル変性シリコーン、シリコーンレジン等のシリコーン油;ヤシ油、オリーブ油、コメヌカ油、シアバター等の油脂;ホホバ油、ミウロウ、キャンデリラロウ、ラノリン等のロウ類;セタノール、セトステアリルアルコール、ステアリルアルコール、ベヘニルアルコール、オクチルドデカノール、イソステアリルアルコール、フィトステロール、コレステロール等の高級アルコール;エチルセルロース、ヒドロキシプロピルセルロース、ヒドロキシプロピルメチルセルロース等のセルロース誘導体;ポリビニルピロリドン;カラギーナン;ポリビニルブチラート;ポリエチレングリコール;ジオキサン;ブチレングリコールアジピン酸ポリエステル;アジピン酸ジイソプロピル、ミリスチン酸イソプロピル、ミリスチン酸オクチルドデシル、パルミチン酸イソプロピル、パルミチン酸セチル、イソノナン酸イソノニル、テトラ2-エチルヘキサン酸ペンタエリスリット等のエステル類;デキストリン、マルトデキストリン等の多糖類;カルボキシビニルポリマー、アルキル変性カルボキシビニルポリマー等のビニル系高分子;エタノール、イソプロパノール等の低級アルコール;エチレングリコールモノメチルエーテル、エチレングリコールモノエチルエーテル、エチレングリコールモノプロピルエーテル、ジエチレングリコールモノメチルエーテル、ジエチレングリコールモノエチルエーテル、ジエチレングリコールモノプロピルエーテル、ジエチレングリコールモノブチルエーテル、プロピレングリコールモノエチルエーテル、プロピレングリコールモノプロピルエーテル、ジプロピレングリコールモノエチルエーテル、ジプロピレングリコールモノプロピルエーテル等のグリコールエーテル;水等が挙げられる。 Examples of the base or carrier include liquid paraffin, squalane, petrolatum, gelling hydrocarbons (Plastibase, etc.), ozokerite, α-olefin oligomers, hydrocarbons such as light liquid paraffin; methylpolysiloxane, highly polymerized methylpolysiloxane. , cyclic silicone, alkyl-modified silicone, amino-modified silicone, polyether-modified silicone, polyglycerin-modified silicone, silicone/alkyl chain co-modified polyether-modified silicone, silicone/alkyl chain co-modified polyglycerin-modified silicone, polyether-modified branched silicone, Silicone oils such as polyglycerin-modified branched silicones, acrylic silicones, phenyl-modified silicones, and silicone resins; oils and fats such as coconut oil, olive oil, rice bran oil, and shea butter; waxes such as jojoba oil, bee wax, candelilla wax, and lanolin; cetanol , cetostearyl alcohol, stearyl alcohol, behenyl alcohol, octyldodecanol, isostearyl alcohol, phytosterol, higher alcohols such as cholesterol; cellulose derivatives such as ethyl cellulose, hydroxypropyl cellulose, hydroxypropyl methyl cellulose; polyvinylpyrrolidone; carrageenan; polyvinyl butyrate; polyethylene glycol; dioxane; butylene glycol adipate polyester; esters such as diisopropyl adipate, isopropyl myristate, octyldodecyl myristate, isopropyl palmitate, cetyl palmitate, isononyl isononanoate, pentaerythrityl tetra-2-ethylhexanoate; dextrin , Polysaccharides such as maltodextrin; Vinyl polymers such as carboxyvinyl polymer and alkyl-modified carboxyvinyl polymer; Lower alcohols such as ethanol and isopropanol; Ethylene glycol monomethyl ether, ethylene glycol monoethyl ether, ethylene glycol monopropyl ether, diethylene glycol Glycol ethers such as monomethyl ether, diethylene glycol monoethyl ether, diethylene glycol monopropyl ether, diethylene glycol monobutyl ether, propylene glycol monoethyl ether, propylene glycol monopropyl ether, dipropylene glycol monoethyl ether, dipropylene glycol monopropyl ether; mentioned.
本発明の外用組成物が水及び低級アルコール以外の基剤又は担体を含む場合、上記基剤または担体としては、例えば、高級アルコール、炭化水素、油脂、エステル類、シリコーン油、ロウ類、ビニル系高分子が好ましく、高級アルコール、エステル油、シリコーン油、ビニル系高分子がより好ましい。これらの成分の中では、セタノール、セトステアリルアルコール、ステアリルアルコール、ベヘニルアルコール、トリ2-エチルヘキサン酸グリセリル、ジメチコン、シクロメチコン、ポリエーテル変性シリコーン、ポリグリセリン変性シリコーン、カルボキシビニルポリマーがさらに好ましい。 When the composition for external use of the present invention contains a base or carrier other than water and a lower alcohol, examples of the base or carrier include higher alcohols, hydrocarbons, fats, esters, silicone oils, waxes, vinyl-based Polymers are preferred, and higher alcohols, ester oils, silicone oils and vinyl polymers are more preferred. Among these components, cetanol, cetostearyl alcohol, stearyl alcohol, behenyl alcohol, glyceryl tri-2-ethylhexanoate, dimethicone, cyclomethicone, polyether-modified silicone, polyglycerin-modified silicone, and carboxyvinyl polymer are more preferred.
以上説明した基剤又は担体は、1種単独で用いてもよいし、2種以上を併用してもよい。またそれらの使用量は当業者に公知の範囲から適宜選択される。 One of the bases or carriers described above may be used alone, or two or more thereof may be used in combination. In addition, the amount of these to be used is appropriately selected from the range known to those skilled in the art.
<添加剤>
本発明の外用組成物には、本発明の効果を損なわない範囲で、化粧品、医薬品、医薬部外品に添加される公知の添加剤、例えば、界面活性剤、安定化剤、酸化防止剤、着色剤、パール光沢付与剤、分散剤、キレート剤、pH調整剤、保存剤、増粘剤、刺激低減剤等を添加することができる。これらの添加剤は、1種単独で用いてもよいし、2種以上を併用することもできる。
<Additive>
The composition for external use of the present invention may contain known additives added to cosmetics, pharmaceuticals, and quasi-drugs, such as surfactants, stabilizers, antioxidants, to the extent that the effects of the present invention are not impaired. Coloring agents, pearl luster imparting agents, dispersing agents, chelating agents, pH adjusting agents, preservatives, thickening agents, irritation reducing agents and the like can be added. These additives may be used singly or in combination of two or more.
上記界面活性剤としては、非イオン性界面活性剤、陽イオン性界面活性剤、陰イオン性界面活性剤、両性界面活性剤等のいずれでもよく、例えば、ソルビタンモノイソステアレート、ソルビタンモノラウレート、ソルビタンモノパルミテート、ソルビタンモノステアレート、ペンタ-2-エチルヘキシル酸ジグリセロールソルビタン、テトラ-2-エチルヘキシル酸ジグリセロールソルビタン等のソルビタン脂肪酸エステル類;モノステアリン酸プロピレングリコール等のプロピレングリコール脂肪酸エステル類;ポリオキシエチレン硬化ヒマシ油40(HCO-40)、ポリオキシエチレン硬化ヒマシ油50(HCO-50)、ポリオキシエチレン硬化ヒマシ油60(HCO-60)、ポリオキシエチレン硬化ヒマシ油80等の硬化ヒマシ油誘導体;モノラウリル酸ポリオキシエチレン(20)ソルビタン(ポリソルベート20)、モノステアリン酸ポリオキシエチレン(20)ソルビタン(ポリソルベート60)、モノオレイン酸ポリオキシエチレン(20)ソルビタン(ポリソルベート80)、イソステアリン酸ポリオキシエチレン(20)ソルビタン等のポリオキシエチレンソルビタン脂肪酸エステル類;ポリオキシエチレンモノヤシ油脂肪酸グリセリル;グリセリンアルキルエーテル;アルキルグルコシド;ポリオキシエチレンセチルエーテル等のポリオキシアルキレンアルキルエーテル;ステアリルアミン、オレイルアミン等のアミン類;ポリオキシエチレン・メチルポリシロキサン共重合体、ラウリルPEG-9ポリジメチルシロキシエチルジメチコン、PEG-9ポリジメチルシロキシエチルジメチコン等のシリコーン系界面活性剤等が挙げられる。これらのうち、非イオン性界面活性剤が好ましく、硬化ヒマシ油誘導体、ポリオキシエチレンソルビタン脂肪酸エステル類、ポリオキシアルキレンアルキルエーテルがより好ましい。
Examples of the surfactant include nonionic surfactants, cationic surfactants, anionic surfactants, amphoteric surfactants, and the like. Examples include sorbitan monoisostearate and sorbitan monolaurate. , sorbitan monopalmitate, sorbitan monostearate, diglycerol sorbitan penta-2-ethylhexylate, and diglycerol sorbitan tetra-2-ethylhexylate; propylene glycol fatty acid esters such as propylene glycol monostearate; Hydrogenated castor such as polyoxyethylene hydrogenated castor oil 40 (HCO-40), polyoxyethylene hydrogenated castor oil 50 (HCO-50), polyoxyethylene hydrogenated castor oil 60 (HCO-60), polyoxyethylene hydrogenated
上記安定化剤としては、例えば、ポリアクリル酸ナトリウム、ジブチルヒドロキシトルエン、ブチルヒドロキシアニソール等が挙げられる。 Examples of the stabilizer include sodium polyacrylate, dibutylhydroxytoluene, butylhydroxyanisole and the like.
上記酸化防止剤としては、例えば、ジブチルヒドロキシトルエン、ブチルヒドロキシアニソール、ソルビン酸、亜硫酸ナトリウム、アスコルビン酸、エリソルビン酸、L-システイン塩酸塩等が挙げられる。 Examples of the antioxidant include dibutylhydroxytoluene, butylhydroxyanisole, sorbic acid, sodium sulfite, ascorbic acid, erythorbic acid, L-cysteine hydrochloride and the like.
上記着色剤としては、例えば、無機顔料、天然色素等が挙げられる。 Examples of the coloring agent include inorganic pigments and natural pigments.
上記パール光沢付与剤としては、例えばジステアリン酸エチレングリコール、モノステアリン酸エチレングリコール、ジステアリン酸トリエチレングリコール等が挙げられる。 Examples of the pearl luster imparting agent include ethylene glycol distearate, ethylene glycol monostearate, and triethylene glycol distearate.
上記分散剤としては、例えば、ピロリン酸ナトリウム、ヘキサメタリン酸ナトリウム、ポリビニルアルコール、ポリビニルピロリドン、メチルビニルエーテル/無水マレイン酸架橋コポリマー、有機酸等が挙げられる。 Examples of the dispersant include sodium pyrophosphate, sodium hexametaphosphate, polyvinyl alcohol, polyvinylpyrrolidone, methyl vinyl ether/maleic anhydride crosslinked copolymer, organic acid and the like.
上記キレート剤としては、例えば、EDTA・2ナトリウム塩、EDTA・カルシウム・2ナトリウム塩等が挙げられる。 Examples of the chelating agent include EDTA.disodium salt, EDTA.calcium.disodium salt, and the like.
上記pH調整剤としては、例えば無機酸(塩酸、硫酸等)、有機酸(乳酸、乳酸ナトリウム、クエン酸、クエン酸ナトリウム、コハク酸、コハク酸ナトリウム等)、無機塩基(水酸化カリウム、水酸化ナトリウム等)、有機塩基(トリエタノールアミン、ジイソプロパノールアミン、トリイソプロパノールアミン等)等が挙げられる。中でも、無機塩基及び/又は有機塩基が好ましく、水酸化カリウム、トリエタノールアミンがより好ましい。 Examples of the pH adjuster include inorganic acids (hydrochloric acid, sulfuric acid, etc.), organic acids (lactic acid, sodium lactate, citric acid, sodium citrate, succinic acid, sodium succinate, etc.), inorganic bases (potassium hydroxide, hydroxide sodium, etc.), organic bases (triethanolamine, diisopropanolamine, triisopropanolamine, etc.), and the like. Among them, inorganic bases and/or organic bases are preferred, and potassium hydroxide and triethanolamine are more preferred.
上記保存剤としては、例えば、安息香酸、安息香酸ナトリウム、デヒドロ酢酸、デヒドロ酢酸ナトリウム、パラオキシ安息香酸イソブチル、パラオキシ安息香酸イソプロピル、パラオキシ安息香酸ブチル、パラオキシ安息香酸エチル、パラオキシ安息香酸プロピル、パラオキシ安息香酸ベンジル、パラオキシ安息香酸メチル、フェノキシエタノール等が挙げられる。 Examples of the preservative include benzoic acid, sodium benzoate, dehydroacetic acid, sodium dehydroacetate, isobutyl parahydroxybenzoate, isopropyl parahydroxybenzoate, butyl parahydroxybenzoate, ethyl parahydroxybenzoate, propyl parahydroxybenzoate, and parahydroxybenzoic acid. benzyl, methyl paraoxybenzoate, phenoxyethanol and the like.
上記増粘剤としては、例えば、ポリビニルアルコール、ポリビニルピロリドン、カルボキシビニルポリマー等のビニル系増粘剤、メチルセルロース、エチルセルロース、ヒドロキシエチルセルロース、ヒドロキシメチルセルロース、ヒドロキシプロピルセルロース、ヒドロキシプロピルメチルセルロース、カルボキシメチルセルロース、カルボキシエチルセルロース等のセルロース系増粘剤、グアーガム、ペクチン、プルラン、ゼラチン、ローカストビーンガム、カラギーナン、寒天、キサンタンガム、アクリル酸メタクリル酸アルキル共重合体、ポリエチレングリコール、ベントナイト、アルギン酸、アルギン酸プロピレングリコール、マクロゴール、コンドロイチン硫酸ナトリウム、ヒアルロン酸、ヒアルロン酸ナトリウム、(アクリル酸ヒドロキシエチル/アクリロイルジメチルタウリンNa)コポリマー、(アクリロイルジメチルタウリンアンモニウム/ビニルピロリドン)コポリマー等が挙げられる。これらのうち、ビニル系増粘剤、セルロース系増粘剤が好ましく、カルボキシビニルポリマー、ポリビニルアルコール、ポリビニルピロリドン、メチルセルロース、エチルセルロース、ヒドロキシエチルセルロース、ヒドロキシメチルセルロース、ヒドロキシプロピルセルロース、ヒドロキシプロピルメチルセルロース、カルボキシメチルセルロース、カルボキシエチルセルロースがより好ましい。 Examples of the thickener include vinyl thickeners such as polyvinyl alcohol, polyvinylpyrrolidone and carboxyvinyl polymer, methylcellulose, ethylcellulose, hydroxyethylcellulose, hydroxymethylcellulose, hydroxypropylcellulose, hydroxypropylmethylcellulose, carboxymethylcellulose, carboxyethylcellulose, and the like. cellulose thickener, guar gum, pectin, pullulan, gelatin, locust bean gum, carrageenan, agar, xanthan gum, alkyl acrylate methacrylate copolymer, polyethylene glycol, bentonite, alginic acid, propylene glycol alginate, macrogol, chondroitin sulfate. sodium, hyaluronic acid, sodium hyaluronate, (hydroxyethyl acrylate/acryloyldimethyltaurate Na) copolymer, (acryloyldimethyltaurate ammonium/vinylpyrrolidone) copolymer, and the like. Among these, vinyl-based thickeners and cellulose-based thickeners are preferable, and carboxyvinyl polymer, polyvinyl alcohol, polyvinylpyrrolidone, methylcellulose, ethylcellulose, hydroxyethylcellulose, hydroxymethylcellulose, hydroxypropylcellulose, hydroxypropylmethylcellulose, carboxymethylcellulose, carboxy Ethyl cellulose is more preferred.
上記刺激低減剤としては、例えば、甘草エキス、アルギン酸ナトリウム、アラビアゴム、ポリビニルピロリドン等が挙げられる。 Examples of the irritation reducing agent include licorice extract, sodium alginate, gum arabic, polyvinylpyrrolidone, and the like.
<製剤形態>
本発明の外用組成物の製剤形態は特に限定されず、例えば、軟膏剤、液剤、懸濁剤、乳化剤(乳液及びクリーム)、ゲル剤、リニメント剤、ローション剤、パップ剤、ミスト、エアゾール剤、パウダー、顆粒等が挙げられる。これらのうち、液状~半固体状の製剤形態が好ましく、特に、液剤、ローション剤、軟膏剤、ゲル剤、乳化剤に適用すると有用である。これらの製剤は、常法、例えば第17改正日本薬局方製剤総則に記載の方法等に従い製造することができる。
<Formulation form>
The formulation form of the composition for external use of the present invention is not particularly limited. powders, granules, and the like. Among these, liquid to semi-solid formulations are preferred, and are particularly useful when applied to liquids, lotions, ointments, gels, and emulsifiers. These formulations can be produced according to a conventional method, for example, the method described in the Japanese Pharmacopoeia General Rules for Pharmaceutical Preparations, 17th Edition.
(2)ヒト以外に用いられる組成物である場合
本発明の組成物がヒト以外に用いられる場合、具体的には繊維製品用、硬質表面用、空間用等として用いられる組成物である場合、上記必須成分以外に含んでもよい任意成分としては、例えば、多価アルコール、界面活性剤、消臭剤、一般に使用される各種の溶剤、油剤、ゲル化剤、硫酸ナトリウムやN,N,N-トリメチルグリシン等の塩、pH調整剤、酸化防止剤、防腐剤、殺菌・抗菌剤、香料、色素、紫外線吸収剤等が挙げられる。なお、上記組成物において、これらの成分はそれぞれ1種単独で用いてもよいし、2種以上を併用してもよい。更に、多価アルコール類や界面活性剤は、繊維製品、硬質表面、人体、ペット等に付着した悪臭成分の揮発を抑制するばかりでなく、消臭成分であるアミノ単糖又はその塩を安定に分散させ、悪臭成分との接触を向上させて、消臭効果を更に高めることができる。
(2) When the composition is used for non-humans When the composition of the present invention is used for non-humans, specifically when it is a composition for textile products, hard surfaces, spaces, etc. Examples of optional components that may be included in addition to the above essential components include polyhydric alcohols, surfactants, deodorants, various commonly used solvents, oils, gelling agents, sodium sulfate, N, N, N- Salts such as trimethylglycine, pH adjusters, antioxidants, preservatives, bactericidal/antibacterial agents, perfumes, pigments, ultraviolet absorbers, and the like. In addition, in the said composition, these components may each be used individually by 1 type, and may use 2 or more types together. Furthermore, polyhydric alcohols and surfactants not only suppress volatilization of malodorous components adhering to textiles, hard surfaces, human bodies, pets, etc., but also stabilize amino monosaccharides or salts thereof, which are deodorizing components. By dispersing it, the contact with the malodorous component can be improved, and the deodorant effect can be further enhanced.
上記多価アルコールは、繊維製品、硬質表面、空間等に付着した悪臭成分の揮発を抑制する効果を奏する成分である。このような多価アルコール類としては、例えば、グリセリン、エチレングリコール、プロピレングリコール、1,3-プロパンジオール、ブタンジオール、ジエチレングリコール、ジプロピレングリコール、ポリエチレングリコール、ポリプロピレングリコール等が挙げられる。これらの中では、ジエチレングリコール、ジプロピレングリコールが好ましい。 The above polyhydric alcohol is a component that has the effect of suppressing volatilization of malodorous components adhering to textile products, hard surfaces, spaces, and the like. Examples of such polyhydric alcohols include glycerin, ethylene glycol, propylene glycol, 1,3-propanediol, butanediol, diethylene glycol, dipropylene glycol, polyethylene glycol and polypropylene glycol. Among these, diethylene glycol and dipropylene glycol are preferred.
本発明の組成物がヒト以外に用いられる場合、具体的には繊維製品用、硬質表面用、空間用等として用いられる組成物である場合、このような本発明の組成物における上記多価アルコール類の含有量は、使用形態によって異なるが、通常0.001質量%以上であり、0.001~30質量%であることが好ましく、0.005~10質量%であることが更に好ましい。 When the composition of the present invention is used for non-humans, specifically when it is a composition used for textile products, hard surfaces, spaces, etc., the above polyhydric alcohol in the composition of the present invention Although the content of the class varies depending on the form of use, it is usually at least 0.001% by mass, preferably 0.001 to 30% by mass, more preferably 0.005 to 10% by mass.
上記界面活性剤としては特に制限はなく、陰イオン界面活性剤、陽イオン界面活性剤、両性界面活性剤、非イオン界面活性剤が挙げられる。具体的には、分子中に少なくとも炭素数8~18のアルキル基又はアルケニル基を有し、親水部には、カルボン酸塩、スルホン酸塩、硫酸エステル塩、リン酸エステル塩、4級アンモニウム塩、スルホベタイン、カルボベタイン、アミンオキシド、(ポリ)オキシアルキレン、(ポリ)アルカノールアミン、(ポリ)グリコシド、(ポリ)グリセリン骨格を有する化合物等が挙げられる。また、炭素数8~18のアルキル基又はアルケニル基と親水部とは、エーテル基、エステル基、アミド基、アルキル基から選ばれる1種以上を介して結合していてもよい。これらの界面活性剤の中では、スルホン酸塩、硫酸エステル塩、リン酸エステル塩、4級アンモニウム塩、カルボベタイン、アミンオキシド、(ポリ)グリコシド、(ポリ)グリセリン型の界面活性剤が好ましい。 The surfactant is not particularly limited, and includes anionic surfactants, cationic surfactants, amphoteric surfactants, and nonionic surfactants. Specifically, it has an alkyl or alkenyl group having at least 8 to 18 carbon atoms in the molecule, and the hydrophilic portion includes carboxylate, sulfonate, sulfate, phosphate, and quaternary ammonium salt. , sulfobetaine, carbobetaine, amine oxide, (poly)oxyalkylene, (poly)alkanolamine, (poly)glycoside, compounds having a (poly)glycerol skeleton, and the like. Also, the alkyl group or alkenyl group having 8 to 18 carbon atoms and the hydrophilic portion may be bonded through one or more selected from an ether group, an ester group, an amide group and an alkyl group. Among these surfactants, sulfonate, sulfate, phosphate, quaternary ammonium salt, carbobetaine, amine oxide, (poly)glycoside, and (poly)glycerin type surfactants are preferred.
本発明の組成物がヒト以外に用いられる場合、具体的には繊維製品用、硬質表面用、空間用等として用いられる組成物である場合、このような本発明の組成物における上記界面活性剤の含有量は、使用形態によっても異なるが、通常0.001質量%以上であり、0.001~30質量%であることが好ましく、0.01~10質量%であることがより好ましい。 When the composition of the present invention is used for non-humans, specifically when it is a composition used for textile products, hard surfaces, spaces, etc., the above-mentioned surfactant in the composition of the present invention The content of is usually 0.001% by mass or more, preferably 0.001 to 30% by mass, and more preferably 0.01 to 10% by mass, although it varies depending on the form of use.
上記溶剤としては、例えば、エタノール、エチレングリコールやプロピレングリコールのモノエチル又はモノブチルエーテル、ジエチレングリコールやジプロピレングリコールのモノエチル又はモノブチルエーテル、ベンジルアルコール、ベンジルオキシエタノール、フェノール性化合物のエチレンオキシド又はプロピレンオキシド付加物等が挙げられる。
<pH>
本発明の上記組成物のpHは、通常pH5.0~9.0であり、pH6~8.5であることが好ましい。なお、このpHは、pH調整剤等の使用により調整することができる。
Examples of the solvent include ethanol, monoethyl or monobutyl ether of ethylene glycol or propylene glycol, monoethyl or monobutyl ether of diethylene glycol or dipropylene glycol, benzyl alcohol, benzyloxyethanol, ethylene oxide or propylene oxide adducts of phenolic compounds, and the like. mentioned.
<pH>
The pH of the composition of the present invention is generally pH 5.0 to 9.0, preferably pH 6 to 8.5. In addition, this pH can be adjusted by using a pH adjuster or the like.
<上記組成物の製造方法>
上記組成物の製造方法は特に制限されず、必須成分である上記式(I)で表されるラクトン化合物、必要に応じて配合されるその他の若年女性の体臭を構成する匂い成分、組成物を製造するのに必要な各種成分(上記任意成分等)を適宜選択、配合して、常法により製造することができる。なお、本発明の組成物は乳化を行った組成物であってもよし、可溶化させた組成物であってもよい。
<Method for producing the above composition>
The method for producing the above composition is not particularly limited, and the lactone compound represented by the above formula (I), which is an essential component, and other odor components that constitute the body odor of young women to be blended as necessary, and the composition. Various components necessary for the production (such as the optional components described above) can be appropriately selected and blended, and the production can be carried out by a conventional method. The composition of the present invention may be an emulsified composition or a solubilized composition.
<上記組成物の用途>
本発明の上記組成物の使用形態は、液状、ゲル状、粉状、粒状等の固体状とすることができるが、液状として使用することが好ましい。液状の場合には、特にスプレー、ローション等として、ハンカチ、タオル等の布地、スーツ、セーター等の衣類、枕、シーツ等の寝具、カーテン、ソファー等の繊維製品、食器、なべ等の調理器具、調理台、レンジ、床、壁、壁紙、ゴミ箱、便器、浴槽、排水口等の硬質表面を有するもの、及び空間に用いることが適している。また、紙や不織布等に浸漬、噴霧させて空気清浄器のフィルターとして用いる等、据え置き型として使用することもできる。本発明の組成物は、例えば中年以降の加齢臭が気になる女性が使用した上記繊維製品、硬質表面、空間等の消臭剤として好適に用いることができる。頻繁に洗浄等ができない対象物に対しても、匂いの面では一定期間に渡って気持ちよく使用することができる。
<Application of the above composition>
The composition of the present invention may be used in a solid form such as liquid, gel, powder, and granules, but it is preferably used in a liquid form. In the case of liquid, especially as a spray, lotion, etc., cloth such as handkerchiefs, towels, clothes such as suits and sweaters, bedding such as pillows and sheets, textile products such as curtains and sofas, kitchen utensils such as tableware and pans, etc. It is suitable for objects and spaces with hard surfaces such as countertops, ranges, floors, walls, wallpaper, trash cans, toilet bowls, bathtubs, and drains. It can also be used as a stationary type, for example, by immersing it in paper or a non-woven fabric or spraying it, and using it as a filter for an air purifier. The composition of the present invention can be suitably used, for example, as a deodorant for the textile products, hard surfaces, spaces, etc. used by middle-aged and older women who are concerned about aging odor. Even for an object that cannot be washed frequently, it can be comfortably used for a certain period of time in terms of odor.
<使用形態>
本発明の上記組成物は、例えば、ミストタイプのスプレー容器に充填し、一回の噴霧量を0.1~1mlに調整したものが好ましい。使用するスプレー容器としては、トリガースプレー容器(直圧あるいは蓄圧型)やディスペンサータイプのポンプスプレー容器等の公知のスプレー容器を用いることができる。
<Usage form>
The composition of the present invention is preferably, for example, filled in a mist-type spray container, and the amount of one spray is adjusted to 0.1 to 1 ml. As the spray container to be used, known spray containers such as a trigger spray container (direct pressure or pressure accumulation type) and a dispenser type pump spray container can be used.
[若年女性の体臭モデル組成物]
本発明は、若年女性の体臭を構成する匂い成分を含有し、上記匂い成分として下記式(I)で表されるラクトン化合物を少なくとも含む、若年女性の体臭モデル組成物も含む。本発明者らにより、若年女性の体臭を構成する匂い成分と、中年以降の女性の体臭を構成する匂い成分とを比較すると、上記特定のラクトン化合物が若年女性でより多く含まれており、加齢と共に減少することが明らかになった。本発明の若年女性の体臭モデル組成物は、実際の若年女性の体臭により近く、加齢臭の判定、加齢臭の抑制効果の判定等の際に、基準として用いることができる。
[Young female body odor model composition]
The present invention also includes a body odor model composition for young women, which contains an odor component that constitutes the body odor of young women, and at least a lactone compound represented by the following formula (I) as the odor component. When the present inventors compared the odor components that make up the body odor of young women with the odor components that make up the body odor of middle-aged and older women, the above-mentioned specific lactone compound is contained more in young women, It was found to decrease with aging. The body odor model composition for young women of the present invention is closer to the actual body odor of young women, and can be used as a reference for determining aging-related odors, determining effects of suppressing aging-related odors, and the like.
(式中、Rは、炭素数2~9のアルキル基である。)
(Wherein, R is an alkyl group having 2 to 9 carbon atoms.)
上記式(I)で表されるラクトン化合物については、[若年女性臭補充用の外用組成物]の項の説明を適用できる。 For the lactone compound represented by the above formula (I), the description in the section [Composition for external use for replenishing the odor of young women] can be applied.
若年女性の体臭を構成する匂い成分は、上記式(I)で表されるラクトン化合物以外にも多種類存在する。本発明の若年女性の体臭モデル組成物は、上記式(I)で表されるラクトン化合物以外のその他の若年女性の体臭を構成する匂い成分を含んでいることが好ましい。その他の若年女性の体臭を構成する匂い成分としては、例えばアルデヒド類、脂肪酸類、ケトン類、アンモニア等が挙げられる。本発明の外用組成物が含むその他の若年女性の体臭を構成する匂い成分としては、女性の加齢に伴って体臭中の含有量が減少する成分を含むことが好ましい。 In addition to the lactone compound represented by the above formula (I), there are many types of odor components that constitute the body odor of young women. The body odor model composition for young women of the present invention preferably contains an odor component that constitutes the body odor of young women other than the lactone compound represented by the above formula (I). Other odor components that make up the body odor of young women include, for example, aldehydes, fatty acids, ketones, and ammonia. Other odor components that constitute the body odor of young women contained in the composition for external use of the present invention preferably include components whose content in the body odor decreases with aging of the woman.
[加齢臭判定用指標剤]
本発明は、上記式(I)で表されるラクトン化合物を少なくとも含む組成物であって、女性の加齢臭判定の指標として用いられる、加齢臭判定用指標剤も含む。また、本発明は、上記式(I)で表されるラクトン化合物を少なくとも含む組成物であって、女性の体臭年齢の判定の指標として用いられる、体臭年齢判定用指標剤も含む。本発明者らにより、若年女性の体臭を構成する匂い成分と、中年以降の加齢臭が気になる年代の女性の体臭を構成する匂い成分とを比較すると、上記特定のラクトン化合物が若年女性でより多く含まれており、それらが加齢と共に減少することが明らかになった。本発明の加齢臭判定用指標剤及び体臭年齢判定用指標剤は、若年女性と中年以降の加齢臭が気になる年代の女性の体臭との違いにより、加齢臭の判定、加齢臭の抑制効果の判定、体臭年齢の判定等の際に、基準として用いることができる。
[Index agent for determining aged odor]
The present invention also includes a composition containing at least the lactone compound represented by the above formula (I), and an index agent for determining aged odor, which is used as an index for determining aged odor in women. The present invention also includes a composition containing at least the lactone compound represented by the above formula (I), which is used as an index for determining the age of body odor in women. When the present inventors compared the odor components that make up the body odor of young women with the odor components that make up the body odor of middle-aged and later women who are concerned about aging odor, it was found that the above-mentioned specific lactone compound It was found that females contained more and that they decreased with age. The index agent for judging aging odor and the index agent for judging age of body odor of the present invention can be used for judging aging odor and increasing body odor according to the difference between the body odor of young women and women in the middle-aged and older generations. It can be used as a reference when determining the effect of suppressing old age odor, determining the age of body odor, and the like.
上記式(I)で表されるラクトン化合物については、[若年女性臭補充用の外用組成物]の項の説明を適用できる。 For the lactone compound represented by the above formula (I), the description in the section [Composition for external use for replenishing the odor of young women] can be applied.
[アンチエージング効果評価方法]
本発明は、被験物質の使用による、体臭中に含まれる上記式(I)で表されるラクトン化合物の含有量の変化を指標として、被験物質のアンチエージング効果を評価する、アンチエージング効果評価方法も含む。本発明者らにより、若年女性の体臭を構成する匂い成分と、中年以降の加齢臭が気になる年代の女性の体臭を構成する匂い成分とを比較すると、上記特定のラクトン化合物が若年女性でより多く含まれており、それらが加齢と共に減少することが明らかになった。本発明はこの知見に基づいて完成されたもので、被験物質(医薬品、サプリメント、各種飲食品等)のアンチエージング効果を評価する際に、それらの使用により、女性の体臭に変化を起こし、若年女性の体臭に多く含まれ加齢とともに減少する匂い成分の含有量を増加させ、体臭を若返らせる効果があるか否かを指標とするものである。なお、上記式(I)で表されるラクトン化合物については、[若年女性臭補充用の外用組成物]の項の説明を適用できる。
[Anti-aging effect evaluation method]
The present invention provides an anti-aging effect evaluation method in which the anti-aging effect of a test substance is evaluated using the change in the content of the lactone compound represented by the above formula (I) contained in body odor due to the use of the test substance as an index. Also includes When the present inventors compared the odor components that make up the body odor of young women with the odor components that make up the body odor of middle-aged and later women who are concerned about aging odor, it was found that the above-mentioned specific lactone compound It was found that females contained more and that they decreased with age. The present invention was completed based on this knowledge, and when evaluating the anti-aging effects of test substances (drugs, supplements, various foods and drinks, etc.), their use causes changes in women's body odor, The index is whether or not there is an effect of rejuvenating body odor by increasing the content of odor components that are abundantly contained in women's body odor and decrease with age. As for the lactone compound represented by the above formula (I), the description in the section [Composition for external use for replenishing the odor of young women] can be applied.
[アンチエージング物質スクリーニング方法]
本発明は、被験物質の使用による、体臭中に含まれる上記式(I)で表されるラクトン化合物の含有量の変化を指標として、アンチエージング効果を有する物質をスクリーニングする、アンチエージング物質スクリーニング方法も含む。本発明者らにより、若年女性の体臭を構成する匂い成分と、中年以降の加齢臭が気になる年代の女性の体臭を構成する匂い成分とを比較すると、上記特定のラクトン化合物が若年女性でより多く含まれており、それらが加齢と共に減少することが明らかになった。本発明はこの知見に基づいて完成されたもので、被験物質(医薬品、サプリメント、各種飲食品等)のアンチエージング効果を評価し、優れた物質をスクリーニングする際に、それらの使用により、女性の体臭に変化を起こし、若年女性の体臭に多く含まれ加齢とともに減少する匂い成分の含有量を増加させ、体臭を若返らせる効果があるか否かを指標とするものである。なお、上記式(I)で表されるラクトン化合物については、[若年女性臭補充用の外用組成物]の項の説明を適用できる。
[Anti-aging substance screening method]
The present invention provides an anti-aging substance screening method, which comprises screening for a substance having an anti-aging effect using the change in the content of the lactone compound represented by the above formula (I) contained in body odor due to the use of a test substance as an indicator. Also includes When the present inventors compared the odor components that make up the body odor of young women with the odor components that make up the body odor of middle-aged and later women who are concerned about aging odor, it was found that the above-mentioned specific lactone compound It was found that females contained more and that they decreased with age. The present invention was completed based on this knowledge, and when evaluating the anti-aging effect of test substances (drugs, supplements, various food and drink, etc.) and screening excellent substances, their use It is an indicator of whether or not there is an effect of changing body odor, increasing the content of odor components that are abundant in the body odor of young women and decreasing with age, and rejuvenating the body odor. As for the lactone compound represented by the above formula (I), the description in the section [Composition for external use for replenishing the odor of young women] can be applied.
[体臭組成改善剤]
本発明は、上記式(I)で表されるラクトン化合物の産生促進物質及び/又は上記式(I)で表されるラクトン化合物の合成促進物質を含有することを特徴とする、体臭組成改善剤も含む。本発明の体臭組成改善剤は、例えば上述のアンチエージング物質スクリーニング方法により選定された物質を含む。本発明の体臭組成改善剤は内服、外用のどちらでもよく、これを用いると体臭中のラクトン化合物が増加し、ラクトン化合物含有量が多い若年女性の体臭と同様の匂いを発生させることができる。なお、上記式(I)で表されるラクトン化合物については、[若年女性臭補充用の外用組成物]の項の説明を適用できる。
[Body odor composition improving agent]
The present invention is a body odor composition-improving agent characterized by containing a substance promoting the production of the lactone compound represented by the above formula (I) and/or a substance promoting the synthesis of the lactone compound represented by the above formula (I). Also includes The body odor composition-improving agent of the present invention contains, for example, a substance selected by the anti-aging substance screening method described above. The body odor composition-improving agent of the present invention may be used either internally or externally, and when it is used, the lactone compound in the body odor increases, and an odor similar to the body odor of young women with a high lactone compound content can be generated. As for the lactone compound represented by the above formula (I), the description in the section [Composition for external use for replenishing the odor of young women] can be applied.
[加齢臭対策剤]
本発明には、上述の体臭組成改善剤を含む加齢臭対策剤、特に女性用の加齢臭対策剤も含まれる。
[Anti-aging odor agent]
The present invention also includes an anti-aging odor agent, particularly an anti-aging odor agent for women, containing the body odor composition improving agent described above.
[ラクトン化合物作用向上剤]
本発明には、上記式(I)で表されるラクトン化合物の作用を向上させる、ラクトン化合物作用向上剤も含まれる。本発明のラクトン化合物作用向上剤は内服、外用のどちらでもよく、これを用いると体臭中のラクトン化合物の作用が向上し、ラクトン化合物含有量が多い若年女性の体臭と同様の匂いを発生させることができる。なお、上記式(I)で表されるラクトン化合物については、[若年女性臭補充用の外用組成物]の項の説明を適用できる。
[Lactone compound action improver]
The present invention also includes a lactone compound action improver that improves the action of the lactone compound represented by formula (I) above. The lactone compound effect improver of the present invention may be used either internally or externally, and when used, the effect of the lactone compound in the body odor is improved, and an odor similar to the body odor of young women with a high lactone compound content is produced. can be done. As for the lactone compound represented by the above formula (I), the description in the section [Composition for external use for replenishing the odor of young women] can be applied.
[体臭改善剤]
本発明には、上述のラクトン化合物作用向上剤を含む体臭改善剤も含まれる。
[Body odor improving agent]
The present invention also includes a body odor improving agent containing the lactone compound action enhancer described above.
以下、実施例により本発明をより詳細に説明するが、本発明はこれらにより何ら限定されない。 EXAMPLES The present invention will be described in more detail below with reference to examples, but the present invention is not limited by these examples.
[試験1]
背中部に布を縫い付けたTシャツを、10代後半~50代までの日本人女性(n=50)に入浴後から翌日の入浴前まで着衣させ、布を回収後、5分類(ノネナール臭、脂肪酸臭、アミン/アンモニア臭、S系臭、SWEET臭)にて官能評価を専門パネラー(プロフェッショナル)により6段階スコアにて実施した。なお、上記6段階スコア(臭気強度;0~5)の基準を表1に示し、結果を図1~4に示した。なお、図1及び2はSWEET臭官能評価スコアを、図3はノネナール臭官能評価スコアを示す。さらに、回収した布に関してヘッドスペースガスクロマトグラフィー質量分析計(HSS-GC/MS)を用いて臭気分析を実施した。ノネナールの濃度(ppm)と被験者(サンプル)の年齢との相関についての検討結果を図4に示した。また、それぞれのラクトン成分(γ-デカラクトン、γ-ウンデカラクトン)の濃度(ppm)と被験者(サンプル)の年齢との相関についても検討し、結果を図5に示した。
[Test 1]
Japanese women (n = 50) in their late teens to 50s wore T-shirts with cloth sewn on their backs after bathing until before bathing the next day. , fatty acid odor, amine/ammonia odor, S-based odor, and SWEET odor), sensory evaluation was performed by professional panelists on a 6-point scale. Table 1 shows the criteria for the 6-level score (odor intensity; 0 to 5), and the results are shown in FIGS. 1 and 2 show SWEET odor sensory evaluation scores, and FIG. 3 shows nonenal odor sensory evaluation scores. Furthermore, an odor analysis was performed on the recovered cloth using a headspace gas chromatography-mass spectrometer (HSS-GC/MS). FIG. 4 shows the results of a study on the correlation between the concentration (ppm) of nonenal and the age of the subject (sample). Also, the correlation between the concentration (ppm) of each lactone component (γ-decalactone, γ-undecalactone) and the age of the subject (sample) was examined, and the results are shown in FIG.
図1及び2に示すとおり、10代後半女性を頂点として20代前半までSWEET臭が高く、加齢に伴い、その臭気が減少していくことが分かった。なお、図2の各データを年代別に棒グラフ化したものが図1である。また、図3及び図4に示すとおり、ノネナール臭は年齢と官能スコアに明確な相関関係が認められず、男性と比較して臭気強度そのものが低いことが分かった。また、HSS-GC/MSにより、SWEET臭の主要成分はγ-デカラクトン、γ-ウンデカラクトンであることがわかった。 As shown in FIGS. 1 and 2, it was found that the SWEET odor was high in females in their late teens until their early twenties, and that the odor decreased with aging. FIG. 1 is a bar graph of each data in FIG. 2 by age group. In addition, as shown in FIGS. 3 and 4, no clear correlation was observed between age and sensory score for nonenal odor, and it was found that the odor intensity itself was lower than that of men. HSS-GC/MS also revealed that the main components of the SWEET odor were γ-decalactone and γ-undecalactone.
γ-デカラクトン、γ-ウンデカラクトンの総量と年齢の相関を調べた結果、図5に示すとおり、SWEET臭の官能スコアと同様に10代を頂点として、20代まで高く、加齢に伴い、30代以降で濃度が減少していくことも確認できた。35歳付近がSWEET臭の大きな変化点(ニオイの曲り角)であることがわかった。 As a result of examining the correlation between the total amount of γ-decalactone and γ-undecalactone and age, as shown in FIG. It was also confirmed that the concentration decreased after the age of 30. It turned out that around 35 years old is a big change point of SWEET odor (turning point of odor).
[試験2]
Trans-2-nonenalを含むモデル加齢臭 10μL及び各種γ-ラクトンの単品原料1μLをそれぞれ含浸させた綿球(白十字No.10)を容器にいれ密封した。30分後にモデル加齢臭に対する快・不快度を評価した。評価はエバリュエーターを中心とした4名のパネルで行った。各種γ-ラクトンは、ジプロピレングリコールで1%もしくは10%に希釈して用いた。評価スコアの基準を下記表2に示し、結果を表3及び図5に示した。
[Test 2]
A cotton ball (white cross No. 10) impregnated with 10 μL of model aging odor containing trans-2-nonenal and 1 μL of single raw materials of various γ-lactones was placed in a container and sealed. After 30 minutes, the pleasantness/unpleasantness of the model aging odor was evaluated. The evaluation was performed by a panel of four people, mainly evaluators. Various γ-lactones were diluted with dipropylene glycol to 1% or 10% and used. The evaluation score criteria are shown in Table 2 below, and the results are shown in Table 3 and FIG.
モデル加齢臭に対する不快度は、γ-バレロラクトン(比較例1)では改善しなかったが、γ-ヘキサラクトン(実施例1)、γ-ヘプタラクトン(実施例2)、γ-オクタラクトン(実施例3)、γ-デカラクトン(実施例4)、γ-ウンデカラクトン(実施例5)を添加した場合には、においの質が改善し、快なにおいとなった。 Discomfort against model aging odor was not improved by γ-valerolactone (Comparative Example 1), but γ-hexalactone (Example 1), γ-heptalactone (Example 2), γ-octalactone ( When adding Example 3), γ-decalactone (Example 4), and γ-undecalactone (Example 5), the odor quality was improved and the odor was pleasant.
[試験3]
各種の香りを嗅ぎながら、写真の女性(計4枚)の印象を評価した。具体的には、「無香料」及び6段階臭気強度表示法の臭気強度2に揃えた「2-ノネナール」、「石鹸香料」、「ラクトンC10/ラクトンC11含有香料」を用意し、それらのうちの1種類の香りを嗅ぎながら女性(実年齢平均40歳)の写真を見て、「女性らしさ」、「若々しさ」、「魅力度」に対するアンケート調査を実施した(n=52)。評価は一般男性・一般女性(30歳以上)で行った。無香料を100%とした場合の「女性らしさ」、「若々しさ」、「魅力度」についての印象(%)を図7に示した。
[Test 3]
While smelling various scents, the impressions of the women in the photographs (four in total) were evaluated. Specifically, "fragrance-free" and "2-nonenal", "soap fragrance", "lactone C10 / lactone C11-containing fragrance" with an odor intensity of 2 according to the 6-step odor intensity indication method are prepared. While looking at photographs of women (average real age of 40) while smelling one type of scent, a questionnaire survey on "femininity", "youthfulness", and "attractiveness" was conducted (n = 52). The evaluation was performed by general males and general females (aged 30 and over). Fig. 7 shows the impressions (%) of "femininity", "youthfulness", and "attractiveness" when the fragrance-free is taken as 100%.
γ-デカラクトン(R=6)及び/又はγ-ウンデカラクトン(R=7)を含む香りがある場合には、写真の女性の見た目年齢が下がり、若々しさがアップする評価を受けた。また、女性らしさ、魅力度、好感度もアップする評価を受けた。一般的な女性の多くが加齢に伴い、自分自身の体臭の変化を感じていることが知られているが、その原因の一つとして若年女性特有の体臭成分に「SWEET臭」のある「ラクトンC10/ラクトンC11」が30代以降で減少することによって体臭変化が起こるものと推察された。さらに、上記試験結果より、「ラクトンC10/ラクトンC11」の機能として、女性らしさ、若々しさ、魅力度を上げる効果があることも分かった。本研究により、女性の加齢臭に対するアプローチとして、単純に洗浄によって落とすだけではなく、「ラクトンC10/ラクトンC11」の香りを付与することで、女性の加齢臭の悩みに対してより効果的なアプローチが可能であると考えられた。 When there was a scent containing γ-decalactone (R=6) and/or γ-undecalactone (R=7), the women in the photograph were evaluated to be younger and more youthful. In addition, it was evaluated that femininity, attractiveness, and favorability increased. It is known that many ordinary women feel changes in their own body odor as they age. It was inferred that body odor changes occur due to the decrease in lactone C10/lactone C11 after the age of 30. Furthermore, from the above test results, it was also found that the function of "Lactone C10/Lactone C11" is to increase femininity, youthfulness, and attractiveness. Through this research, as an approach to women's aging odor, not only removing it by washing, but also adding the scent of "Lactone C10 / Lactone C11" is more effective for women's aging odor. approach was considered possible.
[試験4]
下記表4の組成の洗浄剤(ボディーソープ)を常法により調製した。
[Test 4]
A cleansing agent (body soap) having the composition shown in Table 4 below was prepared by a conventional method.
上記表4の組成の洗浄剤(ボディーソープ)の使用前後で、女性の印象の変化を評価した。具体的には、女性(n=2)を見て、「女性らしさ」、「魅力度」、「若々しさ」、「フレッシュさ」に対するアンケート調査を実施した。試料使用前を100%とし、試料使用後の「女性らしさ」、「魅力度」、「若々しさ」、「フレッシュさ」についての印象(%)を表5に示した。 Before and after using the cleansing agent (body soap) having the composition shown in Table 4, changes in the impression of women were evaluated. Specifically, looking at women (n=2), a questionnaire survey was conducted on "femininity," "attractiveness," "youthfulness," and "freshness." Table 5 shows the impressions (%) of "femininity", "attractiveness", "youthfulness" and "freshness" after using the samples, with the values before using the samples as 100%.
[試験5]
下記表6の組成の制汗剤を常法により調製した。
[Test 5]
An antiperspirant having the composition shown in Table 6 below was prepared by a conventional method.
上記表6の組成の制汗剤の使用前後で、女性の印象の変化を評価した。具体的には、女性(n=2)を見て、「女性らしさ」、「魅力度」、「若々しさ」、「フレッシュさ」に対するアンケート調査を実施した。試料使用前を100%とし、試料使用後の「女性らしさ」、「魅力度」、「若々しさ」、「フレッシュさ」についての印象(%)を表7に示した。 Before and after using the antiperspirant having the composition shown in Table 6, changes in the impression of women were evaluated. Specifically, looking at women (n=2), a questionnaire survey was conducted on "femininity," "attractiveness," "youthfulness," and "freshness." Table 7 shows the impressions (%) of "femininity", "attractiveness", "youthfulness", and "freshness" after using the samples, with the values before using the samples taken as 100%.
以下に、本発明の外用組成物の製剤処方例を示す。なお、表8に記載の各ラクトンの数値(%)は、各処方例にそれぞれの組み合わせを使用した場合の、組成物全体における最終濃度(重量%)を示す。 Below, formulation examples of the composition for external use of the present invention are shown. The numerical value (%) of each lactone shown in Table 8 indicates the final concentration (% by weight) in the entire composition when each combination is used in each formulation example.
<製剤処方例1:ボディソープ>
表8に記載のラクトン化合物の組み合わせのいずれか
ラウリン酸 5重量%
パルミチン酸 5重量%
ステアリン酸 5重量%
水酸化カリウム 適量
グリセリン 5重量%
ジブチルヒドロキシトルエン 0.01重量%
エデト酸2ナトリウム 0.05重量%
フェノキシエタノール 0.3重量%
塩化ベンザルコニウム 0.1重量%
ラウレス硫酸ナトリウム 5重量%
ヤシ油脂肪酸アミドプロピルベタイン 5重量%
ポリクオタニウム-10 0.5重量%
ポリクオタニウム-7 0.2重量%
カオリン 0.5重量%
炭 0.05重量%
アスコルビン酸リン酸マグネシウム 0.5重量%
ヒドロキシエチルセルロース 0.3重量%
水 残部
合計 100重量%
<Formulation Formulation Example 1: Body Soap>
Any of the combinations of lactone compounds listed in Table 8 Lauric acid 5% by weight
Palmitic acid 5% by weight
Stearic acid 5% by weight
Potassium hydroxide appropriate amount Glycerin 5% by weight
Dibutyl hydroxytoluene 0.01% by weight
Disodium edetate 0.05% by weight
Phenoxyethanol 0.3% by weight
Benzalkonium chloride 0.1% by weight
Sodium laureth sulfate 5% by weight
Coconut fatty acid amidopropyl betaine 5% by weight
Polyquaternium-10 0.5% by weight
Polyquaternium-7 0.2% by weight
Kaolin 0.5% by weight
Charcoal 0.05% by weight
Magnesium ascorbyl phosphate 0.5% by weight
Hydroxyethyl cellulose 0.3% by weight
water
Total 100% by weight
<製剤処方例2:泡吐出型ボディウッシュ>
表8に記載のラクトン化合物の組み合わせのいずれか
ラウリン酸PEG-80ソルビタン 5重量%
ココイルグルタミン酸2ナトリウム 4重量%
ココイルグリシンナトリウム 2重量%
ソルビトール 5重量%
ココイルメチルタウリンタウリンナトリウム 2重量%
クエン酸 適量
エデト酸2ナトリウム 0.05重量%
コカミドDEA 1重量%
ココアンホ酢酸ナトリウム 3重量%
ポリクオタニウム-7 0.05重量%
グリチルリチン酸ジカリウム 0.3重量%
水 残部
合計 100重量%
<Formulation Formulation Example 2: Foaming type body wash>
Any of the combinations of lactone compounds listed in Table 8 PEG-80 sorbitan laurate 5% by weight
Disodium cocoyl glutamate 4% by weight
Sodium cocoylglycinate 2% by weight
Sorbitol 5% by weight
Cocoyl methyl taurate taurine sodium 2% by weight
Citric acid Appropriate amount Disodium edetate 0.05% by weight
Cocamide DEA 1% by weight
Sodium cocoamphoacetate 3% by weight
Polyquaternium-7 0.05% by weight
Dipotassium glycyrrhizinate 0.3% by weight
water
Total 100% by weight
<製剤処方例3:洗顔料>
表8に記載のラクトン化合物の組み合わせのいずれか
ラウリン酸 5重量%
ミリスチン酸 10重量%
パルミチン酸 7重量%
ステアリン酸 7重量%
水酸化カリウム 適量
ブチレングリコール 5重量%
グリセリン 5重量%
トコフェロール 0.05重量%
エデト酸2ナトリウム 0.05重量%
フェノキシエタノール 0.3重量%
サリチル酸 0.2重量%
ヤシ油脂肪酸アミドプロピルベタイン 5重量%
ポリクオタニウム-10 0.3重量%
ポリクオタニウム-7 0.1重量%
l-メントール 0.3重量%
香料 0.2重量%
水 残部
合計 100重量%
<Formulation Formulation Example 3: Face wash>
Any of the combinations of lactone compounds listed in Table 8 Lauric acid 5% by weight
Myristic acid 10% by weight
Palmitic acid 7% by weight
Stearic acid 7% by weight
Potassium hydroxide Appropriate amount Butylene glycol 5% by weight
Glycerin 5% by weight
Tocopherol 0.05% by weight
Disodium edetate 0.05% by weight
Phenoxyethanol 0.3% by weight
Salicylic acid 0.2% by weight
Coconut fatty acid amidopropyl betaine 5% by weight
Polyquaternium-10 0.3% by weight
Polyquaternium-7 0.1% by weight
l-menthol 0.3% by weight
Perfume 0.2% by weight
water
Total 100% by weight
<製剤処方例4:シャンプー>
表8に記載のラクトン化合物の組み合わせのいずれか
ラウレス硫酸ナトリウム 30重量%
ココイルグルタミン酸トリエタノールアミン 5重量%
ラウロイルメチルアラニンナトリウム 5重量%
ラウラミドプロピルヒドロキシスルタイン 5重量%
クエン酸 適量
ジメチコン 0.3重量%
メチルパラベン 0.2重量%
エデト酸2ナトリウム 0.1重量%
ポリクオタニウム-10 0.5重量%
ポリクオタニウム-39 0.1重量%
ポリクオタニウム-7 0.1重量%
香料 0.8重量%
水 残部
合計 100重量%
<Formulation Formulation Example 4: Shampoo>
Any of the combinations of lactone compounds listed in Table 8 Sodium Laureth Sulfate 30% by weight
Cocoyl glutamic acid triethanolamine 5% by weight
Sodium lauroylmethylalanine 5% by weight
Lauramidopropyl hydroxysultaine 5% by weight
Citric acid Appropriate amount Dimethicone 0.3% by weight
Methylparaben 0.2% by weight
Disodium edetate 0.1% by weight
Polyquaternium-10 0.5% by weight
Polyquaternium-39 0.1% by weight
Polyquaternium-7 0.1% by weight
Perfume 0.8% by weight
water
Total 100% by weight
<製剤処方例5:シャンプー>
表8に記載のラクトン化合物の組み合わせのいずれか
オレフィン(C14-16)スルホン酸ナトリウム 15重量%
POEラウリルエーテル酢酸Na 5重量%
ヤシ油脂肪酸ジエタノールアミド 5重量%
ヤシ油脂肪酸TEA液 5重量%
ヤシ油脂肪酸アミドプロピルベタイン液 5重量%
クエン酸 適量
エデト酸2ナトリウム 0.1重量%
塩化ベンザルコニウム 1重量%
ポリクオタニウム-10 0.6重量%
ポリクオタニウム-7 0.1重量%
香料 0.5重量%
水 残部
合計 100重量%
<Formulation Formulation Example 5: Shampoo>
Any of the combinations of lactone compounds listed in Table 8 Sodium olefin (C14-16) sulfonate 15% by weight
POE Na lauryl ether acetate 5% by weight
Coconut fatty acid diethanolamide 5% by weight
Coconut oil fatty acid TEA liquid 5% by weight
Coconut fatty acid amidopropyl betaine liquid 5% by weight
Citric acid Appropriate amount Disodium edetate 0.1% by weight
Benzalkonium chloride 1% by weight
Polyquaternium-10 0.6% by weight
Polyquaternium-7 0.1% by weight
Perfume 0.5% by weight
water
Total 100% by weight
<製剤処方例6:ヘアコンディショナー>
表8に記載のラクトン化合物の組み合わせのいずれか
グリセリン 5重量%
ヒアルロン酸 0.1重量%
グリチルリチン酸ジカリウム 0.1重量%
スクワラン 0.1重量%
塩化ステアリルトリメチルアンモニウム 4重量%
ポリクオタニウム-10 0.5重量%
セタノール 2重量%
POE-モノステアリルグリセリルエーテル 1重量%
ジブチルヒドロキシトルエン 0.01重量%
フェノキシエタノール 0.3重量%
EDTA-2Na 0.05重量%
l-メントール 0.2重量%
香料 0.3重量%
水 残部
合計 100重量%
<Formulation Formulation Example 6: Hair Conditioner>
Any of the combinations of lactone compounds listed in Table 8 Glycerin 5% by weight
Hyaluronic acid 0.1% by weight
Dipotassium glycyrrhizinate 0.1% by weight
Squalane 0.1% by weight
Stearyltrimethylammonium chloride 4% by weight
Polyquaternium-10 0.5% by weight
Cetanol 2% by weight
POE-monostearyl glyceryl ether 1% by weight
Dibutyl hydroxytoluene 0.01% by weight
Phenoxyethanol 0.3% by weight
EDTA-2Na 0.05% by weight
l-menthol 0.2% by weight
Perfume 0.3% by weight
water
Total 100% by weight
<製剤処方例7:ヘアトリートメント>
表8に記載のラクトン化合物の組み合わせのいずれか
プロピレングリコール 5重量%
アセチル化ヒアルロン酸 0.01重量%
アラントイン 0.3重量%
テトラ2-エチルヘキサン酸ペンタスリエット 1重量%
臭化セチルトリメチルアンモニウム 2.5重量%
ポリクオタニウム-7 0.1重量%
セトステアリルアルコール 2重量%
ステアリルアルコール 2重量%
POE-硬化ヒマシ油 1重量%
ジブチルヒドロキシトルエン 0.01重量%
パラオキシ安息香酸メチル 0.3重量%
EDTA-2Na 0.05重量%
香料 0.5重量%
水 残部
合計 100重量%
<Formulation Formulation Example 7: Hair Treatment>
Any of the combinations of lactone compounds listed in Table 8 Propylene glycol 5% by weight
Acetylated hyaluronic acid 0.01% by weight
Allantoin 0.3% by weight
Tetra-2-ethylhexanoic acid pentathuriet 1% by weight
Cetyltrimethylammonium bromide 2.5% by weight
Polyquaternium-7 0.1% by weight
2% by weight of cetostearyl alcohol
Stearyl alcohol 2% by weight
POE - hydrogenated castor oil 1% by weight
Dibutyl hydroxytoluene 0.01% by weight
Methyl paraoxybenzoate 0.3% by weight
EDTA-2Na 0.05% by weight
Perfume 0.5% by weight
water
Total 100% by weight
<製剤処方例8:ヘアエッセンス>
表8に記載のラクトン化合物の組み合わせのいずれか
ブチレングリコール 5重量%
加水分解ヒアルロン酸 0.1重量%
イプシロンアミノカプロン酸 0.05重量%
塩化アルキルトリメチルアンモニウム 0.7重量%
塩化O-[2-ヒドロキシ-3-(トリメチルアンモニオ)
プロピル]グァーガム 0.5重量%
ジエチレングリコールモノエチルエーテル 2重量%
POE-ソルビタンモノイソステアレート 0.8重量%
エタノール 20重量%
フェノキシエタノール 0.3重量%
香料 0.1重量%
水 残部
合計 100重量%
<Formulation Formulation Example 8: Hair Essence>
Any of the combinations of lactone compounds listed in Table 8 Butylene glycol 5% by weight
Hydrolyzed hyaluronic acid 0.1% by weight
Epsilon aminocaproic acid 0.05% by weight
Alkyltrimethylammonium chloride 0.7% by weight
O-[2-hydroxy-3-(trimethylammonio) chloride
Propyl]guar gum 0.5% by weight
Diethylene glycol monoethyl ether 2% by weight
POE-sorbitan monoisostearate 0.8% by weight
Phenoxyethanol 0.3% by weight
Perfume 0.1% by weight
water
Total 100% by weight
<製剤処方例9:ヘアミスト>
表8に記載のラクトン化合物の組み合わせのいずれか
加水分解コラーゲン 1重量%
ブチレングリコール 5重量%
加水分解ヒアルロン酸 0.1重量%
グリチルリチン酸ジカリウム 0.05重量%
ポリクオタニウム-51 0.5重量%
流動パラフィン 0.5重量%
モノイソステアリルグリセリルエーテル 1重量%
エタノール 30重量%
パラオキシ安息香酸プロピル 0.3重量%
香料 0.3重量%
水 残部
合計 100重量%
<Formulation Formulation Example 9: Hair Mist>
Any of the combinations of lactone compounds listed in Table 8 Hydrolyzed Collagen 1% by weight
butylene glycol 5% by weight
Hydrolyzed hyaluronic acid 0.1% by weight
Dipotassium glycyrrhizinate 0.05% by weight
Polyquaternium-51 0.5% by weight
Liquid paraffin 0.5% by weight
Monoisostearyl glyceryl ether 1% by weight
Ethanol 30% by weight
Propyl paraoxybenzoate 0.3% by weight
Perfume 0.3% by weight
water
Total 100% by weight
<製剤処方例10:制汗クリーム>
表8に記載のラクトン化合物の組み合わせのいずれか
ベンザルコニウム塩化物 0.07重量%
イソプロピルメチルフェノール 0.07重量%
クロルヒドロキシアルミニウム 4重量%
シクロペンタシロキサン 25重量%
ポリアクリル酸アルキル 6重量%
POE・POPジメチコン共重合体 3.5重量%
グリチルリチン酸ジカリウム 0.05重量%
濃グリセリン 7重量%
イソノナン酸イソノニル 5重量%
イソステアリン酸ソルビタン 5重量%
l-メントール 0.5重量%
香料 0.3重量%
水 残部
合計 100重量%
<Formulation Formulation Example 10: Antiperspirant Cream>
Any of the combinations of lactone compounds listed in Table 8 Benzalkonium chloride 0.07% by weight
Isopropylmethylphenol 0.07% by weight
Aluminum chlorohydroxyl 4% by weight
Polyalkyl acrylate 6% by weight
POE/POP dimethicone copolymer 3.5% by weight
Dipotassium glycyrrhizinate 0.05% by weight
Concentrated glycerin 7% by weight
isononyl isononanoate 5% by weight
Sorbitan isostearate 5% by weight
l-menthol 0.5% by weight
Perfume 0.3% by weight
water
Total 100% by weight
<製剤処方例11:制汗ジェル>
表8に記載のラクトン化合物の組み合わせのいずれか
ベンザルコニウム塩化物 0.06重量%
イソプロピルメチルフェノール 0.05重量%
クロルヒドロキシアルミニウム 8重量%
メタケイ酸アルミン酸マグネシウム 0.5重量%
ジプロピレングリコール 10重量%
ポリオキシプロピレングリコール 0.5重量%
ヒドロキシプロピルメチルセルロース 0.5重量%
キサンタンガム 0.5重量%
エタノール 10重量%
l-メントール 0.3重量%
l-メンチルグリセリルエーテル 0.3重量%
ハッカ油 0.3重量%
香料 0.3重量%
水 残部
合計 100重量%
<Formulation Formulation Example 11: Antiperspirant Gel>
Any of the combinations of lactone compounds listed in Table 8 Benzalkonium chloride 0.06% by weight
Isopropylmethylphenol 0.05% by weight
Chlorohydroxy aluminum 8% by weight
Magnesium aluminometasilicate 0.5% by weight
Dipropylene glycol 10% by weight
Polyoxypropylene glycol 0.5% by weight
Hydroxypropyl methylcellulose 0.5% by weight
Xanthan gum 0.5% by weight
Ethanol 10% by weight
l-menthol 0.3% by weight
l-menthyl glyceryl ether 0.3% by weight
Peppermint oil 0.3% by weight
Perfume 0.3% by weight
water
Total 100% by weight
<製剤処方例12:制汗スプレー>
表8に記載のラクトン化合物の組み合わせのいずれか
イソプロピルメチルフェノール 0.1重量%
パラフェノールスルホン酸亜鉛 1重量%
セバシン酸ジエチル 4重量%
タルク 5重量%
ナイロン末 1重量%
香料 0.5重量%
エタノール 15重量%
ジメチルエーテル 残部
合計 100重量%
<Formulation Formulation Example 12: Antiperspirant Spray>
Any of the combinations of lactone compounds listed in Table 8 Isopropylmethylphenol 0.1% by weight
Zinc paraphenolsulfonate 1% by weight
Diethyl sebacate 4% by weight
Talc 5% by weight
Nylon powder 1% by weight
Perfume 0.5% by weight
dimethyl ether balance
Total 100% by weight
<製剤処方例13:制汗ロールオン>
表8に記載のラクトン化合物の組み合わせのいずれか
ベンザルコニウム塩化物 0.06重量%
イソプロピルメチルフェノール 0.06重量%
パラフェノールスルホン酸亜鉛 5重量%
ブチレングリコール 5重量%
クロルヒドロキシアルミニウム 0.05重量%
タルク 3重量%
ナイロン末 0.5重量%
臭化セチルトリメチルアンモニウム液 1重量%
ヒドロキシプロピルメチルセルロース 0.5重量%
l-メントール 0.1重量%
香料 0.3重量%
水 40重量%
エタノール 残部
合計 100重量%
<Formulation Formulation Example 13: Antiperspirant roll-on>
Any of the combinations of lactone compounds listed in Table 8 Benzalkonium chloride 0.06% by weight
Isopropylmethylphenol 0.06% by weight
Zinc paraphenolsulfonate 5% by weight
butylene glycol 5% by weight
Aluminum chlorohydroxyl 0.05% by weight
Talc 3% by weight
Nylon powder 0.5% by weight
Cetyltrimethylammonium bromide liquid 1% by weight
Hydroxypropyl methylcellulose 0.5% by weight
l-menthol 0.1% by weight
Perfume 0.3% by weight
ethanol balance
Total 100% by weight
<製剤処方例14:制汗ミスト>
表8に記載のラクトン化合物の組み合わせのいずれか
ベンザルコニウム塩化物 0.05重量%
イソプロピルメチルフェノール 0.06重量%
パラフェノールスルホン酸亜鉛 1重量%
ブチレングリコール 5重量%
クロルヒドロキシアルミニウム 0.02重量%
セリサイト複合体 0.3重量%
臭化セチルトリメチルアンモニウム液 0.5重量%
l-メントール 0.3重量%
香料 0.3重量%
水 10重量%
エタノール 残部
合計 100重量%
<Formulation Formulation Example 14: Antiperspirant Mist>
Any of the combinations of lactone compounds listed in Table 8 Benzalkonium chloride 0.05% by weight
Isopropylmethylphenol 0.06% by weight
Zinc paraphenolsulfonate 1% by weight
butylene glycol 5% by weight
Aluminum chlorohydroxyl 0.02% by weight
Sericite complex 0.3% by weight
Cetyltrimethylammonium bromide liquid 0.5% by weight
l-menthol 0.3% by weight
Perfume 0.3% by weight
10% by weight of water
ethanol balance
Total 100% by weight
<製剤処方例15:制汗スティック>
表8に記載のラクトン化合物の組み合わせのいずれか
ベンザルコニウム塩化物 0.055重量%
イソプロピルメチルフェノール 0.05重量%
クロルヒドロキシアルミニウム 5重量%
ポリエチレンワックス 5重量%
マイクロクリスタリンワックス 5重量%
モノステアリン酸グリセリル 3重量%
イソノナン酸イソノニル 5重量%
タルク 12重量%
メチルポリシロキサン 2重量%
デカメチルペンタシロキサン 0.3重量%
シリル化処理無水ケイ酸 15重量%
セタノール 2重量%
ヒドロキシアパタイト 0.3重量%
臭化セチルトリメチルアンモニウム液 0.5重量%
l-メントール 0.5重量%
酸化亜鉛 0.3重量%
香料 0.3重量%
ステアリルアルコール 残部
合計 100重量%
<Formulation Formulation Example 15: Antiperspirant Stick>
Any of the combinations of lactone compounds listed in Table 8 Benzalkonium chloride 0.055% by weight
Isopropylmethylphenol 0.05% by weight
Chlorohydroxy aluminum 5% by weight
Polyethylene wax 5% by weight
Microcrystalline wax 5% by weight
Glyceryl monostearate 3% by weight
isononyl isononanoate 5% by weight
Talc 12% by weight
2% by weight of methylpolysiloxane
Decamethylpentasiloxane 0.3% by weight
Silylated anhydrous
Cetanol 2% by weight
Hydroxyapatite 0.3% by weight
Cetyltrimethylammonium bromide liquid 0.5% by weight
l-menthol 0.5% by weight
Zinc oxide 0.3% by weight
Perfume 0.3% by weight
stearyl alcohol balance
Total 100% by weight
<製剤処方例16:ふき取り化粧水>
表8に記載のラクトン化合物の組み合わせのいずれか
エタノール 15重量%
ポリオキシエチレンポリオキシプロピレンデシルテトラデシル
エーテル 1重量%
加水分解ホホバエステル 0.01重量%
メチルシロキサン網状重合体 0.01重量%
アスコルビン酸リン酸マグネシウム 0.3重量%
香料 0.05重量%
パラベン 0.3重量%
クエン酸 適量
精製水 残部
合計 100重量%
<Formulation Formulation Example 16: Wiping Lotion>
Any of the combinations of lactone compounds listed in Table 8
Polyoxyethylene polyoxypropylene decyltetradecyl ether 1% by weight
Hydrolyzed jojoba ester 0.01% by weight
Methylsiloxane network polymer 0.01% by weight
Magnesium ascorbyl phosphate 0.3% by weight
Perfume 0.05% by weight
Paraben 0.3% by weight
Citric acid appropriate amount
Remainder of purified water
Total 100% by weight
<製剤処方例17:デオドラントシート>
表8に記載のラクトン化合物の組み合わせのいずれか
イソプロピルメチルフェノール 0.05重量%
パラフェノールスルホン酸亜鉛 1重量%
エタノール 30重量%
臭化セチルトリメチルアンモニウム液 0.5重量%
ブチレングリコール 1重量%
セリサイト複合体 0.1重量%
カオリン 0.3重量%
フェノキシエタノール 0.1重量%
香料 0.1重量%
クエン酸 適量
精製水 残部
合計 100重量%
<Formulation Formulation Example 17: Deodorant sheet>
Any of the combinations of lactone compounds listed in Table 8 Isopropylmethylphenol 0.05% by weight
Zinc paraphenolsulfonate 1% by weight
Ethanol 30% by weight
Cetyltrimethylammonium bromide liquid 0.5% by weight
Butylene glycol 1% by weight
Sericite complex 0.1% by weight
Kaolin 0.3% by weight
Phenoxyethanol 0.1% by weight
Perfume 0.1% by weight
Citric acid appropriate amount
Remainder of purified water
Total 100% by weight
<製剤処方例18:衣類・布製品用消臭剤>
表8に記載のラクトン化合物の組み合わせのいずれか
緑茶エキス 0.5重量%
ビグアニド化合物 0.2重量%
エタノール 10.0重量%
精製水 残部
合計 100重量%
<Formulation Formulation Example 18: Deodorant for clothing and fabric products>
Any of the combinations of lactone compounds listed in Table 8 Green tea extract 0.5% by weight
Biguanide compound 0.2% by weight
Ethanol 10.0% by weight
Remainder of purified water
Total 100% by weight
<製剤処方例19:空間用消臭剤>
表8に記載のラクトン化合物の組み合わせのいずれか
ジプロピレングリコール 0.1重量%
エタノール 10.0重量%
クエン酸 0.1重量%
シクロデキストリン 0.05重量%
水酸化ナトリウム 適量
精製水 残部
合計 100重量%
<Formulation Formulation Example 19: Space deodorant>
Any of the combinations of lactone compounds listed in Table 8 Dipropylene glycol 0.1% by weight
Ethanol 10.0% by weight
Citric acid 0.1% by weight
Cyclodextrin 0.05% by weight
Sodium hydroxide appropriate amount
Remainder of purified water
Total 100% by weight
<製剤処方例20:ドライシャンプー1>
表8に記載のラクトン化合物の組み合わせのいずれか
LPG(液化石油ガス) 50重量%
エタノール 残量
オクテニルコハク酸デンプンAl 5重量%
タルク 3重量%
シリカ 2重量%
メントール 0.2重量%
イソプロピルメチルフェノール 0.005重量%
香料 0.1重量%
合計 100重量%
<Formulation Formulation Example 20: Dry Shampoo 1>
Any of the combinations of lactone compounds listed in Table 8 LPG (Liquefied Petroleum Gas) 50% by weight
Ethanol balance Starch octenyl succinate Al 5% by weight
Talc 3% by weight
Silica 2% by weight
Menthol 0.2% by weight
Isopropylmethylphenol 0.005% by weight
Perfume 0.1% by weight
Total 100% by weight
<製剤処方例21:ドライシャンプー2>
表8に記載のラクトン化合物の組み合わせのいずれか
ジメチルエーテル 60重量%
エタノール 残量
ホホバ油 2重量%
オクテニルコハク酸デンプンAl 3重量%
コーンスターチ 3重量%
水 5重量%
メチルパラベン 0.1重量%
ジブチルヒドロキシトルエン 0.05重量%
香料 0.2重量%
合計 100重量%
<Formulation Formulation Example 21: Dry Shampoo 2>
Any of the combinations of lactone compounds listed in Table 8
Ethanol remaining amount Jojoba oil 2% by weight
Starch octenyl succinate Al 3% by weight
Cornstarch 3% by weight
Water 5% by weight
Methylparaben 0.1% by weight
Dibutyl hydroxytoluene 0.05% by weight
Perfume 0.2% by weight
Total 100% by weight
本発明によれば、女性の体臭を若返らせることができるため、女性の加齢臭対策用として好適な外用組成物を提供することができる。また、例えば寝具などの使用等により体臭成分が付着しやすい対象物に対して本発明の組成物を用いることで、付着した体臭成分から発せられる匂いを若返らせる効果が期待できることから、本発明の組成物は繊維製品用、硬質表面用或いは空間用としても好適に用いることができる。さらに本発明によれば、アンチエージング効果のある物質の評価方法を提供することもできる。 INDUSTRIAL APPLICABILITY According to the present invention, since it is possible to rejuvenate body odor of women, it is possible to provide a composition for external use suitable as a countermeasure against aging odor for women. In addition, by using the composition of the present invention on an object to which body odor components tend to adhere due to the use of bedding, etc., the effect of rejuvenating the odor emitted from the adhered body odor components can be expected. The composition can also be suitably used for textiles, hard surfaces or spaces. Furthermore, according to the present invention, it is also possible to provide a method for evaluating a substance having an anti-aging effect.
Claims (11)
若年女性の体臭を構成する匂い成分を補うために用いられる、若年女性臭補充用の組成物。
(式中、Rは、炭素数2~9のアルキル基である。) A composition containing at least a lactone compound represented by the following formula (I),
A composition for replenishing the odor of young women, which is used for supplementing odor components constituting the body odor of young women.
(Wherein, R is an alkyl group having 2 to 9 carbon atoms.)
(式中、Rは、炭素数2~9のアルキル基である。) A body odor model composition for young women, comprising an odor component that constitutes the body odor of young women, and at least a lactone compound represented by the following formula (I) as the odor component.
(Wherein, R is an alkyl group having 2 to 9 carbon atoms.)
女性の加齢臭判定の指標として用いられる、加齢臭判定用指標剤。
(式中、Rは、炭素数2~9のアルキル基である。) A composition containing at least a lactone compound represented by the following formula (I),
An index agent for judging aging odor, which is used as an index for judging aging odor in women.
(Wherein, R is an alkyl group having 2 to 9 carbon atoms.)
(式中、Rは、炭素数2~9のアルキル基である。) A method for evaluating the anti-aging effect of a test substance, wherein the anti-aging effect of a test substance is evaluated using the change in the content of the lactone compound represented by the following formula (I) contained in the body odor as an index due to the use of the test substance.
(Wherein, R is an alkyl group having 2 to 9 carbon atoms.)
(式中、Rは、炭素数2~9のアルキル基である。) An anti-aging substance screening method comprising screening for a substance having an anti-aging effect using, as an index, a change in the content of a lactone compound represented by the following formula (I) contained in body odor due to the use of a test substance.
(Wherein, R is an alkyl group having 2 to 9 carbon atoms.)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2017182355 | 2017-09-22 | ||
JP2017182355 | 2017-09-22 | ||
JP2018021148 | 2018-02-08 | ||
JP2018021148 | 2018-02-08 | ||
JP2021178295A JP7199495B2 (en) | 2017-09-22 | 2021-10-29 | Composition for replenishing young female odor |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2021178295A Division JP7199495B2 (en) | 2017-09-22 | 2021-10-29 | Composition for replenishing young female odor |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2023051985A true JP2023051985A (en) | 2023-04-11 |
Family
ID=65810250
Family Applications (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2019543559A Active JP7036833B2 (en) | 2017-09-22 | 2018-09-10 | Composition for young female odor replenishment |
JP2021168600A Active JP6970855B1 (en) | 2017-09-22 | 2021-10-14 | Anti-aging effect evaluation method and anti-aging substance screening method |
JP2021168599A Active JP6970854B1 (en) | 2017-09-22 | 2021-10-14 | Body odor model composition for young women and index agent for determining aging odor |
JP2021178295A Active JP7199495B2 (en) | 2017-09-22 | 2021-10-29 | Composition for replenishing young female odor |
JP2022202821A Pending JP2023051985A (en) | 2017-09-22 | 2022-12-20 | Composition for young female odor replenishment |
Family Applications Before (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2019543559A Active JP7036833B2 (en) | 2017-09-22 | 2018-09-10 | Composition for young female odor replenishment |
JP2021168600A Active JP6970855B1 (en) | 2017-09-22 | 2021-10-14 | Anti-aging effect evaluation method and anti-aging substance screening method |
JP2021168599A Active JP6970854B1 (en) | 2017-09-22 | 2021-10-14 | Body odor model composition for young women and index agent for determining aging odor |
JP2021178295A Active JP7199495B2 (en) | 2017-09-22 | 2021-10-29 | Composition for replenishing young female odor |
Country Status (3)
Country | Link |
---|---|
JP (5) | JP7036833B2 (en) |
CN (1) | CN111107831B (en) |
WO (1) | WO2019059023A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP7348118B2 (en) * | 2020-03-23 | 2023-09-20 | 株式会社マンダム | Method for producing oil-in-water emulsion composition |
JP7304274B2 (en) * | 2019-11-19 | 2023-07-06 | 株式会社マンダム | cosmetic composition |
CN114302704A (en) * | 2019-11-19 | 2022-04-08 | 株式会社漫丹 | Cosmetic composition |
WO2023111297A1 (en) | 2021-12-17 | 2023-06-22 | Basf Se | Lactones for enhancing the activity of antimicrobial agents |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH11189783A (en) * | 1997-12-26 | 1999-07-13 | Soda Aromatic Co Ltd | Composition for imparting aroma, flavor and aroma and taste, food and drink, perfume, cosmetic and tobacco containing the same added thereto |
JP3584285B2 (en) * | 2001-04-27 | 2004-11-04 | 独立行政法人情報通信研究機構 | Distortion image correction method and apparatus |
JP2002327193A (en) | 2001-04-27 | 2002-11-15 | Kiyomitsu Kawasaki | Compound perfume and washing-softening agent composition containing the compound perfume |
JP5212592B2 (en) | 2007-01-12 | 2013-06-19 | 花王株式会社 | Vigorous perfume composition |
JP2011012016A (en) | 2009-07-01 | 2011-01-20 | Kose Corp | Kit for imparting perfumery to cosmetic |
JP5803002B2 (en) | 2011-06-24 | 2015-11-04 | ライオン株式会社 | Fragrance composition and treatment composition for textile products containing the same |
JP2016117699A (en) | 2014-12-24 | 2016-06-30 | ライオン株式会社 | Aerosol type deodorant composition |
CN106316767B (en) * | 2015-06-19 | 2019-06-11 | 中国石油化工股份有限公司 | Lactone compound aromatization method |
-
2018
- 2018-09-10 CN CN201880061099.2A patent/CN111107831B/en active Active
- 2018-09-10 JP JP2019543559A patent/JP7036833B2/en active Active
- 2018-09-10 WO PCT/JP2018/033443 patent/WO2019059023A1/en active Application Filing
-
2021
- 2021-10-14 JP JP2021168600A patent/JP6970855B1/en active Active
- 2021-10-14 JP JP2021168599A patent/JP6970854B1/en active Active
- 2021-10-29 JP JP2021178295A patent/JP7199495B2/en active Active
-
2022
- 2022-12-20 JP JP2022202821A patent/JP2023051985A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
JP7036833B2 (en) | 2022-03-15 |
JP6970854B1 (en) | 2021-11-24 |
JPWO2019059023A1 (en) | 2020-12-17 |
JP7199495B2 (en) | 2023-01-05 |
JP2022023952A (en) | 2022-02-08 |
JP2022009136A (en) | 2022-01-14 |
CN111107831B (en) | 2022-11-25 |
JP6970855B1 (en) | 2021-11-24 |
JP2022029456A (en) | 2022-02-17 |
WO2019059023A1 (en) | 2019-03-28 |
CN111107831A (en) | 2020-05-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7199495B2 (en) | Composition for replenishing young female odor | |
KR101729863B1 (en) | Compositions | |
JP6449589B2 (en) | Skin and / or hair lightening mixture | |
JP7479113B2 (en) | Medicine containing ginger root CO2 extract and non-therapeutic method thereof | |
KR101904684B1 (en) | Cosmetic compositions | |
KR20150103138A (en) | Skin-exterior anti-ageing composition and production method therefor | |
JP2007529445A (en) | Substances with prebiotic action used in deodorants | |
JP7084165B2 (en) | Detergent composition | |
JP7084567B2 (en) | Personal care composition comprising a glutathione precursor comprising nicotinamide and an amino acid | |
JP2017057146A5 (en) | ||
CN109384650A (en) | 1,2- alkanediol and preparation method thereof | |
CN107922882A (en) | spice mixture | |
JP2018533609A (en) | Reduction of skin ache | |
CN109310620A (en) | A kind of Haircare composition | |
JP2014001155A (en) | Cosmetic oil | |
JP2018021085A (en) | Composition for external use | |
JP6185278B2 (en) | Composition for external use | |
CN116583257A (en) | Compositions comprising (bio) -alkanediols | |
JP6377423B2 (en) | Composition for external use | |
JP7082623B2 (en) | Composition for personal care with cystine | |
JP2021167304A (en) | Epidermal keratinocyte growth stimulator, skin turnover promoter, skin metabolism promoter, topical skin composition, epidermal keratinocyte growth stimulation method, skin turnover promoting method, and skin metabolism promoting method | |
JP6311049B1 (en) | Acne prevention and / or treatment for back acne | |
JP2021167305A (en) | Anti-inflammatory agent, inflammation aging inhibitor and topical skin composition | |
JP6284730B2 (en) | Composition for external use | |
JP2021123532A (en) | Topical skin composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20230117 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20231003 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20231121 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240202 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20240514 |